STRAWBERRY (FRAGARIA X ANANASSA DUCH.) TANNINS AS INGREDIENTS OF NUTRACEUTICALS WITH POTENTIAL ANTI-GASTRITIS PROPERTIES by M. Fumagalli
UNIVERSITÀ DEGLI STUDI DI MILANO 
 
Dottorato in Scienze Farmacologiche Sperimentali e Cliniche 
 
XXXI ciclo 
 
Dipartimento di Scienze Farmacologiche e Biomolecolari 
 
 
 
 
 
Strawberry (Fragaria X ananassa Duch.) tannins 
as ingredients of nutraceuticals with potential 
anti-gastritis properties 
 
Settore Scientifico Disciplinare Bio/14 
 
 
 
 
Marco FUMAGALLI 
 
 
 
Tutor: Prof. Mario DELL’AGLI 
 
Coordinatore: Prof. Alberico L. CATAPANO 
 
 
 
A.A. 2017 - 2018 
  
Table of contents 
 
1.	INTRODUCTION	................................................................................................................................	1 1.1	INFLAMMATION	............................................................................................................................................................	2 1.2	GASTRITIS	........................................................................................................................................................................	2 1.2.1	Acute	gastritis	........................................................................................................................................................	3 1.2.2	Chronic	gastritis	....................................................................................................................................................	4 1.3	GASTRITIS	RELATED	TO	HELICABACTER	PYLORI	..........................................................................................	5 1.3.1	Helicobacter	pylori	infection	............................................................................................................................	5 1.3.2	H.	pylori	and	oxidative	stress	........................................................................................................................	10 1.4	ROLE	OF	CYTOKINES	IN	THE	PATHOLOGY	....................................................................................................	13 1.5	NF-kB	TRANSCRIPTION	FACTOR	........................................................................................................................	16 1.5.1	Structure	...............................................................................................................................................................	16 1.5.2	Canonical	pathway	............................................................................................................................................	17 1.5.3	Non-canonical	pathway	..................................................................................................................................	17 1.5.4	Role	of	the	NF-kB	in	gastric	inflammation	.............................................................................................	18 1.5.5	Natural	inhibitors	of	NF-κB	...........................................................................................................................	19 1.6	Nrf2	TRANSCRIPTION	FACTOR	...........................................................................................................................	20 1.6.1	Structure	...............................................................................................................................................................	20 1.6.2	Mechanism	of	Keap1-Nrf2	pathway	..........................................................................................................	21 1.6.3	Benefits	and	risks	of	Keap1-Nrf2	pathway	.............................................................................................	21 1.7	PHARMACOLOGICAL	THERAPIES	......................................................................................................................	23 1.7.1	Different	pharmacological	treatments	.....................................................................................................	23 1.7.2	Therapy	failure	...................................................................................................................................................	24 1.8	TANNINS	........................................................................................................................................................................	25 1.8.1	Hydrolizable	tannins	........................................................................................................................................	25 1.8.2	Condensed	tannins	...........................................................................................................................................	26 1.9	FRAGARIA	X	ANANASSA	DUCH.	.............................................................................................................................	27 1.9.1	Botanical	description	.......................................................................................................................................	27 1.9.2	Nutritional	profile	.............................................................................................................................................	27 1.9.3	Polyphenolic	content	.......................................................................................................................................	28 1.9.4	Factors	affecting	micronutrients	and	polyphenols	content	............................................................	31 1.9.5	Biological	activities	of	Fragaria	X	ananassa	Duch.	..............................................................................	32 1.10	FRAGARIA	VESCA	L.	.................................................................................................................................................	36 1.10.1	Botanical	description	....................................................................................................................................	36 1.10.2	Polyphenolic	content	.....................................................................................................................................	36 1.10.3	Biological	activities	of	Fragaria	vesca	L.	...............................................................................................	37 
2.	AIM	OF	THE	WORK	........................................................................................................................	38 
  
3.	MATERIALS	AND	METHODS	.......................................................................................................	42 3.1	CELL	CULTURE	............................................................................................................................................................	43 3.1.1	AGS	cells	................................................................................................................................................................	43 3.1.2	GES-1	cells	............................................................................................................................................................	43 3.1.3	Maintenance	of	cell	culture	...........................................................................................................................	43 3.2	BACTERIAL	CULTURE	..............................................................................................................................................	44 3.3	CELL	TREATMENTS	..................................................................................................................................................	44 3.4	 PREPARATION	 OF	 FRAGARIA	 EXTRACTS	 AND	 ISOLATION	 OF	 PURE	 COMPOUNDS	(AGRIMONIIN	AND	CASUARICTIN)	...........................................................................................................................	45 3.5	QUANTIFICATION	OF	TANNIN-ENRICHED	EXTRACTS	AND	IN	VITRO	DIGESTED	EXTRACT	..	46 3.6	CYTOTOXICITY	ASSAY	..............................................................................................................................................	47 3.7	PLASMIDS	AMPLIFICATION	..................................................................................................................................	48 3.8	TRASIENT	TRANSFECTION	...................................................................................................................................	48 3.8.1	Calcium	phosphate	method	..........................................................................................................................	48 3.8.2	Lipofectamine	method	....................................................................................................................................	49 3.9	NF-kB	AND	Nrf2	NUCLEAR	TRANSLOCATION	..............................................................................................	50 3.9.1	Nuclear	and	cytoplasmatic	extraction	......................................................................................................	50 3.9.2	Protein	quantification	.....................................................................................................................................	50 3.9.3	ELISA	assay	..........................................................................................................................................................	51 3.10	IN	VITRO	GASTRIC	DIGESTION	OF	FRAGARIA	X	ANANASSA	EXTRACT	............................................	51 3.11	MEASUREMENT	OF	THE	RELEASE	OF	PRO-INFLAMMATORY	MEDIATORS	.................................	51 3.11.1	IL-8	release	........................................................................................................................................................	51 3.11.2	IL-6	release	........................................................................................................................................................	52 3.11.3	MMP-9	release	..................................................................................................................................................	53 3.12	ORAC	ASSAY	(OXYGEN	RADICAL	ABSORBANCE	CAPACITY)	...............................................................	53 3.13	GENE	EXPRESSION	.................................................................................................................................................	54 3.13.1	RNA	extraction	.................................................................................................................................................	54 3.13.2	cDNA	synthesis	................................................................................................................................................	54 3.13.3	qPCR	.....................................................................................................................................................................	54 3.14	STATISTICAL	ANALYSIS	........................................................................................................................................	55 
4.	RESULTS	............................................................................................................................................	56 4.1	INHIBITORY	ACTIVITY	OF	FRAGARIA	EXTRACTS	ON	IL-8	RELEASE	AND	NF-kB	SIGNALING	IN	TNFa-TREATED	AGS	CELLS	..........................................................................................................................................	57 4.1.1	 Inhibitory	 effect	 of	 Fragaria	X	 ananassa	 extract	 on	 IL-8	 and	 NF-kB	 pathway	 in	 TNFa-treated	AGS	cells	...........................................................................................................................................................	57 4.1.2	Inhibitory	effect	of	Fragaria	vesca	extract	on	IL-8	and	NF-kB	pathway	in	TNFa-treated	AGS	cells	.....................................................................................................................................................................................	58 4.1.3	Inhibitory	effect	of	Fragaria	X	ananassa	extract,	after	in	vitro	gastric	digestion,	on	IL-8	and	NF-kB	pathway	in	TNFa-treated	AGS	cells	........................................................................................................	59 4.2	CHEMICAL	COMPOSITION	OF	TANNIN-ENRICHED	EXTRACTS	FROM	STRAWBERRIES	...........	61 
  
4.3	INHIBITORY	ACTIVITY	OF	PURE	TANNINS	AND	ELLAGIC	ACID	ON	IL-8	RELEASE	AND	NF-kB	SIGNALING	IN	TNFa-TREATED	AGS	CELLS	...........................................................................................................	62 4.3.1	Inhibitory	effect	of	agrimoniin	on	IL-8	and	NF-kB	pathway	in	TNFa-	treated	AGS	cells	...	63 4.3.2	Inhibitory	effect	of	casuarictin	on	IL-8	and	NF-kB	pathway	in	TNFa-	treated	AGS	cells	...	64 4.3.3	Inhibitory	effect	of	procyanidins	B1	on	IL-8	and	NF-kB	pathway	in	TNFa-treated	AGS	cells	..............................................................................................................................................................................................	65 4.3.4	Inhibitory	effect	of	ellagic	acid	on	IL-8	and	NF-kB	pathway	in	TNFa-	treated	AGS	cells	...	66 4.4	SUMMARY	OF	IC50	VALUES	..................................................................................................................................	67 4.5	CHARACTERIZATION	OF	GES-1	CELL	LINE	....................................................................................................	68 4.5.1	TNFa-induced	IL-8,	IL-6	and	MMP-9	release	and	NF-kB	driven	transcription	in	GES-1	and	AGS	cells	............................................................................................................................................................................	68 4.5.2	TNFa-induced	pro-inflammatory	genes	in	GES-1	and	AGS	cells	..................................................	70 4.6	INHIBITORY	ACTIVITY	OF	STRAWBERRY	TANNINS	ON	NF-kB	PATHWAY	AND	THE	RELEASE	OF	PRO-INFLAMMATORY	MEDIATORS	IN	GES-1	CELLS	..................................................................................	72 4.6.1	Fragaria	X	ananassa	extract	inhibit	NF-kB	driven	transcription	and	the	release	of	IL-8,	IL-6	and	MMP-9	in	GES-1	cells	......................................................................................................................................	72 4.6.2	Pure	ellagitannins	inhibit	NF-kB	driven	transcription	and	the	release	of	IL-8,	IL-6	and	MMP-9	in	GES-1	cells	..............................................................................................................................................................	73 4.7	AGRIMONIIN	AND	CASUARICTIN	INHIBIT	THE	EXPRESSION	OF	SOME	PRO-INFLAMMATORY	GENES	IN	GES-1	AND	AGS	CELLS	...............................................................................................................................	75 4.8	 INHIBITORY	 ACTIVITY	 OF	 FRAGARIA	 X	ANANASSA	 EXTRACT	 ON	H.	 PYLORI-INDUCED	 IL-8	RELEASE	................................................................................................................................................................................	76 4.9	ANTIOXIDANT	ACTIVITIES	OF	STRAWBERRY	TANNINS	.........................................................................	77 4.9.1	Antioxidant	capacity	of	the	strawberry	extract	and	pure	ellagitannins	....................................	77 4.9.2	Agrimoniin	and	Casuarictin	inhibit	Nrf2	nuclear	translocation	in	GES-1	and	AGS	cells	....	77 
5.	DISCUSSION	.....................................................................................................................................	79 
6.	BIBLIOGRAPHY	..............................................................................................................................	86 
 
 
 
   1 
 
 
 
 
 
 
 
 
 
 
 
 
1. INTRODUCTION 
 
   2 
1.1 INFLAMMATION 
	When	a	tissue	receives	an	injurious	stimulus	causing	death	or	suffering	of	some	of	its	cells,	it	generates	a	series	of	tissue	and	vascular	reactions	leading	to	the	eradication	of	the	trigger	agent,	the	removal	of	cellular	debris	and	the	repair	of	the	damaged	tissue.	These	processes,	which	determine	an	accumulation	of	fluids	and	cells	in	the	extravascular	space,	are	defined	inflammation.		The	inflammatory	process	aims	to:	circumscribe	the	lesion,	eliminate	the	cause	of	damage	and	repair	damaged	tissues	to	restore	their	function.		The	damaging	agents	are	divided	in	exogenous	factors	(viral,	bacterial	or	fungal	infections,	traumas,	 environmental	 toxic	 substances,	 etc.)	 and	 endogenous	 factors	 (tumors,	autoimmune	diseases,	etc.).	Inflammation	and	tissue	repair	can	become	harmful	to	the	organism,	causing	tissue	damage,	when	the	stimulation	persists	for	a	long	time	and	the	phases	of	destruction,	inflammation	and	repair	are	activated	simultaneously	in	an	uncontrolled	way.	On	the	basis	of	the	vascular	response,	cellular	infiltrate	and	nature	of	the	injurious	agent,	inflammation	 can	 be	 distinguished	 in	 acute	 and	 chronic.	 The	 first	 is	 relatively	 short	 and	characterized	by	movement	of	fluids	and	cells	from	the	vessels	to	the	extra	vascular	tissues,	in	 order	 to	 circumscribe	 the	 lesion,	 to	 eliminate	 the	 causes	 of	 damage	 and	 to	 repair	 the	tissues.	Chronic	 inflammation,	on	 the	other	hand,	 is	a	 long-lasting	 inflammation	 in	which	active	 inflammation,	 tissue	 destruction	 and	 healing	 occur	 at	 the	 same	 time.	 Both	 are	regulated	 and	 amplified	 by	 a	wide	 range	 of	 soluble	mediators	 having	 plasma	 or	 cellular	origin,	 that	 participate	 as	 positive	 or	 negative	 signals	 to	 the	 development	 of	 the	inflammatory	response	(Celotti	F.,	2013).	
	
1.2 GASTRITIS 	The	stomach	 is	anatomically	divided	 in	several	portions,	 called:	 cardia,	 fundus,	body	and	antrum.	The	gastric	mucosa	is	the	layer	of	the	stomach	which	contains	the	glands	and	the	gastric	pits.	 In	humans	 it	 is	 about	1	mm	 thick	and	 it	 is	 constituted	of	 a	 simple	 columnar	epithelium,	lamina	propria	(thin	layer	of	connective	tissue),	and	muscularis	mucosae	(a	thin	layer	of	muscle,	located	outside	the	lamina	propria	and	separated	from	the	submucosa).	The	gastric	epithelium	consists	of	a	monolayer	of	cells	covered	by	mucus	and	that	invaginate	in	order	to	form	functional	gastric	glands	or	pits,	which	can	be	cardiac,	oxyntic	and	pyloric.	Cardiac	glands	are	located	closest	to	the	oesophagus	and	lined	mostly	by	mucus	secreting	
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cells;	the	oxyntic	glands	in	the	fundus	and	corpus	of	the	stomach	have	chief	cells	that	produce	pepsinogen,	 parietal	 cells	 which	 release	 hydrochloric	 acid	 and	 intrinsic	 factor	 and	enterochromaffine-like	cells	responsible	for	histamine	release;	pyloric	glands	in	the	antrum	contain	G	and	D	cells	are	responsible	for	gastrin	and	somatostatin	production,	respectively.	Gastritis	 is	 an	 inflammation	 of	 the	 gastric	mucosa	with	 different	 clinical,	 etiological	 and	etiopathogenetic	 characteristics.	 They	 are	 generally	 divided	 in	 acute	 gastritis	 (with	infiltration	of	neutrophils)	and	chronic	gastritis	(with	infiltration	of	lymphocytes	and	plasma	cells	into	the	lamina	propria)	(Celotti	F.,	2013).	
		
	
																																													
1.2.1 Acute gastritis 
 Acute	gastritis	is	characterized	by	a	diffuse,	but	transient,	inflammation	of	the	mucosa,	with	possible	erosion	(loss	of	 the	superficial	 layer	of	 the	mucosa),	which,	although	 it	does	not	exceed	the	muscularis	mucosae,	can	cause	bleeding.		The	most	significant	clinical	symptom	is	pyrosis	(heartburn).	The	majority	of	these	gastritis	resolve	spontaneously	in	a	few	days	with	the	re-epithelialization	of	the	mucosa.	The	most	important	pathogenetic	elements	are	mucosa	 ischemia,	direct	damage	to	 the	mucosa	and	hyperchlorhydria.	Although	in	some	patients	the	cause	of	the	disease	is	not	known,	it	is	often	associated	 with	 stress,	 use	 of	 drugs	 (NSAIDs	 and	 chemotherapeutics),	 abuse	 of	 alcohol,	smoking,	ingestion	of	corrosive	substances,	presence	of	uremia,	duodenal	reflux	or	pathogen	infections	(mostly	induced	by	Helicobacter	pylori,	in	which	gastritis	evolves	in	chronic	form).	
regulated by changing pH[13] and by contact with gastric 
epithelial cells[14]. 
OipA
The outer inflammatory protein A (OipA) is a 34kDa 
cell surface protei  encoded by the hopH gene and was 
initially described as a promoter for IL-8 production 
in T4SS-independent manner and increased inflamma-
tion[15]. OipA expression was shown to be controlled by 
a slipped-strand repair mechanism related to the number 
of  CT dinucleotide repeats at the 5′ e d f  the gene and 
is correlated with severe clinical outcomes, including 
duodenal ulcer and gastric cancer[15,16]. Subsequent studies 
showed that oipA mutant strains have reduced adherence 
to gastric cancer cell lines, AGS and Kato-Ⅲ although 
the host receptor for the OipA adhesion has not been 
identified[15]. 
H. PYLORI VIRULENCE FACTORS THAT 
AFFECT THE GASTRIC EPITHELIUM 
Among the armamentarium of  virulence factors ex-
pressed by H. pylori, in addition to the adhesins described 
above, there are bacterial products that are translocated 
into host epithelial cells via a type 4 secretion system 
(T4SS) encoded within the cag pathogenicity island (cag 
PAI) as well as factors that are secreted by H. pylori and 
exert their effects independently of  the intact bacteria 
interacting with the epithelium. In fact, it has been esti-
mated that at any given time only 20% of  the colonizing 
bacteria are in direct interaction with the epithelium[17]. 
Cag PAI
The H. pylori cag pathogenicity island (PAI) is perhaps 
the most studied virulence factor. Cag PAI consists of  
a cluster of  31 genes, most of  which code for a T4SS. 
The T4SS is in essence a needle-like structure that pen-
etr tes the epithelial cell membrane and translocates H. 
pylori products into epithelial cells. One of  the products 
injected is the effector protein CagA[18], which is en-
coded at one end of  cagPAI and does not seem to have 
homologues in other bacterial species. CagA is perhaps 
the most virulent factor associated with H. pylori and its 
presence in an infecting strain is regarded as a risk factor 
for peptic ulcer disease and gastric cancer. Once CagA is 
delivered into host epithelial cells, it undergoes tyrosine 
phosphorylation at Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs 
in the C terminus by Src and Abl kinases[19-21]and initiate 
signaling events described below in detail. There are four 
major types of  EPIYA motifs (A, B, C, and D) based on 
the specific amino acid sequence bordering the EPIYA 
motif  on both sides[22]. EPIYA-A, EPIYA-B and EPI-
YA-C motifs in tandem are found in “western strains” 
while CagA with EPIYA-A, EPIYA-B and EPIYA-D 
motifs are found in “East-Asian strains”[23]. It should be 
pointed out that these motifs contribute to the polymor-
phism in the C-terminus of  the protein and are found as 
tandem repeats ranging in number from one to seven[24]. 
The quantity of  EPIYA motifs is proportional to the 
levels of  phosphorylation and the effects seen in epithe-
lial cells[25], which will be described in detail below. These 
properties of  CagA and its role in pathogenesis are well 
known and accepted by experts in the field. 
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Figure 1  Helicobacter pylori colonization the antrum of the stomach. The gastric epithelium consists of a single layer of cells that invaginate in order to form car-
diac, oxyntic or/and pyloric gland. Cardiac glands are located closest to the esophagus, while the oxyntic glands located in the fundus and corpus of the stomach and 
contain chief cells, parietal cells and enterochromaffine-like cells (ECL). Pyloric glands which located in the antrum contain G and D cells. H. pylori colonization is only 
limited to the antrum of the stomach. 
Fundus
Body
Antrum
Esophagus
Cardia
Pyloric sphincter
Duodenum 
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Alzahrani S et al . H. pylori  and gastric epithelial cell interactions
Figure	 1.	 Human	 stomach	 and	 distribution	 of	 the	 different	 types	 of	 cells.	 (Image	 from	Alzahrani	et	al.	2014).	
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v Stress:	 situations	of	 severe	physical	 stress,	 such	as	physical	 trauma,	burns	or	serious	infections,	can	cause	gastritis.	
v Use	of	analgesic	and	anti-inflammatory	drugs:	high	use	or	abuse	of	non-steroidal	anti-inflammatory	drugs	(NSAIDs),	such	as	acetylsalicylic	acid,	ibuprofen,	naproxen,	may	lead	to	the	gastric	mucosa	damage,	which	can	evolve	to	gastritis	or	ulcer.	The	elderly	people	are	the	most	at	risk	due	to	increased	vulnerability	of	the	mucosa	(senile	atrophy)	and	prolonged	contact	between	NSAIDs	and	gastric	mucosa	(delay	in	gastric	emptying).	These	 effects	 are	 explained	 by	 two	 main	 mechanisms:	 the	 first	 one	 is	 due	 to	 direct	damage	 to	 the	gastric	mucosa,	while	 the	second	one	 is	due	 to	 the	 inhibition	of	COX-1	enzyme,	which	is	responsible	for	prostaglandins	(PGs)	synthesis;	PGs	stimulate,	at	the	gastric	level,	the	mucus	and	bicarbonate	production	and	participate	in	the	maintenance	of	adequate	local	blood	flow,	thus	carrying	out	a	protective	effect	on	the	mucosa.				
	
v Alcohol	Abuse:	ethanol	is	able	to	irritate	and	corrode	the	gastric	mucosa,	making	the	stomach	more	vulnerable	to	digestive	juices.	
	
v Bile	reflux:	bile,	the	substance	that	contributes	to	the	absorption	and	digestion	of	fats,	is	produced	by	the	liver	and	it	is	released	after	meals	in	the	upper	part	of	the	small	intestine.	In	normal	conditions,	the	pyloric	sphincter	prevents	the	bile	reflux	into	the	stomach,	but	in	the	presence	of	an	altered	functionality	of	this	sphincter,	bile	can	reach	the	stomach	causing	irritation	followed	by	gastric	inflammation.		
1.2.2 Chronic gastritis 
	Chronic	gastritis	is	divided	in	two	different	types,	called	A	and	B.	These	two	different	kinds	of	 chronic	 gastritis	 show	 different	 etiology,	 localization	 and	 associated	 symptomatology.	Type	A	gastritis	probably	has	an	autoimmune	origin,	in	90%	of	cases	there	are	anti-parietal	cells	antibodies	and	in	50%	of	cases	anti-intrinsic	factor	antibodies;	it	is	localized	mainly	at	the	 level	 of	 the	 body	 and	 the	 fundus	 of	 the	 stomach	 and	 is	 characterized	 by	 hypo-	 or	achlorhydria,	pernicious	anemia	(due	to	the	destruction	of	the	parietal	cells),	hyperplasia	of	G	 cells	 and	 hypergastremia.	 Parietal	 cells	 produce	 hydrochloric	 acid	 and	 intrinsic	 factor,	their	 progressive	 decrease	 may	 produce	 an	 increase	 of	 the	 pH	 of	 the	 stomach	(hypochlorhydria	and	achlorhydria)	and	a	loss	of	the	intrinsic	factor	that	compromises	the	absorption	of	vitamin	B12,	causing	pernicious	anemia.	Type	B	gastritis	is	the	most	common	form,	it	is	mainly	localized	in	the	antrum	of	the	stomach	but,	if	it	persists	for	a	long	time	(15-20	years),	the	entire	stomach	can	be	involved.	Type	B	gastritis	is	associated	with	hypochlorhydria,	but	not	with	pernicious	anemia.	The	etiology	of	
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the	disease	 is	 linked	 to	 the	presence	of	Helicobacter	pylori	 in	 the	gastric	mucosa	and	 the	eradication	of	 the	bacterium	 leads	 to	 the	 resolution	of	histological	 alterations	 (Celotti	 F.,	2013).		
1.3 GASTRITIS RELATED TO HELICABACTER PYLORI 	
1.3.1 Helicobacter pylori infection 
 
Helicobacter	pylori	(H.	pylori)	is	a	Gram-negative	bacterium,	specialized	in	the	colonization	of	the	human	stomach	(Warren	J.R.	et	al.,	1983),	a	unique	ecological	niche	characterized	by	acid	 condition	 lethal	 for	 most	 microbes.	 H.	 pylori	 is	 so	 well	 adapted	 to	 this	 unfriendly	environment	that,	after	the	first	infection	which	usually	occurs	early	in	life,	it	establishes	a	life-long	 chronic	 infection	 (Achtman	 M.	 et	 al.,	 2001).	 The	 selection	 of	 a	 niche	 with	 no	competition	and	the	ability	to	establish	a	chronic	infection	make	H.	pylori	one	of	the	most	successful	 human	 bacterial	 parasites,	 which	 colonizes	 more	 than	 half	 of	 the	 human	population	(Parsonnet	J.,	1995).	
H.	pylori	 colonization	 is	mainly	 limited	 to	 the	antrum	of	 the	 stomach.	The	most	 common	consequence	 of	 H.	 pylori	 infection	 is	 chronic	 gastritis,	 but	 some	 infected	 people	 are	asymptomatic,	 with	 moderate	 inflammation	 detectable	 only	 by	 biopsy	 and	 histology.	However,	 chronic	 infection	 may	 lead	 to	 the	 development	 of	 severe	 gastroduodenal	pathologies,	 including	stomach	and	duodenal	ulcers	 (around	10-15%	of	 infected	people),	adenocarcinomas	and	stomach	lymphomas	(around	1-2%	of	infected	people).	The	different	outcomes	 of	 the	 infection	 are	 believed	 to	 be	 substantially	 influenced	 by	 an	 excessive	 or	inappropriate	reaction	of	the	host,	bacterial	polymorphisms	and	environmental	factors	(Go	M.F.,	1997;	Peek	R.M.	et	al.,	2006;	Parsonnet	J.	et	al.,	1991;	Moss	S.	et	al.,	1992;	Ernst	P.B.	et	al.,	2000).		In	south	and	east	Europe,	South	America,	Asia	and	Africa	the	prevalence	of	H.	pylori	in	the	population	is	often	higher	than	50%.	Low	socioeconomic	conditions	have	been	associated	with	 the	 infection	 (Den	 Hollander	W.J.	 et	 al.,	 2013),	 but	 the	way	 of	 transmission	 is	 still	unclear,	 probably	 interpersonal	 and	 environmental	 transmission,	 such	 as	 drinking	contaminated	water,	appear	to	be	the	main	routes.		The	ability	of	the	bacterium	to	colonize	the	harsh	environment	of	the	human	stomach	and	to	induce	 inflammation	 is	 achieved	 through	 a	 combination	 of	 virulence	 factors,	 including	urease,	 adhesion	 molecules	 and	 toxic	 proteins	 (CagA	 and	 VacA).	 Different	 studies	 have	shown	the	multiple	effects	that	H.	pylori	has	on	gastric	epithelial	cells,	such	as	induction	of	apoptosis,	cell	proliferation,	and	destruction	of	epithelial	cell	junctions	(Xia	H.H.	et	al.,	2001).	
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v Urease	
H.	pylori	dedicates	several	genes	to	the	biosynthesis	of	a	cytosolic	urease,	a	Ni2+	containing	enzyme	(Hu	L.-T.	et	al.,	1990;	Labigne	A.	et	al.,	1991),	which	hydrolyses	urea	into	NH3	and	CO2;	this	enzyme	is	a	dodecamer	of	six	UreA	and	six	UreB	subunits.	Urea	is	taken	up	by	H.	
pylori	 through	a	proton	gated	 channel	 (Weeks	D.L.	 et	 al.,	 2000).	 Its	hydrolysis	by	urease	generates	ammonia	that	buffers	the	cytosol	and	periplasm	generating	a	neutral	layer	around	the	bacterial	surface.	The	essential	role	of	urease	as	a	virulence	 factor	 is	 confirmed	since	urease-defective	H.	pylori	mutants	cannot	colonize	the	stomach	(Eaton	K.A.	et	al.,	1991).	 Urea	is	toxic	to	the	bacterium	at	neutral	pH	because	an	unfavorable	alkaline	environment	is	generated	 (Clyne	M.	 et	 al.,	 1995).	 Therefore,	 the	 urea	 channel	 is	 regulated	 positively	 by	protons,	opening	at	acidic	pH	values	to	allow	more	urea	in	to	buffer	cytosolic	and	surface	pH,	and	closing	at	neutral	pH	to	avoid	over	alkalinization.	 Urease,	 among	 the	 soluble	 proteins	 released	 by	 H.	 pylori,	 might	 also	 help	 to	 recruit	neutrophils	 and	 monocytes	 in	 the	 inflamed	 mucosa	 leading	 to	 production	 of	 pro-inflammatory	cytokines.	The	local	production	of	cytokines	by	urease-stimulated	monocytes	may	play	a	central	role	in	the	development	of	H.	pylori	gastric	inflammation	(Harris	P.R.	et	al.,	1996).		
v Flagella	Although	well	equipped	to	survive	in	strong	acid,	H.	pylori	is	not	an	acidophile	bacterium	and	needs	to	leave	the	lumen,	also	to	avoid	discharge	in	the	intestine.	 With	 its	 flagella,	H.	 pylori	 can	 reach	 the	 thick	mucus	 layer	 that	 covers	 and	 protects	 the	epithelial	lining	of	the	stomach	mucosa.	Here,	propelled	by	its	flagella,	the	helicoidal	shaped	bacterium	travels	across	the	viscous	mucus	film. Mucus	has	defined	permeability	properties	and	acts	as	a	semipermeable	barrier	that	allows	the	 flow	 of	 protons	 from	 the	 H+	 releasing	 oxyntic	 cells	 to	 the	 stomach	 lumen,	 but	 not	backwards.	On	the	contrary,	it	is	poorly	permeable	to	bicarbonate	anions.	The	net	result	is	that	there	is	a	large	pH	gradient	from	the	stomach	lumen	(strongly	acid)	to	the	apical	surface	of	stomach	mucosa	(only	slightly	acidic).	Non-motile	mutants	cannot	colonize	the	stomach	(Josenhans	C.	et	al.,	2001;	Bhaskar	K.R.	et	al.,	1992). 	
v Adhesion	molecules	An	essential	 step	 in	 the	 colonization	by	H.	pylori	and	 its	ability	 to	mediate	effects	on	 the	gastric	epithelium	is	the	establishment	of	intimate	interactions	with	the	epithelial	surface.	These	interactions	are	largely	mediated	by	outer	membrane	proteins	(OMPs),	that	serve	as	
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adhesins.	The	H.	pylori	genome	has	more	than	30	genes	which	encode	OMPs	that	are	divided	into	Hop	(Helicobacter	outer	membrane	pro	teins)	and	Hor	(hop-related)	subgroups.	The	Hop	group	of	proteins	contains	H.	pylori	adhesion	molecules	such	as	BabA,	SabA,	AlpA/B,	HopZ	and	OipA	(Backert	S.	et	al.,	2011).	BabA	binds	to	the	Lewisb	antigen	of	human	gastric	epithelial	cells;	this	binding	enhances	the	type	 4	 secretion	 system’s	 ability	 to	 exert	 the	 pathogenicity	 of	 H.	 pylori	 that	 includes	triggering	production	of	pro-inflammatory	cytokines	(Ishijima	N.	et	al.,	2011);	SabA	serves	as	a	 receptor	 for	 the	bacteria,	which	uses	sialic	acid	binding	adhesion	protein	 (SabA),	an	outer	membrane	protein,	to	bind	to	sialyl-Lewisx	(Mahdavi	J.	et	al.,	2002).	In	the	early	stages	of	 infection,	 binding	 between	 BabA	 and	 Lewisb	 is	 essential;	 however,	 with	 increased	inflammation,	 the	 expression	 of	 sialyl-Lewisx	 antigen	 also	 increases;	 thus,	H.	 pylori	SabA	enhances	the	adherence	to	the	inflamed	gastric	mucosa	(Yamaoka	Y.,	2008).			
v H.	pylori	neutrophil-activating	protein	(HP-NAP)	
H.	pylori	does	not	invade	the	epithelial	layer,	and	its	components	and	metabolites	have	to	permeate	 the	 epithelial	 barrier	 to	 induce	 the	 chemotaxis	 and	 activation	 of	 inflammatory	cells.		A	 150-kDa	 protein	 oligomer	 composed	 of	 identical	 15-kDa	 subunits,	 called	 H.	 pylori	neutrophil-activating	 protein	 (HP-NAP),	 was	 shown	 to	 promote	 the	 adhesion	 of	 human	neutrophils	to	endothelial	cells	and	the	production	of	reactive	oxygen	radicals	(Yoshida	N.	et	al.,	1993;	Evans	D.J.	et	al.,	1995).	Purified	recombinant	HP-NAP,	free	of	LPS,	is	chemotactic	for	 human	 neutrophils	 and	 monocytes,	 indicating	 that	 it	 might	 have	 a	 role	 in	 the	accumulation	of	 these	cells	at	 the	site	of	 infection.	HP-NAP	is	a	powerful	stimulant	of	 the	production	of	reactive	oxygen	radicals	and	acts	through	a	cascade	of	intracellular	activation	events:	 it	 includes	 the	 increase	 of	 cytosolic	 Ca2+	 and	 the	 phosphorylation	 of	 proteins	(cytosolic	 subunits	of	 the	NADPH	oxidase),	 leading	 to	 the	assembly	of	 functional	NADPH	oxidase	on	the	neutrophil	plasma	membrane	(Satin	B.	et	al.,	2000).	NADPH	oxidase	produces	superoxide	anions	and	reactive	oxygen	intermediates	(ROIs).		
v Vacuolating	cytotoxin	A	(VacA)	Vacuolating	cytotoxin	A	(VacA)	is	a	95-kDa	protein	of	H.	pylori	that	induces	the	formation	of	large	cytoplasmic	vacuoles	(Cover	T.L.	et	al.,	1992).	It	is	an	important	antigen	in	the	human	immune	response	to	H.	pylori,	playing	a	key	role	as	virulence	factor	of	H.	pylori,	which	confers	a	strong	competitive	advantage	to	wild-type	strains	with	respect	to	VacA-defective	mutants	in	the	colonization	of	the	stomach	(Salama	N.	et	al.,	2001).	The	toxin	is	an	oligomer. 
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VacA	inhibits	the	stimulation	of	T-cell	clones,	specific	for	epitopes	generated	in	the	antigen	processing	compartment.	H.	pylori	does	depress	the	local	immune	response	because	VacA-specific	CD4+	T	 cells	 are	 found	at	 low	 levels	 in	 the	 stomach	mucosa	of	H.	pylori-infected	subjects	(D’Elios	M.M.	et	al.,	1997);	moreover,	persistent	H.	pylori	infection	down-modulates	specific	CD8+	cytotoxic	T	cell	response,	prolonging	viral	infection	(Shirai	M.	et	al.,	1998).	The	inhibition	of	local	antigen	processing	by	VacA	could	be	part	of	a	strategy	of	survival	for	H.	
pylori	that	could	significantly	contribute	to	chronic	infection	of	the	human	stomach.		It	 binds	 to	 the	 apical	 portion	 of	 epithelial	 cells	 and	 inserts	 into	 the	 plasma	 membrane,	forming	a	hexameric	anion-selective	channel	of	 low	conductance.	These	channels	 release	bicarbonate	and	organic	anions	from	the	cell	cytosol	to	support	bacterial	growth.	The	toxin	channels	 are	 slowly	 endocytosed	 and	 eventually	 reach	 late	 endosomal	 compartments,	increasing	 their	 permeability	 to	 anions	 with	 enhancement	 of	 the	 electrogenic	 vacuolar	ATPase	 (v-ATPase)	proton	pump.	 In	 the	presence	of	weak	bases,	 including	 the	 ammonia	generated	 by	 the	 Helicobacter	 pylori	 urease,	 osmotically	 active	 acidotropic	 ions	 will	accumulate	in	the	endosomes.	This	leads	to	water	influx	and	vesicle	swelling,	an	essential	step	in	vacuole	formation	(Ricci	V.	et	al.,	1997;	Molinari	M.	et	al.,	1997;	Papini	E.	et	al.,	1997).	VacA	 toxin	 alters	 tight	 junctions	 and	 increases	 the	 paracellular	 route	 of	 permeability	providing	iron,	nickel	and	other	nutrients,	essential	for	H.	pylori	growth,	from	the	underlying	mucosa	(Pelicic	V.	et	al.,	1999).	 VacA	associates	with	mitochondria	and,	alone	or	in	cooperation	with	endogenous	proteins,	it	 promotes	 cytochrome	 c	 release,	 leading	 to	 cell	 death	 by	 apoptosis	 (Galmiche	 A.	 et	 al.,	2000).			
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membrane of cells, where it forms anion-specific chan-
nels of low conductance59. The electrophysiological
properties of these channels are similar to those of the
hexameric channels that VacA forms in planar lipid
bilayers after low-pH activation60,61.
The secreted VacA toxin has a strong tendency to
oligomerize into rosettes62 (FIG. 4). The oligomeric form
of VacA has little vacuolating activity, but it is activated
by short exposure to acid or alkaline media and,
remarkably, it is not denatured at pH 1.5 and has an
unusual resistance to pepsin digestion63,64. Low pH dis-
sociates the VacA oligomer into monomers, exposing
hydrophobic patches on the surface, which mediate its
insertion into biological membranes65.
Polarized epithelial monolayers develop TRANS-
EPITHELIAL RESISTANCE (TER) by sealing the cell borders of
adjacent cells through TIGHT JUNCTIONS and other intercel-
lular structures. The measurable TER correlates with the
degree of cell sealing66.Acid-activated VacA added api-
cally to epithelial monolayers grown on filters, induces a
rapid drop of TER with a concomitant increase in
paracellular permeability to small organic molecules
and to Fe3+ and Ni2+ (REF. 67) (FIG. 4). H. pylori grown on
the APICAL SURFACE of the epithelial cells causes the same
increase in permeability, whereas VacA-defective H.
pylori strains do not68. These results indicate that one
function of VacA might be to increase the supply of
essential nutrients — necessary for growth of H. pylori
— from the underlying tissue. This TER effect of VacA
could be mediated through specific interactions with the
recently identified cytosolic protein VIP54 (REF. 69).
VacA activity is blocked by cytochalasin D and by
dominant-negative mutants of proteins involved in
endocytosis58,70, indicating that plasma-membrane-
inserted VacA is endocytosed58 through an ATP- and
actin-dependent mechanism. At least part of VacA is
internalized through non-clathrin-coated structures
and reaches early and then late endosomes71,72, where
the VacA channel is expected to preserve its functions as
it is active at low pH.
VacA-induced vacuoles are acidic because their lim-
iting membrane contains the vacuolar-type ATPase
proton pump (v-ATPase), the operation of which is
essential for vacuole formation73. Accordingly, vacuoles
are promoted by the accumulation of membrane-per-
meable weak bases that are trapped by protonation in
their lumen71 (FIG. 4). These vacuoles contain mem-
brane protein markers of late endosomes and lyso-
somes, and their formation requires active Rab7, a
small GTPase involved in controlling membrane trans-
port through late endosomal compartments74. This
indicates that vacuole biogenesis is a specific process
taking place at the level of late endosomes, and not a
generalized swelling of flattened and tubular com-
partments due to cell damage. Negative-staining elec-
tron microscopy of biopsies of stomach mucosa from
H. pylori-infected patients and of VacA-treated HeLa
cells shows vacuoles largely devoid of the large array of
internal membranes and multivesicular bodies charac-
teristic of late endosomes/lysosomes71. Therefore,VacA
induces an extensive rearrangement of the internal
a second highly divergent segment is present in the
second half of p58 (REF. 56), which is probably involved
in target-cell interaction. The two alleles might have
evolved to bind different receptors57.
VacA is mainly released in the limited volume
sandwiched between the mucus layer and the apical
domain of stomach epithelial cells. So, the existence of
a high-affinity VacA receptor on the apical domain is
not strictly necessary. Indeed, a non-saturable number
of low-affinity receptors were found for radioactive
VacA on HeLa cells58, and different groups have
reported different putative VacA receptors. Whatever
the mode of binding, VacA inserts into the plasma
Figure 4 | Current model of the cellular alterations
induced by VacA cytotoxin. a | The toxin is an oligomer. 
b | It binds to the apical portion of epithelial cells and inserts
into the plasma membrane, forming a hexameric anion-
selective channel of low conductance. These channels
release bicarbonate and organic anions from the cell cytosol
to support bacterial growth. The toxin channels are slowly
endocytosed and eventually reach late endosomal
compartments, increasing their permeability to anions with
enhancement of the electrogenic vacuolar ATPase (v-
ATPase) proton pump. In the presence of weak bases,
including the ammonia generated by the Helicobacter pylori
urease, osmotically active acidotropic ions will accumulate in
the endosomes. This leads to water influx and vesicle
swelling, an essential step in vacuole formation. By an as-yet-
unidentified mechanism, the VacA toxin alters tight junctions
and increases the paracellular route of permeability providing
iron, nickel and other nutrients, essential for H. pylori growth,
from the underlying mucosa.
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Figure	2.	Cellular	alterations	induced	by	VacA	cyt toxin.	(Image	from	M tecucco	and	Rappuoli	2001).	
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v Pathogenicity	island	(CagPAI)		
H.	 pylori	 isolates	 are	 classified	 as	 cag+	 and	 cag–,	 depending	 on	 the	 presence	 of	 a	pathogenicity	island	(PAI)	of	40	kb,	containing	~30	genes,	termed	cagPAI	(Censini	S.	et	al.,	1996).	Pathogenicity	 islands	 seem	 to	 increase	 the	 fitness	 of	 bacteria	 in	 a	 given	 environment	 by	providing	them	with	environment-specific	functions.	The	cagPAI	provides	H.	pylori	with	at	least	two	unique	properties:	an	increased	transmission	probability	and	the	transformation	of	what	would	be	an	almost	commensal	into	a	potential	pathogen. Many	epidemiological	studies	show	that,	in	humans,	severe	gastric	diseases	are	always	associated	with	infection	by	cag+	strains	(Perez-Perez	G.I.	et	al.,	1999;	Parsonett	J.	et	al.,	1997;	Webb	P.M.	et	al.,	1999).	A	major	pathogenetic	event	contributed	by	the	cagPAI	is	the	induction	of	host	cells	to	release	pro-inflammatory	chemokines	(Crabtree	J.E.	et	al.,	1995;	Cover	T.L.	et	al.,	1992).	 The	 cagPAI	 region	 codes	 for	 the	 building	 blocks	 of	 a	 secretion	 apparatus,	 called	 type	 IV	secretion	 system,	 that	 delivers	 bacterial	 proteins	 directly	 into	 the	 cytosol	 of	 host	 cells	(Christie	P.J.	et	al.,	2000).	Cytotoxin	associated	gene	A	(cagA),	a	128–145-kDa	protein	that	becomes	phosphorylated	in	the	cytosol	of	host	cells	(Asahi	M.	et	al.,	2000;	Odenbrait	S.	et	al.,	2000),	is	the	only	protein	known	so	far	to	be	injected	by	H.	pylori	into	host	cells	(Covacci	A.	et	al.,	1993).	It	 is	 likely	that	other	H.	pylori	proteins	are	delivered	in	a	similar	way,	as	the	intact	type	IV	secretion	system,	but	not	CagA,	is	required	to	induce	the	release	of	IL-8	from	gastric	epithelial	 cells	 (Crabtree	 J.E.	 et	al.,	1995),	although	 it	 cannot	be	excluded	 that	 the	insertion	 of	 the	H.	 pylori	 type	 IV	 needle	 into	 the	 host	 plasma	membrane	 is	 sufficient	 to	activate	 endogenous	 signals.	 The	 type	 IV	 injection	 system	 is	 composed	 of	 a	 pilus-like	structure,	which	crosses	the	inner	and	outer	membrane	of	the	bacterium	and,	like	a	needle,	inserts	into	the	membrane	of	a	host	cell	to	inject	cagA,	and	possibly	other	bacterial	proteins,	into	the	cytosol.		The	proteins	translocated	by	type	IV	secretion	system	trigger	several	intracellular	signaling	pathways	 that	 result	 in	 epithelial	 cell	 gene	 expression	 as	well	 as	 the	 production	 of	 pro-inflammatory	 cytokines	 and	 chemokines.	 A	 central	 mediator	 in	 the	 expression	 of	 these	cytokines/chemokines	 is	 NF-kB,	 a	 transcription	 factor	 that	 is	 the	 convergence	 point	 for	multiple	pathways	activated	by	H.	pylori.	In	addition	to	its	role	in	inducing	pro-inflammatory	cytokines/chemokines,	 the	 target	 gene	 Bcl-XL	 can	 suppress	 the	mitochondrial	 apoptosis	pathway	which	may	lead	to	unregulated	proliferation.	Crabtree	and	Naumenn	summarized	
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the	overall	effects	of	cagPAI	products	in	the	sequential	activation	of	the	IKK	complex,	JNK,	p38	kinase,	NF-kB,	and	AP-1	in	gastric	epithelial	cells	(Crabtree	J.E.	et	al.,	2006).			
1.3.2 H. pylori and oxidative stress 
 The	 presence	 of	H.	 pylori	 results	 in	 reactive	 oxygen	 species	 (ROS)	 and	 reactive	 nitrogen	species	(RNS)	production	by	the	host	in	the	gastric	mucosa;	this	has	been	reported	to	impact	upon	 gastric	 inflammation	 and	 carcinogenesis.	 Excessive	 ROS/RNS	 production	 has	 been	reported	in	H.	pylori-infected	human	gastric	mucosa	(Suzuki	H.	et	al.,	1996),	and	correlates	well	with	 histological	mucosal	 damage	 (Davies	 G.R.	 et	 al.,	 1994)	 and	with	 bacterial	 load	(Zhang	Q.	et	al.,	1997).	Although	 there	 are	 many	 cell	 types	 that	 can	 contribute	 to	 the	 production	 of	 ROS/RNS,	including	the	epithelial	cells,	neutrophils	primarily	contribute	at	the	greatest	amount.		Gastric	 epithelial	 cells	 are	 one	 source	 of	 ROS	 in	 the	 H.	 pylori-infected	 stomach.	 Upon	stimulation	by	bacterial	cytotoxic	 factors	of	H.	pylori	or	cytokines	(Handa	O.	et	al.,	2004),	gastric	 epithelial	 cells	 passively	 produce	 ROS	 as	 by-products	 of	 increased	mitochondrial	respiration	rather	than	as	active	products.	Recently,	not	only	phagocytic	cells	but	also	non-phagocytic	 epithelial	 cells	 of	 the	 alimentary	 tract	 have	 been	 reported	 to	 express	 Nox	(Sumimoto	H.	et	al.,	2005).	H.	pylori	LPS	not	only	activate	neutrophils	to	produce	superoxide	anion,	but	also	 increase	Nox	and	Toll-like	receptor	4	expression	 in	gastric	epithelial	cells	leading	 to	 further	 production	 of	 superoxide	 anion	 (Kawahara	 T.	 et	 al.,	 2001).	 Bacterial	cytotoxic	 factors	 of	 H.	 pylori,	 such	 as	 vacuolating	 cytotoxin,	 cytotoxin	 associated	 gene	product	(CagA),	and	peptidoglycan,	also	stimulate	gastric	epithelial	cells	to	cause	oxidative	stress.	In	addition,	increased	ROS	production	might	be	involved	in	acceleration	of	the	cell	cycle	and	subsequent	cell	proliferation	(Handa	O.	et	al.,	2007).	It	has	been	shown	that	IL-8	expression,	is	up-regulated	by	oxidative	stress	in	gastric	epithelial	cells	(Watanabe	N.	et	al.,	1997).	Gastric	 epithelial	 cells	protect	 themselves	 from	oxidative	 stress	by	activating	antioxidant	defense	 mechanisms,	 including	 oxygen	 scavenger	 enzymes	 such	 as	 SOD,	 catalase	 and	glutathione	 peroxidase	 (Mori	M.	 et	 al.,	 1997),	 as	well	 as	 vitamins	 (Vit)	 E	 and	 C	 (Calvino	Fernandez	M.	et	al.,	2010).	Although	antioxidant	systems	seem	to	be	involved	in	infection	to	counteract	the	increased	ROS	 (Bagchi	 D.	 et	 al.,	 1996),	 when	 H.	 pylori-induced	 excessive	 ROS	 generation	 on	 the	epithelium	 is	 augmented	 by	 reduced	 effectiveness	 of	 antioxidant	 defenses,	 the	 risk	 of	cytotoxicity	 from	 oxidation,	 and	DNA	 damage	 is	 potentially	 increased	 (Smoot	 D.T.	 et	 al.,	2000).	An	impaired	redox	balance	may	then	result	in	cell	death,	which	would	increase	the	
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proliferation	 rate	 of	 the	 remaining	 cells	 and	 thereby	 increase	 the	 chance	 of	 mutations	leading	to	increased	oncogene	expression,	which	ultimately	results	in	gastric	cancer	(Obst	B.	et	al.,	2000).													
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vivo as urease is found on the surface of H. pylori pre-
sent in human biopsies14.
The essential role of urease as a virulence factor is
shown by the fact that urease-defective H. pylori
mutants cannot colonize the stomach15. However, urea
is toxic to the bacterium at neutral pH because an
unfavourable alkaline environment is generated16.
Therefore, the urea channel is regulated positively by
protons, opening at acidic pH values to allow more urea
in to buffer cytosolic and surface pH, and closing at neu-
tral pH to avoid over-alkalinization.
H. pylori urease might cause damage to the host cells
through the production of ammonia, an agent known to
be toxic by itself and/or in conjunction with NEUTROPHIL
metabolites on cultured cells and on stomach tissue
preparations17–19. Membrane-permeant weak bases
cause various cell alterations, including swelling of
intracellular acidic compartments, alterations of vesicu-
lar membrane transport, depression of protein synthesis
and ATP production, and cell-cycle arrest. Ammonia
can also react with intermediates released by the activity
of neutrophil MYELOPEROXIDASE to form carcinogenic
agents that might participate in the H. pylori-associated
development of stomach adenocarcinoma18. However,
ammonia is toxic at high doses, and the concentration
dependence of the toxic effects varies considerably with
cell type and culture conditions; therefore, it is not
immediately evident how toxic the quantities of ammo-
nia are that H. pylori produces in vivo. Moreover, circu-
lation of extracellular fluids should lead to a rapid dilu-
tion of the produced ammonia with a marked
concentration gradient from the bacterial surface to the
medium that surrounds host cells.
The role of urease in the pathogenesis of H. pylori-
associated diseases is not limited to colonization as
ammonia produced by the urease enters the H. pylori
nitrogen metabolism and is eventually incorporated
into proteins20. Urease might also help to recruit neu-
trophils and MONOCYTES in the inflamed mucosa and to
activate production of PROINFLAMMATORY CYTOKINES21.
Moreover, urease is one of the main antigens recognized
by the human immune response to H. pylori22, although
the extent and the nature of this immune response after
infection are not fully clear23.
Swimming through the mucus
Although well equipped to survive in strong acid, H.
pylori is not an acidophile and needs to leave the lumen,
also to avoid discharge in the intestine. With its polar-
sheathed flagella, H. pylori is a good swimmer and
reaches the thick mucus layer that covers and protects
the epithelial lining of the stomach mucosa. Here, pro-
pelled by its flagella, the helicoidal-shaped bacterium
travels across the viscous mucus film like a screw into a
cork; non-motile mutants cannot colonize the stom-
ach24. The movement of H. pylori towards the stomach
mucosa is guided by chemotactic factors, which include
urea and bicarbonate ions24,25.
The mucus film is produced by mucous cells that
secrete granules containing highly glycosylated
proteins26. The secreted glycoproteins, together with an
responsible for Ni2+ uptake and insertion into the active
site of the apo-enzyme2,9. Urease is a dodecamer of six
UreA and six UreB subunits, arranged as a double ring of
13-nm diameter10. The amount of urease produced by
the bacterium varies with culture conditions and may
reach as much as 10% of total bacterial protein11.
Urea is taken up by H. pylori through a proton-
gated channel12, and its hydrolysis by urease generates
ammonia that buffers the cytosol and PERIPLASM, and
creates a neutral layer around the bacterial surface (FIG.
2). In vitro, dead H. pylori cells release urease, which
binds strongly to the surface of living cells13, and such
a mode of ‘surface expression’might also operate in
Figure 1 | Schematic representation of the stomach mucosa colonized by Helicobacter
pylori, showing the main virulence factors involved in colonization and disease. During
infection, the bacterium enters the gastric lumen where the urease allows survival in the acidic
environment (red indicates a strongly acidic environment, yellow indicates a mildly acidic one)
by producing ammonia molecules that buffer cytosolic and periplasmic pH as well as the
surface layer around the bacterium (light blue). The flagella propel the helicoidal bacterium into
the mucus layer and allow it to reach the apical domain of gastric epithelial cells, to which it
sticks using specialized adhesins. H. pylori then injects the cagA protein into the host cells by a
type IV secretion system and releases other toxic factors such as H. pylori neutrophil-activating
protein (HP-NAP) and VacA. VacA induces alterations of tight junctions and the formation of
large vacuoles. Vacuoles are evident in cells in culture and in the stomach epithelial cells of
human and mouse biopsies, although they are not apparent in gerbils. The neutrophil-
activating protein HP-NAP crosses the epithelial lining and recruits neutrophils and monocytes,
which extravasate and cause tissue damage by releasing reactive oxygen intermediates (ROIs).
Injected Cag proteins cause alteration of the cytoskeleton, pedestal formation and signal the
nucleus to release proinflammatory lymphokines, which amplify the inflammatory reaction with
recruitment of lymphocytes and further induce the release of ROIs. The combined toxic activity
of VacA and of ROIs leads to tissue damage that is enhanced by loosening of the protective
mucus layer and acid permeation.
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Figure	3.	Repr sentation	of	 th 	 stomach	mucosa	colonized	by	Helicobacter	pylori,	 showing	 the	main	
virulence	factors	involved	in	colonization	and	disease.	During	infectio ,	the	bacterium	is	able	to	ente 	in	the	gastric	lumen	where	the	urease	allows	survival	in	the	acidic	environment	by	producing	ammonia	molecules	that	buffer	cytosolic	and	periplasmic	pH	as	well	as	the	surface	layer	around	the	bacteriu .	Through	its	flagella,	the	bacterium	moves	into	the	mucus	layer	reaching	the	apical	domain	of	gastric	epithelial	cells,	to	which	it	sticks	using	specialized	adhesins.	H.	pylori	then	injects	the	cagA	protein	into	the	host	cells	by	a	type	IV	secretion	system	and	releases	other	toxic	factors	such	as	H.	pylori	neutrophil-activating	protein	(HP-NAP)	and	VacA.	VacA	induces	alterations	of	tight	 junctions	and	the	formation	of	 large	vacuoles.	The	neutrophil-activating	protein	HP-NAP	crosses	the	epithelial	lining	recruiting	neutrophils	and	monocytes,	which	can	cause	tissue	damage	by	releasing	reactive	 oxygen	 intermediates	 (ROIs).	 Injected	 Cag	 proteins	 cause	 alteration	 of	 the	 cytoskeleton,	 pedestal	formation	and	signal	the	nucleus	to	release	pro-inflammatory	lymphokines,	which	amplify	the	inflammatory	reaction	with	recruitment	of	lymphocytes	and	further	induce	the	release	of	ROIs.	(Image	from	Montecucco	and	Rappuoli	2001).			
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1.4 ROLE OF CYTOKINES IN THE PATHOLOGY 
 
H.	 pylori	 is	 a	 Gram-negative	 bacterium	 strictly	 involved	 in	 the	 pathogenesis	 of	 major	gastrointestinal	 diseases,	 such	 as	 peptic	 ulcer	 disease,	 gastric	 carcinoma	 and	 gastric	lymphoma	(Parsonnet	J.	et	al.,	1994);	moreover,	as	documented	in	the	previous	paragraph,	this	microorganism	is	associated	with	gastritis,	which	is	characterized	by	the	infiltration	of	neutrophils,	monocytes,	 lymphocytes	 in	 the	gastric	 epithelium	and	 in	 the	 lamina	propria	(Crabtree	 J.E.	 et	 al.,	 1996).	 This	 bacterium	 is	 not	 invasive,	 but	 it	 is	 able	 to	 induce	 an	inflammatory	response	through	the	contact	with	the	surface	of	the	epithelial	cells.	The	local	production	 of	 chemokines,	 a	 group	 of	 cytokines	with	 chemoattractant	 activity,	 is	 a	 very	important	 factor	 for	 the	 recruitment	 of	 inflammatory	 cells	 at	 the	 site	 of	 inflammation	(Harada	A.	 et	 al.,	 1996);	many	 chemokines	have	been	 identified,	 however	 the	number	 is	constantly	growing.	One	of	the	earliest	cytokines	reported	to	be	produced	by	the	infected	gastric	epithelium	is	interleukin	IL-8	(Crabtree	J.E.	et	al.,	1994).	It	is	well	known	that	H.	pylori	increases	the	IL-8	expression	both	in	vitro	and	in	vivo	(Crabtree	J.E.	et	al.,	1994).	Crabtree	et	al.	 reported	 an	 increase	 in	 IL-8	 content	 in	 the	 gastric	 mucosa	 infected	 with	 H.	 pylori,	moreover	 they	 reported	 a	 study	 showing	 the	 localization	 of	 IL-8	 in	 the	 epithelium	 of	 a	histological	 preparation	 of	 healthy	 gastric	 mucosa	 and	 the	 effective	 increase	 of	 the	expression	of	this	cytokine	in	the	infected	mucosa	(Crabtree	J.E.	et	al.,	1993;	Crabtree	J.E.	et	al.,	1994).	Thus,	IL-8	production	appears	as	a	key	point	in	the	gastritis	associated	with	H.	
pylori	 and	epithelial	 cells	are	probably	 the	main	producers	of	 this	cytokine	 in	 the	gastric	mucosa	(Shimada	T.	et	al.,	1998).	Early	investigations	correlate	IL-8	production	with	CagA	protein	 expression	 by	H.	 pylori	 (Crabtree	 J.E.	 et	 al.,1994;	 Odenbreit	 S.	 et	 al.,	 2002).	 In	 a	detailed	 comparison	 of	H.	 pylori	 strains	 lacking	 CagA	 protein	 with	 those	 expressing	 the	protein,	 CagA	 positive	 strains	 were	 reported	 to	 induce	 higher	 levels	 of	 IL-8	 mRNA	 and	protein	expression	by	gastric	epithelial	cells	(Crabtree	J.E.	et	al.,	1994).	Following	studies,	unexpectedly,	 showed	 that	deletion	of	 the	CagA	gene	has	no	effect	 on	 the	degree	of	 IL-8	induction,	suggesting	that	probably	this	protein	is	not	directly	involved	in	the	mechanism	underlining	chemokine	release.	 In	addition,	 the	presence	of	a	pathogenicity	 island,	which	contains	several	genes	(including	CagA)	has	been	identified;	this	set	of	genes	is	considered	important	for	the	induction	of	IL-8	expression	(Censini	S.,	et	al.,	1996).	The	transcription	factor	NF-kB,	NF-IL6	and	the	activating	protein	AP-1	are	involved	in	the	regulation	of	the	IL-8	gene	transcription	(Matsusaka	T.	et	al.,	1993);	in	particular,	Sharma	et	al.	demonstrated	that	IL-8	induction	induced	by	H.	pylori	in	AGS	gastric	cells	is	regulated	via	an	NF-kB-dependent	transcriptional	process	(Sharma	S.A.	et	al.,	1998).  
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Other	 cytokines	 reported	 to	be	produced	by	 the	 infected	gastric	 epithelium	 include	 IL-6,	tumor	necrosis	factor	alpha	(TNFa)	(Tanahashi	T.	et	al.,	2000),	 IL-1b,	 IL-1a,	granulocyte-macrophage	 colony-stimulating	 factor	 (GM-CSF),	 monocyte	 chemoattractant	 protein-1	(MCP-1)	(Jung	H.C.	et	al.,	1997),	MIF	(Beswick	E.J.	et	al.,	2006)	and	TGF-b	(Beswick	E.J.	et	al.,	2006).	The	 lipopolysaccharide	 (LPS)	 of	H.	 pylori	 and	 the	 release	 of	 bacterial	 proteins	 stimulate	immune	cells	to	produce	IL-1β	and	TNFα	(Mai	U.E.	et	al.,	1991);	these,	in	turn,	are	potent	inducers	of	 IL-8	expression	 in	many	 cell	 types.	 In	 vitro	 studies	have	 shown	 that	 the	 IL-8	expression	in	gastric	epithelial	cells	is	up-regulated	by	these	cytokines	(Watanabe	N.	et	al.,	1997).	Various	studies	have	examined	the	response	of	human	gastric	epithelial	cells	to	purified	H.	
pylori	urease,	since	it	is	the	most	abundant	protein	produced	by	the	bacteria.	These	studies	reported	 that	H.	 pylori	urease	 induces	 the	 production	 of	 IL-6,	 TNFa	 and	 IL-8	 by	 gastric	epithelial	cells	(Tanahashi	T.	et	al.,	2000;	Beswick	E.J.	et	al.,	2006).	Interestingly,	mucosal	IL-6	and	TNFa	increase	in	patients	suffering	from	H.	pylori	chronic	gastritis	(Crabtree	J.E.	et	al.,	1991).	In	a	recent	study	the	cag	PAI	and	OipA	were	examined	for	their	role	in	IL-6	secretion	by	gastric	epithelial	cells	and	both	virulence	factors	were	found	to	increase	the	levels	of	IL-6	production	by	MKN-28	 gastric	 epithelial	 cells	 through	different	 pathways	 (Lu	H.	 et	 al.,	2005).	Interleukin-17	(IL-17)	RNA	transcription	and	secretion	have	been	found	to	increase	in	the	human	gastric	mucosa	during	H.	pylori	infection	and	its	expression	is	up-regulated	in	animal	stomach	after	3	weeks	of	infection	(Kabir	S.,	2011).	Since	gastric	epithelial	cells	express	IL-17	receptors,	IL-17	interaction	with	its	receptor	stimulates	the	epithelial	cells	to	produce	IL-8,	thus	confirming	that	gastric	epithelial	cells	serve	as	important	contributors	for	IL-17	and	IL-8	 synthesis	 during	H.	 pylori	 infection	 (Kabir	 S.,	 2011).	 Furthermore,	 IL-21	 and	 IL-23,	which	are	cytokines	that	induce	and	sustain	IL-17	production,	are	found	to	be	upregulated	in	the	gastric	mucosa	of	patients	infected	with	H.	pylori	(Kabir	S.,	2011).		Another	cytokine	related	to	the	gastritis	caused	by	H.	pylori	 is	IL-21.	In	H.	pylori-negative	patients	affected	by	gastritis,	 the	 level	of	expression	of	this	cytokine	 is	not	different	 from	healthy	patients,	indicating	a	relationship	between	the	bacterium	and	the	production	of	IL-21.	This	relationship	is	further	supported	by	the	fact	that	the	eradication	of	the	bacterium	significantly	reduces	the	expression	of	the	cytokine.	The	treatment	of	AGS	and	MKN-28	cells	with	IL-21	produced	an	increase	of	the	metalloprotease	synthesis,	such	as	MMP-9	and	MMP-2	(Caruso	R.	et	al.,	2007).	M
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extra-cellular	matrix	 proteins	 and	 remodeling	 connective	 tissue	 (Nagase	H.	 et	 al.,	 1999).	Patients	with	H.	pylori-associated	gastritis	exhibit	an	elevated	mucosal	MMP-9	content,	the	level	 of	 which	 decreases	 dramatically	 following	 successful	H.	 pylori	 eradication	 therapy	(Bergin	P.J.,	et	al.	2004;	Kubben	F.J.G.M.	et	al.,	2007).				
																		
mucosa. Initially, the adaptive response was considered as 
a polarized Th1 response; however, more recently other 
CD4+ T cell subsets have been reported in the infected 
mucosa. One of  those subsets are Th17 cells, which are 
key in immune defense against extracellular bacteria, but 
are also commonly found in multiple inflammatory pro-
cesses[100,101]. Interleukin-17 (IL-17) RNA transcription 
and IL-17 secretion have been found to increase in the 
human gastric mucosa during H. pylori infection and its 
expression is up-regulated in animal stomach after 3 wk 
of  infection and its level elevated up to 12 mo post infec-
tion[102]. An animal study that used Mongolian gerbils as 
a model confirmed the in vivo increased expression of  
IL-17 mRNA, especially during the chronic phase of  H. 
pylori infection[103]. Since gastric epithelial cells express 
IL-17 receptors, IL-17 interaction with its receptor stimu-
lates the epithelial cells to produce IL-8; thus confirming 
that gastric epithelial cells serve as important contributors 
for IL-17 and IL-8 synthesis during H. pylori infection[102]. 
Furthermore, IL-21 and IL-23, which are cytokines that 
induce and sustain IL-17 production, are found to be 
upregulated in the gastric mucosa of  patients infected 
with H. pylori. IL-23 expression does not appear to be as-
sociated with CagA protein, but it certainly plays a role in 
sustaining production of  IL-17[102,104].
Pro-carcinogenic responses
One of  the well accepted and significant clinical out-
comes of  H. pylori infection is gastric adenocarcinoma. 
Gastric cancer (GC) remains the second leading cause 
of  cancer-related deaths and close to one million people 
succumb to GC on an annual basis. When diagnosed, the 
5 year survival rate of  GC patients is 15%[105]. Because of  
the clear evidence collected linking H. pylori to GC[106]., 
H. pylori is the first bacterium to have been classified as 
a class Ⅰ carcinogen. As the infection typically results 
in chronic gastritis and inflammation has been linked to 
cancer development[107], this has been one of  most ac-
cepted general mechanisms linking the infection to GC. 
However, not everyone who is infected develops GC. In 
fact, it has been reported that approximately 1%-3% of  
those who are infected develop GC while about 10% de-
velop peptic ulcer disease[106]. There are two histologically 
distinct types of  GC. The first is a diffuse type of  GC 
comprised of  individual infiltrating neoplastic cells that 
fail to form glandular structures. The second type is an 
intestinal type GC that results from the transition of  nor-
mal mucosa to chronic superficial gastritis, followed by 
atrophic gastritis, intestinal metaplasia, and eventual dys-
plasia and adenocarcinoma[108]. Another neoplasia that is 
linked to infection with H. pylori is a non-Hodgkins type 
or mucosal associated tissue lymphoma (MALToma). Al-
though H. pylori strains carrying cagA represent an impor-
tant risk factor for GC development, GC development is 
thought to be the result of  a multifactorial process that 
is orchestrated to include an array of  etiological factors 
as well as several genetic and epigenetic modifications. 
As far as H. pylori virulence factors is concerned, CagA 
was reported to interact with E-cadherin and causing 
deregulation of  β-catenin signaling and this stimulated 
intestinal transdifferentiation of  gastric epithelial cells, a 
premalignant event from which gastric adenocarcinoma 
develops[75]. Also, a study in which CagA alone was trans-
fected into human gastric epithelial cells showed that H. 
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Figure 3  Cytokines production by gastric epithelial cell during Helicobacter pylori Infection. Helicobacter pylori (H. pylori) leads to production of proinflam-
matory cytokines by gastric epithelial cells (GECs). Interactions between the translocated cagA and gastric epithelial cells lead to activation of nuclear factor (NF)-
κB, alteration in gene transcription in the GECs, and secretion of IL-8 by GECs, which leads to recruitment of neutrophils. H. pylori urease induces the production 
of IL-6 and tumor necrosis factor alpha (TNF-α) by GECs. Other cytokines secreted by GECs during H. pylori infection such as, TNF-α, IL-1β, IL-1α, granulocyte-
macrophage colony-stimulating factor, monocyte chemoattractant protein-1 (MCP-1),  migration inhibitory factor and tumor growth factor (TGF)-α. 
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Figure	4.	Cytokines	production	by	gastric	epithelial	cells	during	H.	pylori	infection.	(Image	from	Alzahrani	et	al.	2014).	
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1.5 NF-kB TRANSCRIPTION FACTOR 	
1.5.1 Structure 
 Nuclear	 Factor-kappa	 B	 (NF-κB)	 is	 a	 transcription	 factor	 family	 that	 regulates	 a	 large	number	of	genes	that	are	involved	in	important	physiological	processes,	including	survival,	inflammation,	and	immune	responses.		Five	members	of	 this	 transcription	 factor	 family	have	been	 identified,	 designated	 as	p65	(RelA),	RelB,	c-Rel,	NF-κB1	and	NF-κB2.	NF-κB1	and	NF-κB2	are	expressed	as	the	precursors	p105	 and	 p100,	 which	 are	 cleaved	 to	 the	 functional	 transcription	 factors	 p50	 and	 p52,	respectively	(Hoesel	B.	et	al.,	2013).	The	NF-κB	members	are	ubiquitously	expressed,	but	their	functionality	might	depend	on	specific	cellular	stimuli	(Gilmore	T.D.	et	al.,	2011).	These	transcription	factors	generally	act	as	homo-	or	heterodimers,	and	the	combination	of	every	member	is	possible,	although	some	of	them	have	greater	affinity.	For	instance,	due	to	their	structure,	p65/p50	and	RelB/p52	are	the	most	stable	dimers	(Huang	B.D.	et	al.,	1997;	Huang	B.D.	et	al.,	2005).		The	 five	members	 of	 NF-κB	 family	 share	 an	 evolutionarily	 conserved	N-terminal	 region,	known	 as	 the	 Rel	 homology	 domain	 (RHD),	 which	 is	 essential	 for	 homo-	 and	heterodimerization,	nuclear	 targeting,	and	binding	 to	DNA	or	 IκB.	The	C-terminal	 region,	where	the	transcriptional	activation	domain	(TAD)	is	located,	is	not	conserved	among	the	NF-κB	members	because	p50	and	p52	are	products	of	partial	proteolysis,	and	thus	have	a	glycine-rich	region	instead	of	TAD	(Nolan	G.P.	et	al.,	1993;	Wang	J.	et	al.,	2011).		In	most	quiescent	cells	these	dimers	are	bound	to	inhibitory	molecules	of	the	IκB	family	of	proteins	(inhibitors	of	NF-κB);	the	IκB	family	of	proteins	consists	of	 four	members:	 IκBα,	IκBβ,	IκBε	and	BCL-3.	These	inhibitors	are	characterized	by	ankyrin	repeats,	which	associate	with	 the	 DNA-binding	 domains	 of	 the	 transcription	 factors	 thereby	 making	 them	transcriptionally	inactive.	Binding	of	NF-κB	dimers	to	IκB	molecules	does	not	only	prevent	binding	to	DNA,	but	also	shifts	the	steady-state	localization	of	the	complex	to	the	cytosol.	Nevertheless,	 shuttling	 between	 cytosol	 and	 nucleus	 does	 occur	 (Birbach	A.	 et	 al.,	 2002;	Huang	T.T.	et	al.,	2000),	which	might	be	a	basis	for	a	low	basal	transcriptional	activity	of	NF-κB	given	that	the	IκB/NF-κB	complex	is	subject	to	dissociation	and	re-association	processes.		Activation	of	the	NF-κB	pathway	can	be	initiated	by	a	large	number	of	extracellular	stimuli,	but	 they	 have	 a	 similar	 signal	 transduction	 cascade	 resulting	 basically	 from	 phosphate	transfer.	 This	 signaling	 comprises	 canonical	 (classical)	 and	 non-canonical	 (alternative)	pathways.			
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1.5.2 Canonical pathway 
 In	 the	canonical	pathway,	NF-κB	dimers	are	regulated	by	 inhibitory	molecules	of	 the	 IκB	family,	 which	 prevent	 their	 translocation	 into	 the	 nucleus	 forming	 a	 stable	 complex.	 To	release	the	NF-κB	complex,	signaling	pathways	are	activated	by	pro-inflammatory	cytokine	receptors,	such	as	tumor	necrosis	factor	receptor	(TNFR),	IL-1	receptor	(IL-1R)	and	toll-like	receptor	 (TLR)	 family	 members	 (TLR3,	 TLR4,	 TLR7);	 antigen	 receptors,	 such	 as	 T	 cell	receptor	(TCR)	and	B	cell	receptor	(BCR);	growth	factors,	such	as	epidermal	growth	factor	receptor	(EGFR)	family	members.	These	receptors	are	able	to	activate	the	IκB	kinase	(IKK)	complex,	an	enzyme	complex	containing	 IκB	kinases	 (IKK1/IKKα	and	 IKK2/IKKβ)	and	at	least	one	non-catalytic	accessory	protein	(NF-κB	Essential	Modulator,	NEMO	or	also	termed	IKKγ),	which	phosphorylates	and	facilitates	the	ubiquitination	of	IκBa	(primarily	by	IKKb)	and	its	subsequent	degradation	by	the	26s	proteasome.	The	dimers	p65/p50	and	c-Rel/p50	are	then	translocated	into	the	nucleus	and	activate	target	gene	expression	(Gupta	S.C.	et	al.,	2010;	Chen	J.	et	al.,	2013).		In	the	nucleus,	the	NF-κB	complex	binds	to	sequence-specific	target	DNA,	known	as	κB	sites,	which	are	present	in	promoters	of	the	target	genes,	assemble	with	the	basal	transcriptional	machinery,	and	might	associate	with	other	transcription	factors,	including	AP-1	(c-Jun/c-Fos	complex)	 and	 chromatin	 remodeling	 proteins,	 such	 as	 CREB-binding	 protein	 (CBP)	 and	p300.	In	this	way	NF-κB	factor	can	activate	the	transcription	of	different	target	genes	(Hoesel	B.	et	al.,	2013).		
1.5.3 Non-canonical pathway 
 Non-canonical	 pathway	 originates	 from	 different	 classes	 of	 receptors	 including	 B-cell	activation	 factor	 (BAFFR),	 lymphotoxin	 β-receptor	 (LTβR),	 CD40,	 receptor	 activator	 for	nuclear	factor	kappa	B	(RANK),	TNFR2	and	Fn14	(Sun	S.C.,	2010).	These	lead	to	activation	of	the	NF-κB	inducing	kinase	NIK,	which	phosphorylates	and	activates	predominantly	the	homodimer	IKKα/IKKα.	The	activity	of	the	latter	enzyme	induces	phosphorylation	of	p100	resulting	 in	 its	 ubiquitination	 and	 partial	 degradation	 to	 p52	 (Xiao	 G.	 et	 al.,	 2001).	 The	mechanisms	leading	to	activation	of	the	non-canonical	pathway	are	thus	independent	of	the	activity	of	IKKb	and	NEMO	(Dejardin	E.	et	al.,	2002).		In	many	cases,	p100	is	associated	with	RelB,	so	that	its	proteolytic	processing	induces	the	formation	of	a	transcriptionally	active	RelB/p52-complex	(Solan	N.J.	et	al.,	2002;	Senftleben	U.,	 et	 al.,	 2001),	which	 translocates	 into	 the	nucleus	 regulating	 the	 expression	of	 several	target	genes.		
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Figure	5.	Canonical	and	non-canonical	NF-kB	pathways.	(Image	from	Pires	R.B.	et	al.	2014).	
 
 
1.5.4 Role of the NF-kB in gastric inflammation 
 Nuclear	 Factor-kappa	 B	 (NF-κB)	 is	 a	 transcription	 factor	 family	 that	 regulates	 a	 large	number	of	genes	(more	than	150)	involved	in	important	physiological	processes,	including	survival,	inflammation,	oxidative	stress	response,	immune	responses	and	apoptosis.	Thanks	to	 the	 large	 variety	 of	 stimuli	 able	 to	 activate	 NF-κB	 and	 to	 its	 ability	 in	 regulating	 the	expression	 of	 pro-inflammatory	 cytokines,	 chemokines,	 immunoreceptors	 and	 adhesion	molecules,	 this	 transcription	 factor	 is	generally	 indicated	as	 “The	central	mediator	of	 the	immune	response	in	humans”	(Pahl	L.H.	et	al.	1999).	NF-κB,	 nuclear	 factor-IL6	 (NF-IL6)	 and	 activator	 protein	 AP-1	 are	 involved	 in	 the	transcriptional	regulation	of	the	IL-8	gene	(Mukaida	N.	et	al.,	1990;	Yasumoto	K.	et	al.,	1992),	with	the	role	of	NF-κB	appearing	to	be	the	most	important.	NF-κB	regulates	the	expression	of	a	wide	variety	of	inducible	genes	(Baueuerle	P.A.	et	al.,	1996).	In	gastric	epithelial	cells,	induction	 of	 IL-8	 expression	 by	 pro-inflammatory	 cytokines,	 such	 as	 TNFα	 or	 IL-1b,	 is	associated	with	the	NF-κB	activation	(Yasumoto	K.	et	al.,	1992).	Aihara	et	al.	demonstrated	
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2. The Role of NF-B in Physiology, Inflammation and Cancer
NF-B is recog ized as a crucial component of many immune responses. Innate immune cells,
such as macrophages and dendritic cells (DCs), rely on NF-B for the secretion of pro-inflammatory
cytokines after pattern recognition receptor (PRR) activation [23]. NF-B is also recognized as an
important anti-apoptotic transcription factor for immune cells, such as neutrophils, a d it is essential
for the development of lymphocytes [24–29]. Furthermore, the adaptive immune response activation
and polarization also seem to be dependent on NF-B [26,30]. Professional antigen presenting
cells (usually activated DCs) will make the link between innate and adaptive immunity, presenting
antigens and activating clonal receptors (which suffered gene segment recombination during T cell
development) and its co-receptors from specific T lymphocytes (CD4 for T CD4+ cells and CD8 for
CANONICAL NF-kB PATHWAY NON-CANONICAL NF-kB PATHWAY 
  Introduction 
 19 
that	co-culturing	H.	pylori	with	MKN45,	a	gastric	epithelial	cell	line,	there	is	NF-κB	activation	and	 an	 increased	 IL-8	 transcription.	 In	 their	 study,	 mutating	 the	 NF-κB	 site	 completely	abrogated	 H.	 pylori-simulated	 epithelial	 IL-8	 expression,	 suggesting	 that	 NF-κB	 plays	 a	pivotal	role	in	IL-8	release	and	expression	(Aihara	M.	et	al.,	1997).	Keates	et	al.	also	reported	similar	NF-κB	activation	by	H.	pylori	infection,	using	the	gastric	epithelial	cell	lines	AGS	and	KATOIII	(Keates	S.	et	al.,	1997).	NF-κB	is	also	involved	in	the	expression	of	MMP-9	and	MMP-2	 in	 AGS	 cells,	 two	 gelatinases	 possessing	 an	 important	 role	 in	 the	 gastric	 inflammation	(Caruso	R.	et	al.,	2007).	During	H.	pylori-induced	gastritis,	oxidative	stress	in	gastric	epithelial	cells	is	increased;	ROS	are	known	to	over-express	IL-8	by	activating	oxidant-sensitive	transcription	factors	such	as	NF-κB	 in	 gastric	 epithelial	 cells	 (Kim	 Y.	 et	 al.,	 2011).	 Several	 target	 genes	 of	 NF-κB	 are	involved	in	the	detoxification	of	ROS	(such	as	SOD	and	CAT)	but	some	of	them	that	can	also	have	 a	 pro-oxidant	 function	 such	 as	 nitric	 oxide	 synthases	 (NOS)	 pointing	 at	 a	 complex	interplay	between	ROS	and	NF-κB	(Morgan	M.J.	et	al.,	2010).			
1.5.5 Natural inhibitors of NF-κB 
 The	 central	 role	 of	 NF-κB	 in	 the	 inflammatory	 process	 makes	 this	 factor	 an	 important	molecular	target	to	search	for	new	anti-inflammatory	drugs.	Several	natural	compounds	able	to	inhibit	NF-κB	transcription	factor	have	been	identified,	among	these	molecules	a	large	number	belong	to	the	class	of	polyphenols,	such	as	curcumin,	resveratrol,	epigallocatechin-3-gallate,	quercetin	and	some	lignans	(Nam	N.H.,	2006).	Tsai	et	al.	demonstrated	that	resveratrol	 is	able	to	inhibit	 iNOS	expression	and	NO	production	in	macrophages	 blocking	 LPS-induced	 IκBα	 phosphorylation	 thus	 reducing	 the	 binding	between	NF-κB	and	DNA.	This	suggests	that	the	anti-inflammatory	activity	of	the	resveratrol	could	be	due,	at	least	in	part,	to	the	inhibition	of	NF-κB-dependent	NO	synthesis	(Tsai	S.H.	et	al.,	1999).	Sangiovanni	et	al.	showed	that	some	phenols	extracted	from	olive	oil	(oleuropein	aglycone,	 ligstroside	 aglycone,	 hydroxytyrosol	 and	 tyrosol)	 were	 able	 to	 reduce	 NF-κB	driven	 transcription	 in	 TNFa-treated	 AGS	 cells	 (Sangiovanni	 E.	 et	 al.,	 2012).	 The	 same	research	group	demonstrated	that	the	two	major	ellagitannins	contained	in	blackberry	and	raspberry,	sanguiin	H-6	and	lambertianin,	inhibited	NF-κB	driven	transcription	and	nuclear	translocation	 in	gastric	epithelial	cells	stimulated	with	TNFa	or	 IL-1b	 (Sangiovanni	et	al.,	2013).	Jiang	and	colleagues	demonstrated	that	epigallocatechin-3-gallate	inhibited	TNF-α-induced	nuclear	factor-κB	(NF-κB)	activity	in	macrophage	foam	cells	(Jiang	J.	et	al.,	2012). 			
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1.6 Nrf2 TRANSCRIPTION FACTOR 	
1.6.1 Structure 
 Reactive	oxygen	species	(ROS)	are	biological	molecules	produced	naturally	as	a	by-product	of	oxygen	metabolism	by	aerobic	organisms.	Under	physiological	conditions,	the	ROS	level	will	be	in	equilibrium	in	the	system.	Oxidative	stress	is	the	overproduction	or	imbalanced	production	of	ROS,	which	disturbs	the	normal	antioxidant	mechanism	in	the	system.		The	transcription	factor	Nrf2	(NF-E2-related	factor	2)	is	a	potent	transcriptional	activator	and	plays	a	central	role	in	inducible	expression	of	many	cytoprotective	genes	in	response	to	oxidative	and	electrophilic	stresses	(Itoh	K.	et	al.,	1997;	Motohashi	H.	et	al.,	2004).	Target	genes	 of	 Nrf2	 are	 involved	 in	 the	 glutathione	 synthesis,	 inactivation	 of	 ROS,	 xenobiotic	metabolism	and	drug	transport	(Okawa	H.	et	al.,	2006;	Yates	M.S.	et	al.,	2009).		Nrf2	belongs	to	the	bZIP	factors	of	the	CNC	family.	The	CNC	family	proteins	regulate	gene	expression,	tissue	differentiation	and	development	in	a	variety	of	organisms.	Nrf2	is	the	most	studied	 CNC	 family	 member	 and	 is	 responsible	 for	 the	 expression	 of	 constitutive	 and	inducible	levels	of	phase	II	enzymes	and	endogenous	antioxidants.		The	Nrf2	protein	is	comprised	of	six	highly	conserved	Neh	(Nrf2–ECH	homology)	domains,	Neh1–Neh6.	The	Neh1	domain	contains	the	CNC-type	bZIP	region	which	is	crucial	for	DNA	binding	and	dimerization	with	other	transcription	factors	(Nioi	P.	et	al.,	2005).	The	Neh1	domain	 is	 required	 for	 homo-	 or	 heterodimerization	with	Maf	 proteins	 (MafF,	MafG	 and	MafK)	and	also	with	leucine	zipper	containing	protein	domains	(Motohashi	H.	et	al.,	2002).	The	Neh3	domain	lies	at	the	C-terminal	region	of	Nrf2,	acts	as	a	transactivation	domain	to	promote	 the	 transcription	 of	 antioxidant	 response	 element	 (ARE)-dependent	 genes	 by	means	of	interacting	with	the	chromo-ATPase/helicase	DNA	binding	protein	family	member	CHD6	 (Nioi	 P.	 et	 al.,	 2005).	 The	 Neh4	 and	 Neh5	 domains	 of	 Nrf2	 coordinate	 with	 co-activators	CBP	(CREB/ATF4)	and	BRG1	(brahma-related	gene	1),	respectively	(Moi	P.	et	al.,	1994).	The	Neh6	domain	plays	a	key	role	in	the	Keap1-independent	degradation	pathway	of	Nrf2.	The	degradation	of	Nrf2	 in	 stressed	 cells	 is	 predominantly	mediated	by	 the	 redox-insensitive	Neh6	domain	(McMahon	M.	et	al.,	2004).	The	Neh2	domain	is	present	at	the	N-terminal	region	of	Nrf2.	It	possesses	two	motifs,	namely,	DLG	and	ETGE	motifs.	These	two	motifs	of	Neh2	are	mainly	responsible	for	the	direct	interaction	with	the	negative	regulator,	Keap1,	which	subsequently	guide	the	degradation	of	an	excess	of	Nrf2	 factor	 to	maintain	homeostatic	conditions	(McMahon	M.	et	al.,	2004).		Keap1	is	a	dimeric	protein	consisting	of	624	amino	acid	residues.	Keap1	acts	as	a	substrate	adapter	protein	for	the	E3	ubiquitin	ligase	complex	formed	by	Cul3	and	Rbx1	and	targets	Nf-
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E2/Nrf2	for	ubiquitination	and	degradation	by	the	proteasome	(McMahon	M.	et	al.,	2004;	Bryan	H.K.	et	al.,	2013).	The	Keap1	protein	is	mainly	located	in	the	cytoplasm;	however,	it	also	shuttles	between	cytoplasm	and	nucleus	(Sun	Z.	et	al.,	2011).			
1.6.2 Mechanism of Keap1-Nrf2 pathway 
	Under	 normal	 conditions,	 Nrf2	 is	 constantly	 degraded	 via	 the	 ubiquitin–proteasome	pathway	in	a	Keap1-dependent	manner	(Sekhar	K.R	et	al.,	2002;	McMahon	M.	et	al.,	2003;	Kobayashi	A.	 et	 al.,	 2004).	 In	 the	presence	of	 electrophiles	or	ROS,	Nrf2	dissociates	 from	Keap1	 (its	 degradation	 is	 blocked),	 stabilized	 Nrf2	 translocates	 into	 the	 nucleus,	heterodimerizes	 with	 small	 Maf	 proteins	 and	 activates	 target	 genes	 for	 cytoprotection	through	antioxidant	response	element	(ARE)	⁄	electrophile	response	element	(EpRE)	(Itoh	K.	et	al.,	2004).	Cul3	gets	dissociated	from	the	Keap1–Cul3	complex	in	the	presence	of	ROS.	Hence,	ubiquitination	of	Nrf2	 is	halted,	which	 leads	Nrf2	 to	escape	 from	the	proteasomal	degradation	and	results	in	its	subsequent	nuclear	translocation	(Niture	S.K.	et	al.,	2010).		Thus,	 the	 level	 of	 Nrf2	 protein	 is	 regulated	 by	 degradation	 processes,	 and	 the	 inducible	stabilization	of	Nrf2	 is	 the	essence	of	 the	 cellular	 response	 to	oxidative	and	electrophilic	stresses.	The	stress	conditions	lead	to	the	suspension	of	Keap1–Nrf2	interactions	and	cause	transcription	of	cytoprotective	genes,	which	in	turn,	counteract	the	cellular	oxidative	stress	(Kansanen	E.	et	al.,	2013).	Nrf2	regulates	the	expression	of	various	cytoprotective	genes	by	binding	 specifically	 to	 the	 antioxidant	 response	 element	 (ARE)	 in	 the	 promoters	 of	 the	corresponding	 genes,	 including	 those	 encoding	 xenobiotic	 metabolizing	 enzymes	(NAD(P)H:quinone	oxidoreductase	1	 (NQO1)	and	glutathione	S-transferase	 (GST)),	 stress	response	 proteins,	 growth	 factors,	 and	 nucleotide	 synthesis	 enzymes	 that	 enhance	 cell	proliferation	(Itoh	K.	et	al.,	1997;	Thimmulappa	R.K.	et	al.,	2002;	Mitsuishi	Y.	et	al.,	2012).		
1.6.3 Benefits and risks of Keap1-Nrf2 pathway 
 Nrf2	activation	upregulates	 the	various	 set	of	 enzymes	 for	 the	detoxification	of	 chemical	carcinogens	and	confers	protection	against	carcinogenicity,	mutagenicity	and	other	types	of	toxicity	(Yu	X.	et	al.,	2005).	Several	studies	have	shown	that	Nrf2	protects	against	oxidative	stress,	chemotherapeutic	agents	and	radiotherapy	(Lau	A.	et	al.,	2008;	Kensler	T.W.	et	al.,	2010).	However,	Nrf2	disruption	has	enabled	the	cells	towards	carcinogens,	which	lead	to	the	 progression	 of	 inflammation	 and,	 finally,	 cancer	 formation	 (Slocum	 S.L.	 et	 al.,	 2011;	Takahashi	H.	et	al.,	2015).	This	dual	action	of	Nrf2	has	been	termed	as	a	‘double-edged	sword’	with	respect	to	the	benefits	or	risks	of	the	Keap1–Nrf2	pathway	in	cells	(Lau	A.	et	al.,	2008).	The	Nrf2	transcription	factor	is	associated	with	the	phase	II	enzymes	gene	regulation,	as	it	
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maintains	the	appropriate	level	of	these	enzymes	inside	the	cell.	Excessive	and	uncontrolled	Nrf2	expression	leads	to	the	survival	of	both	normal	as	well	as	cancerous	cells.	Hence,	the	Nrf2	down-stream	gene	expression	balance	 is	required	to	obtain	the	clinical	benefits	and	with	less	side	effects.	The	regulation	of	Nrf2	levels	by	Keap1	is	abrogated	in	some	human	cancers	(Padmanabhan	B.	et	al.,	2006;	Singh	A.	et	al.,	2006).	Mutations	in	Nrf2	and	Keap1	genes	have	been	found	frequently	in	various	cancer	cases.	These	mutations	are	sufficient	to	lead	 to	 constitutive	 activation	 of	 Nrf2	 by	 disrupting	 the	 Nrf2–Keap1	 interaction.	 Nrf2	activation	in	cancers	contributes	to	drug	resistance	by	efflux	of	anticancer	drugs	and	cancer	cell	proliferation	(Ohta	T.	et	al.,	2008;	Singh	A.	et	al.,	2008).	Nrf2	overexpression	accelerates	cancer	cell	proliferation,	because	Nrf2	regulates	genes	involved	in	metabolic	reprograming	and	cell	cycles	(Mitsuishi	Y.	et	al.,	2012).	In	this	context,	the	development	of	Nrf2	inhibitors	is	challenging	for	cancer	treatment.	The	maintenance	 of	 proper	 homeostatic	 conditions	 by	 the	 development	 of	 Nrf2	inhibitors/activators	is	a	vital	therapeutic	strategy.				
 
	
	
 
 
Keap1 can be sub-divided into five different domains, name-
ly, the N-terminal region (NTR), the broad-complex,
tramtrack and bric-à-brac (BTB) domain, the intervening re-
gion (IVR) or the BACK domain, double glycine repeats
(DGR) or β-propeller domain and the C-terminal region
(Stogios and Privé 2004) (Fig. 2). The β-propeller domain
and the C-terminal region together is called Keap1–DC
(Keap1–DC, hereafter).
The BTB domain is essential for homodimerisation of the
Keap1 protein. The BTB domain along with the IVR domain
play an essential role for Nrf2 polyubiquitination and 26S
proteasomal mediated degradation under basal conditions.
Fig. 1 Under homeostatic
conditions, Nrf2 is negatively
regulated and ubiquitinated
through Keap1, and degraded by
the proteasomal degradation
pathway. Under stressed
conditions, Nrf2 dissociates from
Keap1, translocates into the
nucleus and activates
cytoprotective genes
Fig. 2 Domain structures of
Keap1 and Nrf2. aKeap1 consists
of three major functional
domains: the BTB, IVR, and the
Kelch/β-propeller domains. b
The reactive cysteine residues in
Keap1 are indicated with
asterisks. c The Nrf2 protein
contains six domains, Neh1–
Neh6. The ETGE and DLG
motifs in the Neh2 domain are
essential for the direct interaction
with the Kelch domain of Keap1
Biophys Rev (2017) 9:41–56 43
Figure	 6.	 Keap1-Nrf2	 pathway.	 Under	 normal	 conditions,	 Nrf2	 is	 constantly	 degraded	 via	 the	 ubiquitin–proteasome	pathway	in	a	Keap1-dependent	manner.	In	the	presence	of	electrophiles	or	ROS,	Nrf2	dissociates	from	Keap1	and	 translocates	 into	 the	nucleus,	where	 it	binds	 specific	 sequences	 called	ARE	 (Antioxidant	Responsive	Elements).	Nrf2	regulates	the	expression	of	cytoprotective	genes	involved	in	the	response	to	oxidative	stress.	(Image	from	Deshmukh	P.	et	al.	2017).	 
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1.7 PHARMACOLOGICAL THERAPIES 
 
1.7.1 Different pharmacological treatments 
 Various	combinations	of	proton	pump	inhibitors	(PPIs)	and	antimicrobial	agents	have	been	designed	 to	 treat	 H.	 pylori	 infection.	 These	 regimens	 include	 triple	 therapy,	 bismuth-containing	 quadruple	 therapy,	 sequential	 therapy,	 concomitant	 therapy	 (non-bismuth	quadruple	therapy),	and	hydrid	therapy.	
Triple	 therapy:	 this	 therapy	 consists	 in	 a	 conventional	 PPI	 with	 amoxicillin	 and	clarithromycin.	 The	 efficacy	 of	 standard	 triple	 therapy	 is	 decreasing	 in	 many	 regions	worldwide	(Thung	I.	et	al.,	2016);	triple	therapy	is	still	the	most	commonly	used	treatment	against	H.	pylori,	but	a	fast	decrease	in	efficacy	has	forced	gastroenterologists	to	find	other	regimens.		
Quadruple	 therapy:	 this	 regimen	 contains	 bismuth	 subcitrate,	 a	 PPI,	 tetracycline	 and	metronidazole	(Zullo	A.	et	al.,	2017).	
Sequential	therapy:	this	simple	regimen	is	a	dual	therapy	including	a	PPI	plus	amoxicillin	1	g	(both	twice	daily)	given	for	the	first	5	days,	followed	by	standard	triple	therapy	including	a	PPI,	clarithromycin	500	mg	and	tinidazole	500	mg	(twice	daily)	for	the	next	5	days.	The	principle	for	this	regimen	was	that	following	initial	exposure	to	amoxicillin	the	bacterial	cell	wall	will	be	disrupted,	facilitating	penetration	of	the	subsequent	drugs	(Zullo	A.	et	al.,	2000;	 Gerrits	 M.M.	 et	 al.,	 2006;	 Lee	 H.	 et	 al.,	 2017).	 Moreover,	 there	 is	 some	 evidence	indicating	 the	 role	 of	 amoxicillin	 in	 changing	 the	 permeability	 of	 efflux	 pumps	 of	 target	bacteria	(Webber	M.A.	et	al.,	2003).	
Concomitant	therapy:	This	regimen	contains	a	standard	dose	of	PPI,	metronidazole	(500	mg	 twice	 daily),	 clarithromycin	 (500	 mg	 twice	 daily)	 and	 amoxicillin	 (1	 g	 twice	 daily),	administrated	for	the	whole	duration.	The	main	preference	for	concomitant	therapy	rather	than	standard	therapy	is	its	lower	complexity	compared	with	sequential	therapy.		
Hybrid	therapy:	Hybrid	therapy	is	a	regimen	that	is	a	combination	of	sequential	therapy	and	 concomitant	 therapy.	 This	 regimen	 contains	 a	 conventional	 PPI	 and	 amoxicillin	 for	10days	or	14	days	and	metronidazole	and	clarithromycin	for	the	last	7	days	of	therapy	as	a	quadruple	(hybrid)	therapy.											
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1.7.2 Therapy failure 
	Graham	et	al.	reported	three	reasons	for	failure	of	anti-H.	pylori	therapy	(Graham	D.Y.	et	al.,	2010):	I. poor	patient	compliance;	II. antimicrobial	resistance;		III. fast	metabolism	of	conventional	PPIs.		It	has	been	widely	declared	that	clarithromycin	resistance	is	the	crucial	factor	affecting	the	success	 of	 triple	 therapy	 (Gong	 E.J.	 et	 al.,	 2014;	 Kawai	 T.	 et	 al.,	 2014).	 As	 such,	 the	susceptibility	 profile	 to	 clarithromycin	 is	 an	 important	 factor	 before	 prescription	 (Abadi	A.T.B.,	 2017).	 Use	 of	 clarithromycin	 in	 therapeutic	 regimens	 against	H.	 pylori	 should	 be	cautious	in	regions	with	a	resistance	rate	>20%	(Sugano	K.	et	al.,	2015;	Thung	I.	et	al.,	2016).																								
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1.8 TANNINS 
 Tannins	are	polyphenolic	compounds	contained	mainly	 in	 the	vacuoles	of	 the	cells	of	 the	barks,	leaves	and	galls	of	some	plants;	tannins	are	divided	in	hydrolizable	and	condensed	tannins.		
1.8.1 Hydrolizable tannins 
	Hydrolizable	tannins	are	constituted	by	a	molecule	of	sugar	linked	to	molecules	of	gallic	acid	(gallotannins)	 or	 ellagic	 acid	 and	 gallic	 acid	 (ellagitannins).	 Chemically,	 ellagitannins	 are	considered	hexahydroxydiphenoyl	esters	of	carbohydrates.	In	presence	of	specific	enzymes	(such	as	tannase),	ellagitannins	are	hydrolyzed	leading	to	the	release	of	the	ellagic	acid	and	the	sugar	molecule.		These	compounds	are	contained	only	in	few	fruits,	in	particular	red	fruits	of	the	genus	Rubus	(blackberry,	 raspberry,	 cranberry	 and	 cloudberry)	 and	Fragaria	 (strawberry)	 (Häkkinen	S.H.	et	al.,	2000),	and	in	other	fruits	such	as	pomegranate	and	walnuts	(Zafrilla	P.	et	al.,	2001;	Gil	M.I.	et	al.,	2000;	Fukuda	T.	et	al.,	2003).		
			
In	vitro	studies	show	that,	at	the	gastric	level,	ellagitannins	are	not	absorbed	and	they	are	quite	stable,	gastric	acidity	(pH	1.8	-2.0)	and	digestive	enzymes	are	not	able	to	hydrolyze	ellagitannins	to	free	ellagic	acid,	which	can	be	absorbed	in	this	district	(the	stomach	is	the	first	 place	 for	 the	 absorption	 of	 free	 ellagic	 acid)	 (Larrosa	 M.	 et	 al.,	 2010).	 The	 limited	absorption	 of	 the	 ellagitannins,	 at	 the	 gastric	 level,	 suggests	 that	 the	 activity	 of	 these	compounds,	introduced	with	the	diet,	takes	place	mainly	in	situ.	The	ellagitannins,	however,	in	the	intestinal	tract	are	partially	hydrolyzed	to	ellagic	acid	(absorption	of	ellagic	acid	in	the	gut	 is	 very	 limited)	 and	 they	 can	 be	 further	metabolized	 by	 the	 intestinal	microflora	 to	
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Figura 7. Pelargonidina-3-O-glucoside. 
 
PROANTOCIANIDINE: so o tannini condensati; i tannini condensati sono polimeri del 
flavano, constano di molecole di catechina e di epicatechina unite da legami carbonio-
carb nio. 
ELLAGITANNINI: sono ta nini idrolizzabili; i tannini id olizzabili constano di una 
molecola di glucosio, centrale, legata a molecole di acido gallico (gallotannini) o di acido 
ellagico (ellagitannini); quindi gli ellagitannini sono esaidrossidifenoil esteri di carboidrati. 
Questi tannini sono idrolizzati da specifici enzimi (tannasi) nei loro componenti molecolari 
(acido ellagico, acido gallico e corrispondenti porzioni zuccherine) e si decompongono 
lentamente in soluzioni acquose. Un esempio di ellagitannino presente nella fragola è 
l’agrimonina. 
 
 
 
Figura 8. La figura mostra le formule di struttura dell’acido esaidrossidifenico, dell’acido ellagico e 
dell’acido gallico. Quando gli ellagitannini sono esposti a specifici enzimi (le tannasi) si ha l’idrolisi dei 
legami estere ed il riarrangiamento spontaneo del gruppo esaidrossidifenico a dare acido ellagico. L’acido 
ellagico è un dimero e può essere ulteriormente idrolizzato ad acido gallico, un derivato dell’acido benzoico. 
 
 
 
ACIDO 
ESAIDROSSIDIFENICO
ACIDO
 ELLAGICO
ACIDO
GALLICO
Hexahydroxydiphenic	acid	
Ellagic	acid	 Gallic	acid	
Figure	7.	Chemical	structure	of	hexahydroxydiphenic	acid,	ellagic	acid	and	gallic	acid.	
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urolithins,	a	family	of	compounds	characterized	by	the	presence	of	a	dibenzopyran-6-one	structure,	with	different	hydroxyl	 substituents	 (Gasperotti	M.	et	al.,	2010;	Cerda	B.	et	al.,	2005).	Generally	speaking,	the	synthesis	of	urolithins	begins	in	the	small	intestine	with	the	release	of	urolithin	D	and	urolithin	C	and	ends	in	the	distal	part	of	the	colon,	with	the	release	of	urolithin	A	and	urolithin	B	(Espín	J.C.	et	al.,	2007).	Urolithins,	once	absorbed	by	intestinal	cells,	 are	 subjected	 to	 a	 process	 of	 glucuronation	 before	 entering	 the	 portal	 circulation.	However,	 the	 type	of	urolithins	released	 in	 the	gut	 is	strictly	dependent	on	 the	source	of	ellagitannins.	REF	It	has	been	shown,	however,	that	these	molecules	can	reach	concentrations	around	20	μM,	in	humans	following	a	consumption	of	pomegranate	juice,	a	food	rich	in	ellagitannins	(Cerda	B.	 et	 al.,	 2004).	 It	 is	 important	 to	 consider	 that	 there	 are	 significant	 inter-individual	differences	 regarding	 the	 bioavailability	 of	 ellagitannins;	 this	 variability	 is	 probably	dependent	to	the	composition	of	the	microbiota	in	the	human	digestive	tract	(Puupponen-Pimia	 R.	 et	 al.,	 2013).	 The	 composition	 of	 the	 intestinal	 microflora	 is	 different	 among	individuals,	and	this	means	that	each	microbial	community	gives	rise	to	different	metabolic	profiles	(Tappenden	K.A.	et	al.,	2007;	Forester	S.C.	et	al.,	2009);	therefore,	the	metabolism	of	the	constituents	contained	in	foods,	by	the	intestinal	microbiota,	is	one	of	the	key	factors	for	the	 biological	 effects	 exerted	 by	 these	 constituents	 (Tomas-Barberan	 F.A.	 et	 al.,	 2012).	Recently,	 the	 biological	 properties	 of	 the	 ellagitannins	 and	 their	 derivatives	 have	 been	studied	 with	 increasing	 attention,	 showing	 anti-inflammatory	 (Adams	 L.S.	 et	 al.,	 2006;	Dell’Agli	M.,	2010),	anti-proliferative	(Adams	L.S.	et	al.,	2006),	antiviral	(Puupponen-Pimiä	R.	et	al.,	2005),	and	antiplasmodial	activities	(Dell’Agli	M.	et	al.,	2009).			
1.8.2 Condensed tannins 
 Condensed	 tannins	 (proanthocyanidins)	 are	 formed	 by	 molecules	 of	 catechin	 and	epicatechin	 linked	 by	 strong	 carbon-carbon	 bonds.	 Proanthocyanidins	 characterize	exclusively	of	(epi)catechin	units	are	called	procyanidins.	Procyanidins	are	present	in	a	wide	range	of	foods,	such	as	fruits,	legume	seeds,	cereal	grains,	beverages	including	red	wine	and	tea.	Cocoa	contains	the	highest	procyanidins	content	among	all	foods	(Martinez-Micaelo	N.	et	 al.,	 2012).	 Rios	 et	 al.	 demonstrated	 that	 cocoa	 procyanidins	 are	 stable	 during	 gastric	transit	 in	humans	 (Rios	L.Y.	et	al.,	2002),	 therefore	 it	 is	possible	 that	 they	can	act,	 in	 the	stomach,	 in	 their	 unaltered	 form.	 Once	 absorbed,	 procyanidins	 are	 conjugated	 to	glucuronide,	 sulfate	and	methyl	groups,	mostly	 in	 the	mucosa	and	 liver	 (Fraga	C.G.	et	al.,	2011).	Epidemiological	 studies	demonstrate	 that	consumption	of	procyanidins-rich	 foods	reduce	 the	 incidence	 of	 inflammatory	 diseases	 and	 exert	 beneficial	 effects	 on	 several	
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pathologies,	including	metabolic	syndrome,	atherosclerosis	and	cancer	(Khan	N.	et	al.,	2010;	Engler	M.B.	et	al.,	2006).			
1.9 FRAGARIA X ANANASSA DUCH. 
 
1.9.1 Botanical description 
 
Fragaria	X	ananassa	Duch.	is	a	hybrid	species	cultivated	all	over	the	world	for	its	fruits,	used	in	large	quantities	as	fresh	fruits	or	in	food	preparations	such	as	fruit	juices,	smoothies,	jams	etc.	The	plant	is	a	hybrid	originated	from	Fragaria	virginiana	Duch.,	native	to	North	America,	and	
Fragaria	 chiloensis	 L.,	 native	 to	 Chile	 and	 Argentina.	 It	 is	 a	 perennial	 herbaceous	 plant	belonging	to	the	family	of	Rosaceae,	rhizomatous,	with	long	rooting	stolons.	Leaves	consist	of	three	oval	toothed	leaflets.	Flowers,	arranged	at	the	top	of	the	stem,	are	constituted	of	five	white	petals.	The	fruit	is	aggregated	and	consists	of	a	red	fleshy	receptacle	with	numerous	small	achenes,	which	are	the	true	fruits	of	the	strawberry,	scattered	along	the	entire	surface.		
		
 
1.9.2 Nutritional profile 
 On	the	basis	of	its	nutritional	profile,	strawberry	is	a	healthy	food	choice;	fiber	and	fructose	content	may	help	to	regulate	blood	sugar	levels	by	slowing	the	digestion;	moreover,	the	fiber	content	can	also	contribute	to	the	control	of	the	energy	intake	thanks	to	their	satiating	effect.	Strawberries	 are	 a	 source	 of	 essential	 fatty	 acids,	 since	 strawberry	 seed	 oil	 is	 rich	 in	unsaturated	fatty	acids.	
Figure	8.	Image	of	Fragaria	X	ananassa	Duch.	
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Among	the	main	carotenoids	and	tocopherols	identified	in	the	fruit	we	can	find	α-tocopherol,	β-tocopherol,	γ-tocopherol,	δ-tocopherol,	lutein,	etc.	A	very	interesting	aspect	of	strawberry	is	its	high	content	of	vitamin	C;	in	addition	to	vitamin	C,	 the	 presence	 of	 folic	 acid	 can	 contribute	 to	 enhance	 the	 importance	 of	 this	 fruit,	considering	 that	 strawberry	 is	 one	 of	 the	 main	 natural	 sources	 of	 this	 essential	micronutrient	(the	content	is	estimated	in	the	range	20-25	μg	/per	100	g	of	fresh	product).	Strawberry,	 although	 not	 in	 high	 quantities,	 is	 also	 a	 source	 of	 other	 vitamins,	 such	 as	vitamin	A,	E,	K,	B6,	niacin,	riboflavin	and	thiamine.	It	has	been	estimated	 that	a	 consumption	of	about	144	g	of	 strawberries	 can	provide	an	amount	of	manganese	able	to	satisfy	more	than	20%	of	daily	intake	of	this	mineral;	other	important	 minerals	 contained	 are:	 potassium,	 iodine,	 magnesium,	 copper,	 iron	 and	phosphorus.	In	addition	to	these	nutrients,	strawberry	also	contains	several	non-nutritive	components	such	as	phenolic	and	polyphenolic	compounds,	including	flavonoids,	phenolic	acids,	lignans	and	tannins.		
1.9.3 Polyphenolic content 
 Strawberry	contains	different	class	of	polyphenols,	including:	anthocyanins,	responsible	for	the	red	color	of	the	fruit,	flavonols,	flavanols,	hydroxycinnamic	acid	derivatives,	ellagic	acid,	ellagic	acid	glycosides,	ellagitannins	and	proanthocyanidins	(Aaby	K.	et	al.,	2005;	Maatta-Riihinen	K.R.	et	al.,	2004;	Seeram	N.P.	et	al.,	2006;	Clifford	M.N.,	2000;	Buendia	B.	et	al.,	2010).	The	study	performed	by	Buendia	et	al.,	analyzed	and	quantified	polyphenolic	compounds	from	15	different	cultivars	of	strawberry,	obtaining	the	following	results:		
	
Polyphenolic	compounds	 mg/100	g	of	fresh	fruit	Anthocyanins	 20.2	–	47.4	Flavonols	 1.5	–	3.4	Proanthocyanidins	 53.9	–	163.2	Ellagitannins	 9.67	–	22.86	Ellagic	acid	glycosides	 0.88	–	2.06		This	 study	 shows	 that	 strawberries	 are	 an	 important	 source	 of	 polyphenols	 and	proanthocyanidins	 represent	 the	 most	 abundant	 component	 (Buendia	 B.	 et	 al.,	 2010).	Regarding	the	ellagitannins	content,	a	study	carried	on	by	Koponen	and	colleagues	suggests	that	 strawberries	 contain	 larger	 amount	 of	 these	 compounds	 (77.1	mg	 /	 100	 g	 of	 fresh	product)	 (Koponen	 J.M.	 et	 al.,	 2007)	 compared	 to	 that	 reported	 by	 Buendia	 et	 al.	 This	
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difference,	as	 suggested	by	 the	authors,	 is	probably	ascribable	 to	 the	different	extraction	method	used	in	the	two	studies.	It	is	important	to	underline	that	the	information	concerning	the	ellagitannins	content	reported	in	the	literature	is	very	variable.	This	variability	is	due	to	numerous	 factors	 including	 genetic	 differences	 of	 the	 cultivars,	 environmental	 factors	(place,	conditions	of	growth,	storage	of	the	fruit	and	its	ripeness)	as	well	as	the	method	used	for	the	extraction	and	for	the	quantification.	In	a	study	performed	by	Gasperotti	et	al.,	the	authors	have	been	discovered	that	agrimoniin	is	the	main	ellagitannin	contained	in	Fragaria	X	ananassa	Duch.,	as	suggested	by	the	same	research	 group	 in	 a	 previous	 work	 (Vrhovsek	 U.	 et	 al.,	 2012);	 moreover,	 casuarictin,	identified	for	the	first	time	as	a	component	of	strawberry,	is	another	important	ellagitannin	of	Fragaria	X	ananassa	Duch.,	reaching,	in	some	cultivars,	a	concentration	similar	to	that	of	agrimoniin.	The	 total	 content	of	 ellagitannins	 and	ellagic	 acid	 conjugates	 found	 in	 this	 study	 is	 quite	variable,	84.8	-	1636	mg/kg	of	fresh	product,	depending	on	the	cultivars	considered	and	the	fruit	ripening	phase	(Gasperotti	M.	et	al.,	2013).		
Ellagitannins	 mg/Kg	of	fresh	fruit	Agrimoniin	 25	–	510	Casuarictin	 19	–	386	
	
Anthocyanins:	 the	 anthocyanins	 (anthocyanosides)	 are	 water-soluble	 pigments	responsible	for	the	color	of	many	flowers	and	fruits.	On	the	chemical	point	of	view,	they	are	glycosides,	whose	aglycone	(called	anthocyanidin)	derives	from	2-phenylbenzopyril	cation	(flavylium	 cation).	 The	 most	 abundant	 anthocyanoside	 contained	 in	 strawberry	 is	pelargonidin-3-O-glucoside	(Buendia	B.	et	al.,	2010).		
	
	
	
Figure	9.	Flavylium	cation	
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Ellagitannins:	as	described	in	the	previous	paragraph,	ellagitannins	are	formed	by	a	central	molecule	 of	 sugar	 linked	 to	molecules	 of	 gallic	 and	 ellagic	 acid.	 The	 two	most	 abundant	ellagitannins	find	in	strawberry	are	agrimoniin	and	casuarictin	(Gasperotti	M.	et	al.,	2013).						
												 																				 			
Proanthocyanidins:	these	compounds	are	polymers	formed	by	the	condensation	of	flavan-3-ols.	They	are	composed	by	molecules	of	catechin	and	epicatechin	linked	by	strong	carbon-carbon	 bonds.	 An	 example	 of	 procyanidins	 contained	 in	 strawberry	 is	 procyanidins	 B1	(Fumagalli	M.	et	al.,	2016).	
 
	
Figure	10.	Pelargonidin-3-O-glucoside	
Figure	11.	Chemical	structure	of	agrimoniin	(A)	and	casuarictin	(B)	
Figure	12.	Chemical	structure	of	procyanidin	B1	
A	 B	
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1.9.4 Factors affecting micronutrients and polyphenols content 
 Several	factors	such	as	development	and	ripening	stage,	environmental	conditions,	genetic	factors	and	storage	can	influence	the	polyphenolic	content	and	the	antioxidant	capacity	of	the	strawberry	fruit	(Wang	S.Y.	et	al.,	2000;	Tulipani	S.	et	al.,	2011;	Kosar	M.	et	al.,	2004).	The	anthocyanin	profile	of	strawberry	also	varies	during	ripening	but	in	an	opposite	way.	In	all	the	cultivars,	it	has	been	observed	that	the	anthocyanins	accumulate	in	the	fruit	when	it	is	red,	while	low	quantities	have	been	found	in	the	previous	ripening	stages	(Wang	S.Y.	et	al.,	2000;	 Tulipani	 S.	 et	 al.,	 2011;	 Kosar	 M.	 et	 al.,	 2004).	 According	 to	 several	 studies,	 the	antioxidant	 capacity	 of	 strawberry	 decreases	 gradually	 during	 ripening	 and	 decrease	 is	associated	with	a	strong	reduction	of	the	tannic	component,	while	the	non-phenolic	polar	antioxidants	(ex.	vitamin	C)	slightly	increase	during	ripening	(Tulipani	S.	et	al.,	2011;	Kosar	M.	et	al.,	2004;	Olsson	M.E.	et	al.,	2004).	Gasperotti	 et	 al.	 show	 that	 during	 the	 ripening	 phases	 of	 the	 fruit	 (Fragaria	 X	ananassa	Duch.)	 the	 concentration	 of	 ellagitannins	 and	 ellagic	 acid	 conjugates	 rapidly	 decrease,	observation	 that	 is	 common	 in	 all	 the	 cultivars	 evaluated	 in	 the	 study.	 The	 total	concentration	of	ellagitannins	and	ellagic	acid	conjugates	in	the	fruit	at	the	end	of	ripening	is	 about	 half	 of	 that	 found	 in	 the	 green	 fruit	 (Gasperotti	M.	 et	 al.,	 2013).	 This	 decline	 in	ellagitannins	reported	by	Gasperotti	et	al.	is	comparable	with	the	results	published	in	other	papers	(Tulipani	S.	et	al.,	2011;	Pinelli	L.D.D.	et	al.,	2011).	Genetic	 factors	 and	 environmental	 conditions	 play	 a	 key	 role	 in	 the	 chemical	 profile	 of	strawberry,	 micronutrients	 content	 and	 phytochemical	 compounds	 can	 change	 in	 the	different	cultivars	(Wang	S.Y.	et	al.,	2000;	Clifford	M.N.,	2000;	Castro	I.	et	al.,	2002;	Garcia-Viguera	C.	et	al.,	1998;	Lopes-da-Silva	F.	et	al.,	2002).	The	conditions	in	which	the	fruit	is	stored	can	influence	the	phytochemical	profile	and	the	micronutrient	content.	The	storage	temperature	is	a	key	factor	able	to	influence	the	stability	of	 the	 phenolic	 compounds	 in	 the	 post-harvest	 phases	 (Olsson	 M.E.	 et	 al.,	 2004).	 The	flavonoid	content	of	strawberry	increases	during	the	storage	phase	(Jin	P.	et	al.,	2011;	Ayala-Zavala	J.F.	et	al.,	2004),	this	result	could	be	attributed	to	the	phenolic	metabolism	of	the	fruit	after	harvest.	The	storage	positively	influences	the	antioxidant	capacity	of	the	strawberries,	because	the	complex	reactions	that	take	place	inside	them	during	the	post-harvest	period	facilitate	the	formation	of	compounds	with	a	great	antioxidant	capacity,	even	if	the	organoleptic	qualities	of	the	fruit	are	already	deteriorated	significantly	(Piljac-Zegarac	J.	et	al.,	2011).	
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Therefore,	 in	general,	 the	antioxidant	capacity	increases	during	storage	(Tulipani	S.	et	al.,	2010)	or	remains	stable	(Piljac-Zegarac	J.	et	al.,	2011;	Kevers	C.	et	al.,	2007),	in	addition	the	antioxidant	capacity	also	increases	following	a	long	exposure	to	a	high	storage	temperature	(Jin	P.	et	al.,	2011;	Ayala-Zavala	 J.F.	et	al.,	2004).	Although	strawberries	are	consumed	as	fresh	fruits,	many	strawberry-based	products	such	as	fruit	juices,	nectars,	purees,	jams	and	jellies	are	available	on	the	market.	It	has	been	shown	that	fruit	processing	affects	the	content	of	 antioxidant	 substances.	 Several	 studies	 have	 shown	 that	 the	 antioxidant	 content	 of	strawberry-based	 products	 is	 lower	 than	 the	 fresh	 fruit,	 the	 reduction	 degree	 is	 strictly	linked	to	the	time	and	processing	method	(such	as	heat	treatment)	(Hartmann	A.	et	al.,	2008;	Bursac	Kovacevic	D.L.	et	al.,	2009).		
1.9.5 Biological activities of Fragaria X ananassa Duch. 
 
Antioxidant	 activity:	 in	 a	 study	 performed	 by	 Pajk	 et	 al.,	 the	 authors	 assessed	 the	antioxidant	effect	of	strawberries	in	an	animal	model	(pig),	investigating	the	ability	of	the	fruit	to	reduce	oxidative	stress	induced	by	the	intake	of	a	large	amount	of	polyunsaturated	fatty	acids.	The	animals	were	fed	daily	with	a	basal	diet	supplemented	with	seeds	oil	and	strawberries;	the	oxidative	stress	and	the	antioxidant	status	of	the	animals	were	evaluated	at	the	beginning	and	at	the	end	of	the	experiment,	measuring	the	following	parameters:	the	degree	of	DNA	damage	in	mononuclear	blood	cells,	the	concentration	of	malonildialdehyde	(MDA)	in	the	blood	plasma,	24-h	urine	MDA	excretion	rate,	plasma	total	antioxidant	status,	the	concentration	of	tocopherols	in	the	blood	plasma	and	the	concentration	of	glutathione	peroxidase	 in	 the	 erythrocytes.	 The	 results	 obtained	 suggest	 that	 supplementation	with	strawberries	 can	decrease	diet-induced	oxidative	 stress;	 indeed,	 the	 authors	 observed:	 a	reduction	of	MDA,	a	greater	protection	of	the	blood	mononuclear	cells	against	DNA	damage,	an	increase	of	the	antioxidant	state	of	the	plasma	and	a	reduction	of	the	concentration	of	glutathione	peroxidase	in	the	erythrocytes	(Pajk	T.	et	al.,	2006). Henning	et	al.	have	demonstrated	that	the	consumption	of	strawberries,	for	a	long	time	(3	weeks),	delays	LDL	peroxidation	(Henning	S.M.	et	al.,	2010),	while	Tulipani	et	al.	observed	a	significant	 increase	 in	 the	 resistance	 of	 erythrocytes	 to	 oxidative	 damage,	 following	 a	prolonged	strawberry	intake	(2-3	weeks)	(Tulipani	S.	et	al.,	2011).	In	a	study	of	Alvarez-Suarez	et	al.,	several	groups	of	rats	were	fed	with	strawberry	extracts	(40	mg/kg	of	body	weight)	for	10	days.	Subsequently,	a	gastric	lesion	was	induced,	in	the	animals,	using	ethanol.	The	 strawberry	extracts	 contained	high	amounts	of	 anthocyanins	showing	an	important	antioxidant	capacity.	The	results	obtained	in	this	study	showed	that	strawberry	 extracts	were	 able	 to	 exert	 a	 gastroprotective	 effect	 against	 ethanol-induced	
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damages,	 reducing	 lipid	 peroxidation	 and	 preserving/activating	 some	 endogenous	antioxidant	 enzymes	 (SOD	 and	 cat);	 the	 antioxidant	 activity	 shown	 in	 this	 work	 was	probably	 related	 to	 the	 polyphenolic	 content	 of	 the	 extracts	 and,	 in	 particular,	 to	 the	anthocyanins	(Alvarez-Suarez	J.M.	et	al.,	2011).	In	a	further	study,	published	in	2012	by	Ozsahin	et	al.,	 the	authors	have	been	shown	that	strawberry	extracts	(rich	in	flavonoids),	from	three	different	cultivars,	were	able	to	prevent	lipid	peroxidation	in	an	in	vitro	environment	(Ozsahin	A.D.	et	al.,	2012).	Another	work,	performed	by	Gasparrini	et	al.,	aimed	to	evaluate	the	effects	of	strawberry	extracts	on	inflammation	evoked	by	E.	Coli	lipopolysaccharide	in	human	dermal	fibroblast,	by	 measuring	 reactive	 oxygen	 species	 production,	 apoptosis	 rate,	 antioxidant	 enzymes	activity,	mitochondria	functionality	and	also	investigating	the	molecular	pathway	involved	in	inflammatory	and	antioxidant	response.	The	results	demonstrated	that	strawberry	pre-treatment	 reduced	 intracellular	 reactive	 oxygen	 species	 levels,	 apoptotic	 rate,	 improved	antioxidant	 defence	 and	 mitochondria	 functionality	 in	 lipopolysaccharide-treated	cells.	Strawberry	exerted	protective	activities	through	the	inhibition	of	the	NF-kB	signalling	pathway	 and	 the	 stimulation	 of	 the	 Nrf2	 pathway,	 with	 a	mechanism	 AMPK-dependent.	These	results	confirm	the	health	benefits	of	strawberry	in	the	prevention	of	inflammation	and	oxidative	stress	condition	in	lipopolysaccharide-treated	cells	(Gasparrini	M.	et	al.,	2018).	
Anti-inflammatory	 activity:	 Basu	 et	 al.	 demonstrated,	 in	 27	 patients	 with	 metabolic	syndrome,	 that	 a	 daily	 consumption	 (for	 8	 weeks)	 of	 a	 beverage	 containing	 50	 g	 of	lyophilized	 strawberries,	 was	 able	 to	 decrease	 several	 risk	 factors	 related	 to	 the	development	 of	 atherosclerosis,	 such	 as	 total	 and	 LDL	 cholesterol	 and	 the	 levels	 of	 the	adhesion	molecules	in	the	blood	(Basu	A.	et	al.,	2010).	A	cross-over	study,	performed	on	14	women	and	10	men	(mean	age:	50.9	±	15	years;	BMI:	29.2	±	2.3)	 for	6	weeks,	 showed	 that	 the	 consumption	of	 a	 strawberries-based	beverage	before	 a	 meal	 rich	 in	 carbohydrates	 and	 fats	 (associated	 with	 an	 increase	 of	 the	inflammatory	markers	and	oxidative	stress)	reduced,	in	statistically	significant	manner,	the	post-prandial	concentration	of	IL-1b	and	PAI-1,	and,	although	in	not	statistically	significant	manner,	the	concentration	of	IL6,	compared	to	the	group	who	received	placebo	(Ellis	C.L.	et	al.,	2011).	The	aim	of	the	study	of	Parelman	et	al.	was	to	evaluate	the	anti-inflammatory	capacity	and	the	 ability,	 of	 strawberries,	 to	 regulate	 blood	 glucose	 in	 a	mouse	model	 of	 diet-induced	obesity.	Thirty-six	male	mice	(C57BL/6J)	were	divided	in	4	groups,	each	of	these	groups	was	fed	with	a	different	diet:	one	group	was	fed	with	a	low-fat	diet	(LF,	13%	fat),	a	group	with	a	
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low-fat	diet	supplemented	with	strawberry	freeze-dried	(LFSB),	a	group	with	a	high-fat	diet	(HF,	44%	fat)	and	a	group	with	a	high-fat	diet	supplemented	with	strawberry	freeze-dried	(HFSB).	The	results	showed	a	lower	blood	glucose	concentration	in	mice	supplemented	with	strawberries	compared	to	non-supplemented	mice,	and	a	lower	plasma	concentration	of	C-reactive	protein	in	the	LFSB	group	compared	to	the	other	groups;	these	results	suggest	the	possible	role	of	strawberry	in	reducing	the	risks	associated	with	obesity	and	diabetes	and	in	regulating	the	levels	of	some	inflammatory	markers	in	non-obese	individuals	(Parelman	M.A.	et	al.,	2012).	
Antimicrobial	activity:	in	a	study	performed	in	2004,	Chatterjee	and	collaborators	showed	that	the	incubation	of	the	strain	49503	of	Helicobacter	pylori	for	18	hours	with	anthocyanins-enriched	extracts,	of	some	berries	(including	strawberry),	was	able	to	significantly	reduce	the	 growth	 of	 the	 pathogen	 compared	 to	 the	 controls.	 They	 also	 showed	 that	 the	 use	 of	strawberry	extract	with	clarithromycin	increased	the	susceptibility	of	Helicobacter	pylori	to	the	antibiotic	(Chatterjee	A.	et	al.,	2004).	Anthony	and	colleagues	showed	that	the	strawberry	extract	enriched	in	the	polyphenolic	fraction	inhibited	the	growth	of	Giardia	intestinalis,	a	parasite	able	to	colonize	the	human	intestine.	 The	 efficacy	 of	 the	 strawberry	 extract	 was	 similar	 to	 the	 conventional	 drug,	metronidazole	(Anthony	J.P.	et	al.,	2011). 
Anti-hyperglycemic	 activity:	 strawberry	 has	 been	 investigated,	 for	 its	 potential	contribution	to	the	control	of	hyperglycemia	related	to	type	2	diabetes.	Strawberry	extracts	(Fragaria	X	ananassa	Duch.),	from	different	cultivars,	showed	that	the	fruit	 was	 able	 to	 inhibit	 the	 activity	 of	 the	 enzyme	 α-glucosidase,	 this	 could	 suggest	 a	potential	anti-hyperglycemic	effect	of	the	strawberry	(Da	Silva	Pinto	M.	et	al.,	2008).	In	 a	 following	 study	 performed	 by	 Da	 Silva	 Pinto	 et	 al.,	 it	 has	 been	 shown	 that	 the	ellagitannins	contained	 in	Fragaria	X	ananassa	Duch.	possessed	a	high	 inhibitory	activity	against	 the	enzyme	ACE	and	α-amylase,	suggesting	that	these	compounds	may	be	able	to	control	hyperglycemia	and	hypertension	related	to	type	2	diabetes	(Pinto	M.D.	et	al.,	2010).	
Anti-proliferative	activity:	an	important	study	concerning	the	anti-proliferative	activity	of	
Fragaria	X	ananassa	extracts	was	developed	by	Wang	S.	et	al.	The	aim	of	this	study	was	to	test	the	potential	inhibitory	effect	of	strawberry	extracts	on	the	activation	of	AP-1	and	NF-
kB	 transcription	 factors,	 induced	by	 tetradecanoylforbol-13-acetate	 (TPA)	 and	UVB	 rays,	and	assessed	the	inhibitory	effect	on	the	proliferation	and	transformation	of	cancer	cells.			
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The	results	obtained	are	as	follows:	
Ø Fragaria	extracts	inhibited	the	proliferation	of	the	A549	cell	line	(tumor	lung	epithelial	cells)	and	reduced	the	neoplastic	transformation	of	mouse	epidermal	cells	(JB6	P+).	
Ø Pre-treatment	of	mouse	epidermal	cells	(JB6	P+)	with	strawberry	extracts	inhibited	AP-1	and	NF-kB	activation	induced	by	TPA	and	UVB	rays.	
Ø The	 extracts	 blocked	 the	 phosphorylation	 of	 ERKs	 kinases	 induced	 by	 TPA	 and	 the	phosphorylation	of	ERKs	and	JNK	kinases	induced	by	UVB,	in	JB6	P+	cells.	Taken	together,	these	results	suggest	that	strawberry	probably	possess	an	antiproliferative	activity,	reducing:	AP-1	and	NF-kB	activity,	MAPK	signal,	proliferation	and	transformation	of	cancer	cells	(Wang	S.Y.	et	al.,	2005).		Seeram	and	colleagues	have	shown	that	the	extracts	obtained	from	some	berries	(including	
Fragaria	X	ananassa	Duch.)	were	able	to	inhibit,	in	a	concentration-dependent	manner,	the	growth	of	several	tumor	cell	lines,	including	KB	cells,	CAL-27,	MCF-7,	HT-29,	HCT116	and	LNCaP	(Seeram	N.P.	et	al.,	2006).	Zhang	et	al.,	according	to	the	previous	study	performed	by	Seeram	et	al.,	confirmed	that	the	
Fragaria	X	ananassa	extracts	exert	an	anti-proliferative	activity	against	some	human	tumor	cell	lines	(Zhang	Y.	et	al.,	2008).																		
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1.10 FRAGARIA VESCA L.  
 
1.10.1 Botanical description 
 Wild	strawberry	(Fragaria	vesca	L.)	is	a	diploid	species	(2n	=	14)	belonging	to	the	family	of	Rosaceae.	Wild	strawberry	 is	a	 low-growing,	deciduous	perennial	herb,	with	petioles	and	flowering	stems	typically	arising	from	a	single	crown	in	rosette	form.	Occasionally	a	single	crown	may	split	 into	2	or	more	crowns	by	 the	development	of	 an	axillary	meristem,	but	production	of	leaves	and	flowers	is	generally	restricted	to	a	single	meristematic	axis	in	each	ramet.	Petioles	are	generally	0.3	to	6.9	inches	(0.8-17.5	cm)	long,	with	flowering	stems	often	shorter.	Leaves	are	basal	and	palmately	trifoliate,	with	leaflets	0.5	to	2.6	inches	(1.3-6.5	cm)	long	and	0.5	to	2.8	inches	(1.3-	7.0	cm)	wide,	the	terminal	leaflet	being	largest.	Fleshy	fruits	are	up	to	0.4	inch	(1	cm)	thick	and	covered	with	0.05	inch	(1.3-1.4	mm)	long	achenes.	Crowns	arise	from	short	rhizomes,	spreading	and	forming	colonies	by	stolons	that	root	and	produce	plantlets	at	the	nodes.	
		
	
 
1.10.2 Polyphenolic content 
 Del	Bubba	et	al.	analyzed	the	variety	of	phenolic	compounds	contained	in	four	genotypes	of	
Fragaria	 vesca	 L.,	 providing	 for	 the	 first	 time	 a	 complete	 view	 of	 the	 polyphenolic	composition	of	this	species	of	Fragaria.	About	60	phenolic	compounds	have	been	identified,	including	 phenolic	 acids,	 ellagitannins,	 ellagic	 acid	 derivatives,	 flavonols,	 flavanols,	dihydrochalcons	and	anthocyanins	(Del	Bubba	M.	et	al.,	2012).	In	the	work	done	by	Gasperotti	et	al.,	two	different	cultivars	of	Fragaria	vesca	L.	were	used;	they	observed	that	Fragaria	vesca	L.	is	rich	in	ellagitannins	and	ellagic	acid	conjugates	(658	
Figure	13.	Image	of	Fragaria	vesca	L.	
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-	1636	mg/kg	of	fresh	product)	and,	as	demonstrated	in	Fragaria	X	ananassa	Duch.,	the	main	ellagitannin	 is	 agrimoniin.	 In	 addition,	 a	 significant	 presence	 of	 3-O-methyl-3'-O-α-ramnopyranoside	ellagic	acid	(33	-	132	mg/kg	of	fresh	product),	which	is	the	main	ellagic	acid	conjugate	present	in	Fragaria	vesca,	was	also	observed.	Even	in	Fragaria	vesca	L.,	a	substantial	decrease	in	the	total	concentration	of	ellagitannins	and	ellagic	acid	conjugates	during	the	last	ripening	stages	was	assessed	(Gasperotti	M.	et	al.,	2013).		
1.10.3 Biological activities of Fragaria vesca L. 
 
Antioxidant	activity:	a	work	published	by	Kanodia	and	colleagues,	showed	that	the	ethanol	extract	from	Fragaria	vesca	L.,	administered	orally	in	albino	rats	(used	as	animal	model	of	colitis),	at	the	dose	of	500	mg/kg,	was	able	to	counteract	the	oxidative	stress	associated	to	colitis,	at	tissue	level.	The	extract	showed	significant	prevention	of	increase	in	colon	weight	and	disease	activity	index	along	with	decrease	in	macroscopic	and	microscopic	lesion	score	as	 compared	 to	 control	 group.	 Significant	 improvement	 was	 observed	 in	 the	 levels	 of	myeloperoxidase	 (MPO),	 catalase	 (CAT)	 and	 superoxide	 dismutase	 (SOD),	 except	glutathione	(GSH).	Fragaria	vesca	extract	showed	significant	amelioration	of	experimentally	induced	intestinal	colitis,	which	may	be	attributed	to	its	antioxidant	and	anti-inflammatory	properties	(Kanodia	L.	et	al.,	2011).	
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Gastritis	is	an	inflammatory-based	disease	which	can	be	divided	in	acute	or	chronic	form.	Acute	 gastritis	 is	 caused	 by	 several	 risk	 factors,	 such	 as	 stress,	 use	 of	 anti-inflammatory	drugs	(NSAIDs),	alcohol	abuse	and	bile	reflux,	while	the	chronic	form	is	due	to	Helicobacter	
pylori	infection	(H.	pylori).		
H.	pylori	is	a	Gram-negative	bacterium,	specialized	in	the	colonization	of	the	human	gastric	epithelium	through	some	virulence	factors.	It	is	one	of	the	most	successful	human	bacterial	parasites	 which	 can	 persist	 lifelong	 if	 not	 treated	 efficiently	 (Graham	 D.Y.	 et	 al.,	 2010).	During	H.	pylori	infection,	gastric	epithelial	cells	release	several	pro-inflammatory	cytokines,	which	 play	 a	 key	 role	 in	 development	 of	 gastric	 diseases.	 One	 of	 the	 earliest	 cytokines	produced	 by	 the	 infected	 gastric	 epithelium	 is	 IL-8,	 a	 potent	 chemokine	 involved	 in	 the	recruitment	 of	 immune	 cells	 (Crabtree	 J.E.	 et	 al.,	 1994;	 Crabtree	 J.E.	 et	 al.,	 1994).	 This	response	is	highly	dependent	on	the	NF-kB	activation,	a	transcription	factor	deeply	involved	in	the	control	of	the	expression	of	several	pro-inflammatory	mediators,	including	IL-8.		The	bacterium	causes	also	an	increase	of	oxidative	stress	in	the	human	stomach,	and	gastric	epithelial	cells	are	a	source	of	ROS	in	the	H.	pylori-infected	stomach.	ROS	can	also	contribute	to	the	inflammatory	process,	acting	as	common	mediators	of	NF-kB	activation	(Handa	O.	et	al.,	2004).		Currently,	there	are	different	therapeutic	approaches	for	H.	pylori	eradication	based	on	the	administration	 of	 proton	 pump	 inhibitors	 in	 association	 with	 antibiotics;	 although	antimicrobial	 therapy	 appears	 the	 best	 way	 to	 eliminate	 the	 bacterium	 and	 related	inflammation,	 it	 is	 characterized	 by	 some	 factors	 leading	 to	 therapy	 failure,	 including	bacterial	and	host-related	factors,	resistance	to	the	antibiotics	and	side	effects	(Graham	D.Y.	et	 al.,	 2010).	 Common	 anti-inflammatory	 drugs	 (NSAIDs)	 can’t	 be	 used	 in	 this	 context,	because	they,	in	turn,	are	responsible	for	the	development	of	gastric	inflammation.	For	the	reasons	mentioned	above,	the	search	for	new	strategies,	also	derived	from	natural	products,	 as	 adjuvant	 to	 the	 conventional	 pharmacological	 approach,	 is	 needed.	 Several	classes	of	polyphenols	present	 in	 fruits	 and	vegetables	have	demonstrated	 to	possess,	 in	form	of	phytocomplex	or	as	pure	compounds,	anti-inflammatory	and	antioxidant	activity	at	the	gastric	level,	including	tannins	(Graziani	G.	et	al.,	2005;	Lai	S.	et	al.	2009;	Sangiovanni	E.	et	al.,	2013).	Strawberry	is	one	of	the	most	commonly	consumed	fruits	in	the	world	and	it	is	appreciated	for	 its	 organoleptic	 and	 nutritional	 properties.	 Moreover,	 this	 fruit	 contains	 several	polyphenols,	including	anthocyanosides	(mostly	pelargonidin	and	cyanidin	glycosides)	and	
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tannins,	both	condensed	(procyanidins)	and	hydrolysable	tannins	(especially	ellagitannins,	such	as	agrimoniin)	(Buendia	B.	et	al.,	2010;	Gasperotti	M.	et	al.,	2013).	Strawberry	is	one	of	the	few	fruits,	of	our	diet,	containing	ellagitannins,	since	these	compounds	are	uncommon	in	fruits	and	vegetables.	Recently,	our	group	demonstrated	that	ellagitannin-enriched	extracts	from	fruits	of	raspberry	and	blackberry	inhibit	ethanol-induced	gastritis	in	rats	acting	on	the	NF-kB	pathway;	the	anti-inflammatory	effect	was	ascribed,	at	least	in	part,	to	the	presence	of	the	ellagitannins	sanguiin	H-6	and	lambertianin	C.	(Sangiovanni	E.	et	al.,	2013).	Regarding	strawberry,	Alvarez-Suarez	et	al	demonstrated	that	administration	of	a	strawberry	extract	was	 able	 to	 inhibit	 ethanol-induced	 gastritis	 in	 rats;	 notably,	 the	 protective	 effect	 was	ascribed	 to	 anthocyanosides	 (Alvarez-Suarez	 J.M.	 et	 al.,	 2011).	 Although	 tannins	 are	important	 components	 of	 strawberries,	 until	 now	 the	 activity	 of	 strawberry	 tannins	 on	gastric	inflammation,	has	not	been	investigated.	Another	 issue	 that	 should	 be	 taken	 into	 consideration	 is	 that	 these	 compounds	 are	 not	absorbed	and	metabolized	 in	 the	 acid	 environment	of	 the	 stomach,	 suggesting	 that	 their	activity	may	be	exerted	in	situ	(Quideau	Editor.,	2009;	Rios	L.Y.	et	al.,	2002).		Therefore,	strawberry	appears	as	a	valuable	source	of	bioactive	components	that	can	exert	protective	effects	on	the	gastric	epithelium	and	that	deserve	further	investigation.	On	 these	 premises,	 the	 aim	 of	 this	 study	 was	 to	 investigate	 the	 anti-inflammatory	 and	antioxidant	 properties	 of	 strawberry	 tannins	 in	 in	 vitro	 models	 of	 gastric	 inflammation.	Tannin-enriched	extracts	(obtained	from	Fragaria	X	ananassa	and	Fragaria	vesca)	and	pure	compounds	were	assessed	using	two	gastric	cell	lines,	AGS	(tumor	gastric	epithelial	cells)	and	GES-1	(normal	gastric	epithelial	cells).	AGS	cell	 line	is	one	of	the	mostly	used	 in	vitro	models	to	study	the	effects	of	natural	products	at	gastric	level	and	to	study	the	interaction	between	gastric	epithelial	cells	and	H.	pylori,	while	GES-1	cell	line	is	less	used	and	allows	to	reproduce	an	experimental	model	closer	to	a	normal	gastric	epithelium. The	cells	were	stimulated	with	TNFa	(a	cytokine	strictly	involved	in	the	H.	pylori-induced	gastritis),	at	the	concentration	of	10	ng/mL,	or	with	H.	pylori. In	brief,	the	experiments	described	in	this	thesis	were	devoted	to:		
v Obtain	the	chemical	characterization	of	the	tannin-enriched	extracts	from	two	species	of	
Fragaria	(Fragaria	X	ananassa	Duch.	and	Fragaria	vesca	L.)	and	the	evaluation	of	their	antioxidant	 and	 anti-inflammatory	 activities.	 The	 attention	 was	 focused	 on	 several	biological	parameters	related	 to	gastric	 inflammation,	 such	as	 IL-8	release	and	NF-kB	signaling	pathway.	
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v Assess	the	impact	of	the	in	vitro	gastric	digestion	on	the	chemical	and	anti-inflammatory	properties	of	strawberry	tannins.	
v Dissect	the	molecular	mechanisms	underlying	the	effect	of	pure	tannins.	
v Compare	the	effects	of	strawberry	tannins	between	normal	and	tumor	gastric	epithelial	cells	(GES-1	and	AGS).	
v Evaluate	the	effect	of	the	strawberry	extract	in	a	co-culture	with	gastric	epithelial	cells	and	H.	pylori.	By	accomplishing	the	over	mentioned	objectives	it	is	conceivable	to	obtain	in	vitro	robust	evidence	of	the	potential	anti-gastritis	properties	of	strawberry	bioactive	components.	This	evidence	could	represent	a	preliminary	but	indispensable	basis	to	develop	food	supplements	or	adjuvants	for	the	treatment	of	gastritis	and,	potentially,	other	inflammatory	diseases	of	the	stomach.							
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3.1 CELL CULTURE 
 The	experiments	were	performed	using	two	different	gastric	epithelial	cell	lines,	AGS	(tumor	gastric	epithelial	cells)	and	GES-1	(normal	gastric	epithelial	cells).		
3.1.1 AGS cells 
 AGS	cells	(ATCC	American	Type	Culture	Collection)	are	polyploid	cells	derived	from	a	human	gastric	adenocarcinoma.	These	cells	were	obtained	from	a	tumour	resection	of	a	54-year-old	caucasian	woman.	Although	these	cells	show	chromosomal	abnormalities	compared	to	the	corresponding	normal	gastric	cells,	they	represent	a	well-established	in	vitro	model	to	study	the	inflammation	of	the	human	gastric	epithelium.	Human	adenocarcinoma	cells	were	grown	at	37°C	in	Modified	Eagle’s	Medium	F-12	(DMEM-F12,	Gibco,	Thermofisher	Scientific,	United	States)	supplemented	with	10%	heat-inactivated	foetal	calf	serum	(FCS)	(Euroclone	S.p.A,	Pero,	Italy)	(complete	medium),	100	units	penicillin/mL,	100	mg	streptomycin/mL,	2	mM	L-glutamine	 (Gibco,	 Thermofisher	 Scientific,	 United	 States),	 in	 a	 humidified	 atmosphere	containing	5%	CO2.		
3.1.2 GES-1 cells 
 GES-1	cells	derived	from	9-month	human	foetal	gastric	epithelium.	These	cells	were	infected	with	 the	 SV40	 virus	 (immortalized	 cells)	 and	 represent	 a	 cell	 culture	 of	 normal	 gastric	epithelium	(Ke	Y.	et	al.,	1994,	Li	S.	et	al.,	2016).	Gastric	epithelial	cells	were	grown	at	37°C	in	RPMI	1640	medium	(Gibco,	Thermofisher	Scientific,	United	States)	supplemented	with	10%	heat-inactivated	fetal	calf	serum	(FCS)	(Euroclone	S.p.A,	Pero,	Italy)	(complete	medium),	100	units	 penicillin/mL,	 100	 mg	 streptomycin/mL,	 2	 mM	 L-glutamine	 (Gibco,	 Thermofisher	Scientific,	United	States),	in	a	humidified	atmosphere	containing	5%	CO2.		
3.1.3 Maintenance of cell culture 
	Every	three	days	the	culture	medium	was	removed	from	the	75	cm2	flask	(Euroclone	S.p.A,	Pero,	Italy)	and	3	mL	of	0.105	mM	trypsin	with	0.25%	EDTA	(Sigma-Aldrich,	Milan,	Italy)	were	added	 in	order	 to	promote	 the	detachment	of	 the	cells	 from	the	support.	After	 few	minutes,	the	enzymatic	action	of	trypsin	was	inhibited	by	the	addition	of	5	mL	of	complete	medium.	Subsequently,	the	cells	were	rapidly	counted	under	a	microscope	using	a	Burker	chamber	to	calculate	the	volume	of	cell	suspension	needed	to	prepare	the	new	flask	and	the	new	plates/petri	for	the	next	experiments.		
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In	each	flask	were	seeded	1.5	×	106	cells	 in	a	total	volume	of	15	mL	of	complete	medium	(DMEM-F12	for	AGS	and	RPMI	1640	for	GES-1),	while	in	the	plates	and	petri	the	cells	were	distributed	as	follow:	
v in	order	to	evaluate	the	NF-kB	driven	transcription,	 IL-8	promoter	activity	(wild-type	and	mutated)	and	the	release	of	pro-inflammatory	mediators	(IL-8,	IL6	and	MMP9),	the	cells	were	seeded	in	24-well	plates	at	the	density	of	3	x	104	cells/well	in	a	total	volume	of	500	µL/well	of	DMEM-F12	(AGS)	or	RPMI	1640	(GES-1)	complete	medium.	
v in	order	to	evaluate	NF-kB	and	Nrf2	nuclear	translocation,	the	cells	were	seeded	in	100	mm	petri	at	the	density	of	1	x	106	cells/petri	in	a	total	volume	of	10	mL	of	DMEM-F12	(AGS)	or	RPMI	1640	(GES-1)	complete	medium.	Flask,	petri	and	plates	were	incubated	at	37°C	in	a	humidified	atmosphere	containing	5%	CO2	for	72	hours.		
3.2 BACTERIAL CULTURE 	
H.	pylori	strain	(ATCC	American	Type	Culture	Collection)	was	cultured	in	petri	containing	Mueller	Hinton	Broth	(BBLTM,	BD,	Franklin	Lakes,	U.S.A.)	medium	supplemented	with	agar	and	5%	sheep	blood	defibrinated	(LifeTechnologies,	Monza,	Italy).	The	bacteria	were	grown	for	72	hors	under	microaerophilic	conditions	(5%	O2,	10%	CO2,	and	85%	N2	at	37°C	with	100%	humidity).	Before	co-culture	experiments,	 the	bacterium	was	 recovered	 from	each	petri	and	 the	bacterial	 concentration	was	estimated	by	using	 the	value	of	optical	density	(O.D.	value	=	5	correspond	to	2*108	bacteria/mL).			
3.3 CELL TREATMENTS 
 AGS	and	GES-1	cells	were	co-treated	with	the	stimulus	TNFa	(10	ng/mL)	or	the	bacterium	
H.	pylori	(bacterium/cell	ratio	of	50:1)	and	Fragaria	extracts	(from	Fragaria	X	ananassa	or	
Fragaria	vesca)	or	single	compounds	(agrimoniin,	 casuarictin,	procyanidin	B1	and	ellagic	acid)	 at	 different	 concentrations.	 Treatments	were	 performed	 using	 serum-free	medium	(containing	 1%	 L-glutamine	 and	 1%	 penicillin/streptomycin)	 or	 using	 serum-free	 and	antibiotic-free	medium	(containing	1%	L-glutamine)	during	the	co-culture	with	the	H.	pylori.	The	same	percentage	of	solvent	(DMSO)	was	added	in	each	experimental	condition.	During	the	treatment,	cells	were	incubated	at	37°C	in	a	humidified	atmosphere	containing	5%	CO2.	The	 time	 of	 treatment	was	 established,	 for	 every	 parameter,	 on	 the	 basis	 of	 time	 course	experiments	in	which	the	cells	were	exposed	to	the	stimulus	TNFa	(10	ng/mL)	at	different	
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hours	 in	 order	 to	 identify	 the	 maximal	 induction	 of	 each	 parameter	 (IL-8	 release,	 IL-8	promoter	 activity,	NF-kB	driven	 transcription	 and	nuclear	 translocation).	Regarding	 IL-8	release,	IL-8	promoter	activity	and	NF-kB	driven	transcription,	the	cells	were	treated	with	TNFa	for	3,	6,	24	and	30	hours;	the	cytokine	TNFa	showed	the	maximal	induction	after	6-hours	treatment.	The	cells	were	stimulated	with	TNFa	for	1,	2,	3	and	6	hours	to	assess	the	NF-kB	nuclear	translocation;	the	maximal	effect	was	reached	after	1-hour	treatment.	Time-course	experiments	allowed	to	choose	the	best	times	to	investigate	the	effects	of	the	extracts	and	pure	compounds.	Concentrations	of	the	extracts	or	individual	compounds	were	selected	according	to	previous	results	 performed	 by	 our	 group	 on	 the	 same	 cell	 model	 with	 other	 natural	 sources	 of	ellagitannins	(Sangiovanni	E.	et	al.,	2012	PlosOne).	Of	note,	concentrations	in	the	micromolar	order	are	easily	reachable	 in	the	gastric	environment	following	consumption	of	a	portion	(5—75	g)	of	strawberry;	all	the	concentrations	used	in	the	experiments	did	not	show	any	cytotoxicity	in	the	MTT	assay	(described	below).		At	 the	 end	 of	 the	 treatment,	 medium	 or	 cells	 were	 collected	 in	 order	 to	 evaluate	 the	corresponding	parameters.	Epigallocatechin	 gallate	 20	 µM	 (EGCG)	 was	 used	 as	 reference	 compounds	 in	 our	experiments.		
3.4 PREPARATION OF FRAGARIA EXTRACTS AND ISOLATION OF 
PURE COMPOUNDS (AGRIMONIIN AND CASUARICTIN) 
 One	kilogram	of	woodland	strawberries	(Fragaria	vesca)	and	60	g	of	strawberries	(Fragaria	X	ananassa	D.	cv.	Darselect)	were	grown	in	an	experimental	field	in	Vigalzano	(Trento,	Italy).	All	 of	 the	 plants	 were	 grown	 under	 the	 same	 conditions	 to	 minimize	 the	 effect	 of	environmental	and	agronomic	factors.	Strawberries	were	harvested	at	maturity	and	were	frozen	at	−20°C	and	then	transported	to	the	laboratory	for	solvent	extraction.	The	extraction	of	 polyphenols	 was	 carried	 out	 with	 an	 acetone/water	 mixture	 (70:30	 v/v).	 Before	extraction,	 the	 fruit	 and	 extraction	 solution	 were	 cooled	 to	 4	 °C	 to	 limit	 enzymatic	 and	chemical	reactions.	Sixty	grams	of	fresh	fruit	was	homogenized	in	an	847-86	model	Osterizer	blender	at	speed	1,	in	2	×	100	mL	of	a	mixture	of	acetone/water	(70:30	v/v)	for	1	min	and	made	up	to	250	mL	with	the	same	solvent.		Aqueous	 acetone	 strawberry	 extracts	 (1	 kg	 of	 fruits	 extracted	 in	 4	 L	 of	 acetone/water	mixture	 (70:30	v/v))	were	 evaporated	until	 dryness	 in	 a	pear-shaped	 flask,	 using	 rotary	
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evaporation	 under	 reduced	 pressure	 at	 37°C.	 The	 sample	 was	 diluted	 to	 1	 L	 with	methanol/water	mixture	(30:70	v/v)	and	filtered	using	a	Durapore	0.45	μm	filter	(Millipore,	Vimodrone,	Italy).		Then,	the	extracts	were	subjected	to	chromatography	Sephadex	LH-20	in	order	to	remove	anthocyanosides.	A	column	cartridge	(10	×	4	cm)	was	packed	with	Sephadex	LH-20	resin,	connected	 to	 a	 vacuum	 line	 to	 speed	 elution,	 prewashed	 with	 50	 mL	 of	 methanol,	 and	equilibrated	with	100	mL	of	methanol/water	(30:70	v/v).	An	aliquot	of	50	mL	of	the	aqueous	methanol	 extracts	 was	 loaded,	 and	 anthocyanins	 were	 washed	 off	 with	 500	 mL	 of	methanol/water	(30:70	v/v).	The	yellowish	fraction	containing	the	ellagitannins	was	eluted	from	the	cartridge	using	350	mL	of	acetone/water	(70:30	v/v).	The	ellagitannin	fraction	was	dried	using	rotary	evaporation	under	reduced	pressure	at	37°C	and	reconstituted	in	50	mL	of	methanol	for	the	next	isolation	step.		Only	 the	 ellagitannin	 fraction	 from	 woodland	 strawberries	 was	 used	 to	 isolate	 single	compounds	(agrimoniin	and	casuarictin).	The	chromatographic	isolation	of	agrimoniin	and	casuarictin	was	performed	using	preparative	HPLC	with	a	250	×	50	mm,	10	μm,	Discovery	HS	C18	column	(Supelco,	Bellefonte,	PA,	USA),	After	separation,	these	compounds	were	dried	using	rotary	evaporation	under	reduced	pressure	and	then	dissolved	in	the	smallest	possible	volume	of	methanol,	diluted	with	diethyl	ether	and	hexane.	The	pure	isolated	compounds	(ca.	200	mg)	were	recovered	by	filtration	and	precipitation	from	n-hexane	as	an	amorphous	pale	rose	powder,	which	was	further	characterized	by	NMR	and	MS.	The	experiments	were	conducted	 in	 collaboration	with	 the	 research	 group	of	Dr.	 Fulvio	Mattivi	 (Department	of	Food	Quality	and	Nutrition,	Research	and	Innovation	Centre,	Fondazione	Edmund	Mach,	San	Michele	all’Adige,	Italy).		
3.5 QUANTIFICATION OF TANNIN-ENRICHED EXTRACTS AND IN 
VITRO DIGESTED EXTRACT 
	The	quantification	of	the	ellagitannins	and	the	other	polyphenols	were	performed	using	a	Waters	Aquity	 system	 coupled	with	 a	 triple	 quadrupole	 (TQ)	mass	 spectrometer	Waters	UHPLC	Xevo	TQ	(Millford,	Massachusetts,	USA).	In	addition,	proanthocyanidins	contained	in	tannin-enriched	extracts	and	 in	vitro	digested	extract	were	quantified	by	 the	vanillin-HCl	method	(or	vanillin	index).	Proanthocyanidins	were	expressed	as	equivalent	of	(+)-catechin.					
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3.6 CYTOTOXICITY ASSAY 
 The	integrity	of	the	morphology	before	and	after	treatment	was	assessed	by	light	microscope	inspection.	 The	 cytotoxicity	 of	 the	 Fragaria	 extracts	 and	 the	 single	 compounds	 was	evaluated	 by	 the	 3,4,5-dimethylthiazol-2-yl-2-5-diphenyltetrazolium	 bromide	 (MTT)	method	(Sigma-Aldrich,	Milan,	Italy)	(Denizot	F.	et	al.,	1986).	This	assay	is	able	to	evaluate	to	activity	of	the	mitochondrial	enzyme,	called	succinate	dehydrogenase.	The	activity	of	this	enzyme	is	an	index	of	the	viability	and	proliferation	of	the	cells.	This	test	 is	based	on	the	conversion	 of	 the	 MTT	 compound	 (yellow	 color)	 into	 violet	 formazan	 salt,	 through	 the	activity	 the	 mitochondrial	 enzyme	 succinate	 dehydrogenase.	 AGS	 and	 GES-1	 cells	 were	seeded	 in	 24-well	 plates	 (DB	 FalconTM)	 (30000	 cells/well),	 after	 48	 h	 the	 cells	were	 co-treated	with	the	stimulus	and	the	extracts/single	compounds.	At	the	end	of	the	treatment,	the	medium	was	removed	and	200	µL	of	MTT	solution	(0.1	mg/mL)	were	added	in	each	well,	for	45	minutes	at	37°C	and	in	dark	conditions.	Then,	MTT	solution	was	removed	from	each	well	 and	 the	 formazan	 was	 extracted	 from	 the	 cells	 using	 a	 mixture	 isopropanol:DMSO	(90:10).	Formazan	solution	was	transferred	in	to	a	96-well	plate	to	read	the	absorbance	at	550	nm	(VictorTM	X3,	Perkin	Elmer,	Walthman	MA,	USA).		The	results,	about	the	influence	of	the	extracts	or	single	molecules	(agrimoniin,	casuarictin,	procyanidin	B1	and	ellagic	acid)	and	the	stimulus	TNFa	(10	ng/mL)	on	cell	viability,	show	that	 the	 extracts	 and	 pure	 compounds	 are	 not	 cytotoxic	 on	 AGS	 and	 GES-1	 cells	 till	 the	maximal	concentration	tested.	The	concentrations	range	tested	are:	
v 0.05	–	10	µg/mL	for	Fragaria	X	ananassa	extract.	
v 0.1	–	2.5	µg/mL	for	Fragaria	vesca	extract.	
v 0.1	–	5	µM	for	agrimoniin.	
v 0.05	–	5	µM	for	casuarictin.	
v 0.1	–	50	µM	for	procyanidins	B1.	
v 0.05	–	5	µM	for	ellagic	acid.			In	H.	pylori-treated	AGS	and	GES-1	cells,	Fragaria	X	ananassa	extract	doesn’t	show	cytotoxic	effects	till	the	concentration	of	100	µg/mL.						
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3.7 PLASMIDS AMPLIFICATION 
 The	plasmids	amplification	was	carried	out	through	the	use	of	Escherichia	coli	bacteria	(E.	
coli),	 belonging	 to	 DH5α	 strain,	 transformed	 with	 the	 NF-κB-Luc	 or	 IL-8-Luc	 (native	 or	mutated)	plasmids.	The	plasmids	were	extracted	from	the	bacteria	using	a	commercial	kit	(Plasmid	DNA	Purification,	NucleoBond®	Xtra	Maxi,	Macherey-Nagel).	The	first	step	was	a	6	hours	pre-inoculation	phase	(at	37°C	under	stirring),	in	order	to	allow	to	the	transformed	bacteria	to	reach	an	exponential	growth	condition	at	the	time	of	the	inoculum.		The	bacteria	were	grown	in	LB	medium	(Luria-Bertani	Broth	culture	medium,	containing	1%	NaCl,	1%	Bacto	tryptone	and	0.5%	Bacto	yeast	extract)	with	the	addiction	of	ampicillin	(100	 ug/mL);	 the	 antibiotic	 contained	 in	 the	 culture	medium	 allowed	 the	 growth	 of	 the	transformed	bacteria	only,	since	the	plasmid	conferred	resistance	to	ampicillin.	At	the	end	of	the	pre-inoculation	phase,	the	growing	bacteria	were	transferred	in	250	mL	of	LB	 medium	 containing	 ampicillin	 (100	 ug/mL)	 and	 incubated	 overnight	 at	 37°C	 under	stirring.	The	next	day,	the	bacterial	culture	was	centrifuged	at	5000	rpm	for	10	min	in	order	to	 obtain	 a	 bacterial	 pellet,	 which	 was	 suspended	 in	 a	 lysis	 buffer	 (an	 alkaline	 solution	containing	sodium	hydroxide	and	SDS)	to	allow	the	lysis	of	the	bacterial	membrane	and	the	release	of	the	bacterial	content,	including	the	plasmids.		A	solution	composed	by	potassium	acetate	and	acetic	acid	to	buffer	 the	pH	was	added	to	block	the	lysis	allowing,	at	neutral	pH,	the	DNA	renaturation.	The	last	step	was	the	detachment	of	the	plasmids	from	the	filter	by	elution	with	sterile	water.	The	 plasmids	 were	 quantified	 by	 spectrophotometric	 reading	 (Nanodrop	 -	Spectrophotometer	ND-1000,	Euroclone).		
3.8 TRASIENT TRANSFECTION 
 
3.8.1 Calcium phosphate method 
 In	order	to	evaluate	NF-kB	driven	transcription	and	IL-8	promoter	activity,	AGS	cells	were	seeded	 in	24-well	plates	(DB	FalconTM)	(30000	cells/well).	After	48	hours,	 the	cells	were	transiently	transfected	by	the	calcium-phosphate	method	with	different	reporter	plasmids	(NF-kB-LUC,	50	ng/well;	IL-8-LUC,	native	or	mutated,	100	ng/well):	
v NF-kB-LUC,	a	reporter	plasmid	containing	luciferase	gene	under	control	of	a	promoter	characterized	by	the	presence	of	three	responsive	elements	-kB.	
v IL-8-LUC,	a	reporter	plasmid	containing	luciferase	gene	under	control	of	a	fragment	of	the	 native	 promoter	 of	 the	 human	 IL-8	 gene,	 which	 is	 characterized	 by	 different	
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responsive	 sequences	 for	 transcription	 factors	 such	 as	 activator	 protein-1	 (AP-1),	CCAAT-	enhancer-binding	protein-b	(C/EBPb),	and	NF-kB.		
v Mutated	 IL-8-LUC,	 the	 same	plasmid	 previously	 described	mutated	 in	 the	 responsive	sequence	for	NF-kB	transcription	factor.									The	transfection	mix	was	prepared	with	the	following	procedure:	650	µL	Hepes	buffer	saline	2X	 (Na2HPO4	 1.5	 mM,	 NaCl	 280	 mM,	 HEPES	 pH	 7.15,	 50	 mM)	 were	 mixed	 in	 constant	agitation	with	650	µL	of	a	solution	containing	calcium	chloride	(250	mM),	1300	ng	of	NF-kB-LUC	plasmid	or	2600	ng	IL-8-LUC	plasmid	(native	or	mutated)	and	sterile	water.	50	µL	of	this	transfection	mix	was	distributed	in	each	well	of	the	24-well	plates.	After	16	hours,	the	cells	were	treated	with	the	stimulus	and	the	extract/single	compound	for	6	 hours;	 at	 the	 of	 the	 treatment	 100	 µL	 of	 BritelitePlus	 reagent	 (PerkinElmer	 Inc.	Massachusetts,	USA),	a	 lysis	buffer	containing	D-luciferin,	were	added	 in	each	well	of	 the	plates.	The	luminescence,	produced	by	the	reaction	between	luciferase	and	D-luciferin,	was	read	with	VictorTM	X3	(Perkin	Elmer,	Walthman	MA,	USA).		
	 D-LUCIFERIN	+	ATP	+	O2																																					OXYLUCIFERIN	+	PPi	+	AMP	+	CO2	+	Light	
 
3.8.2 Lipofectamine method 
 In	 order	 to	 evaluate	 the	NF-kB	driven	 transcription,	 GES-1	 cells	were	 seeded	 in	 24-well	plates	 (30000	 cells/well).	 After	 48	 hours,	 the	 cells	 were	 transiently	 transfected	 by	 the	lipofectamine	method	with	NF-kB-LUC	(50	ng/well)	reporter	plasmid.	The	transfection	was	performed	 using	 Lipofectamine®	 3000	 (LifeTechnologies,	 Monza,	 Italy)	 in	 the	 ratio	 2	 μl	lipofectamine:	1	μg	DNA,	according	to	the	manufacturer’s	instructions.	After	16	hours,	cells	were	treated	with	the	stimulus	and	the	extracts/single	compounds	for	6h;	at	the	end	of	the	treatment,	luciferase	assay	was	performed	as	previously	described.				
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Fig. 3. In vitro simulated gastric digestion barely attenuates the biological activities of strawberry tannins.
Fig. 4. Agrimoniin inhibits IL-8  promoter activity and secretion in an NF-!B-dependent manner in TNF"-treated AGS cells.
trend applies to sanguiin H-6; on the other hand, ellagic acid is more
potent at inhibiting the promoter activity of the NF-!B reporter
(0.44 #M)  than IL-8  secretion (2.56 #M).  Casuarictin prevented IL-
8  secretion at the same concentratio s required to dampen p65
translocation and NF-!B driven transcription, indicating that this
ellagitannin affects IL-8  solely through inhibition of the NF-!B
pathway. It is worth noting that the two isomers agrimoniin and
sanguiin H-6 inhibited IL-8  secretion by TNF"-treated cells with
considerably different potencies (IC50s of agrimoniin and sanguiin
H6: 0.09  #M and 0.58  #M,  respectively).
Altogether, these results suggest that in our experimental set-
ting: i) casuarictin may  be a pure NF-!B inhibitor while agrimoniin
and sanguiin H-6 most likely inhibit IL-8  secretion also acting on
other biological targets; ii) the ellagic acid moiety contributes to the
biological activity of ellagitannins but other chemical and stereo-
chemical features impact their ability to interact with biological
targets; iii) the representative condensed tannin procyanidin B1,
prevents the TNF"-induced eff cts without interfering with the
NF-!B pathway.
4. Discussion
Population-based studies and research in preclinical models
provide substantial evidence to classify strawberries as a functional
food with preventive and therapeutic benefits versus common dis-
eases, most of which are characterized by chronic inflammation
[13]. The gastro-intestinal tract, especially the stomach, is the first
site of action of functional foods; therefore, the ability to atten-
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Figure	14.	Reporter	plasmids	containing	luciferase	gene	(NF-kB-LUC,	IL-8-LUC	and	mutated	IL-8-LUC)	
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3.9 NF-kB AND Nrf2 NUCLEAR TRANSLOCATION 
 
3.9.1 Nuclear and cytoplasmatic extraction 
 To	assess	the	effect	of	the	extracts	and	individual	compounds	on	the	NF-kB	(p65)	and	Nrf2	nuclear	translocation,	AGS	and	GES-1	cells	were	plated	at	the	density	of	1.5	×	106	cells/mL	in	100	mm	plates.		After	48	hours,	the	cells	were	treated	in	the	following	way:	
v 1	 hour	 treatment	 with	 the	 pro-inflammatory	 mediator	 (TNFa	 10	 ng/mL)	 and	 the	extracts/compounds	to	evaluate	NF-kB	(p65)	nuclear	translocation.	
v 1,	 2,	 3,	 6	 hours	 treatment	 with	 the	 single	 compounds	 to	 evaluate	 Nrf2	 nuclear	translocation.	Nuclear	 extracts	 were	 prepared	 using	 Nuclear	 Extraction	 Kit	 from	 Cayman	 Chemical	Company	 (Michigan,	 USA).	 The	 cells	 were	 detached	 from	 the	 support	 by	 enzymatic	treatment	 with	 trypsin,	 which	 was	 blocked	 after	 few	 minutes	 through	 the	 addition	 of	complete	 DMEM-F12	 medium.	 The	 cells	 were	 centrifuged	 for	 5	 minutes	 at	 300	 g	 and	subsequently	 suspended	 in	 PBS	 (Phosphate	 Buffered	 Saline)	 containing	 phosphatase	inhibitors.	After	performing	several	washing	steps	with	PBS,	the	cells	were	dissolved	in	a	hypotonic	buffer	in	order	to	increase	cell	swelling	and	the	fragility	of	the	cell	membranes.	The	addition	of	10%	Nonidet	P-40,	a	detergent,	produced	the	breakdown	of	cell	membranes	(maintaining	 the	 integrity	 of	 nuclear	 membranes),	 thus	 allowing	 the	 recovering	 of	 the	cytoplasmic	fraction	as	a	supernatant,	following	separation	of	the	cytoplasmic	fraction	from	nuclei	 through	 centrifugation	 (30	 seconds	 to	 14000	 g).	 The	 nuclei	 were	 lysed	 with	 an	extraction	 buffer	 containing	 a	 mixture	 of	 protease	 and	 phosphatase	 inhibitors;	 after	 a	centrifuge	(10	minutes	at	14,000	g),	the	supernatants	containing	the	nuclear	extracts	were	collected	in	0.5	mL	tubes	and	store	at	-80°C	until	assayed.		
3.9.2 Protein quantification 
 The	protein	concentration	of	the	nuclear	extracts	was	evaluated	by	the	Bradford	assay	(Bio-Rad	 Protein	 Assay).	 Bradford	 reagent	 (composed	 of	 Coomassie®	 Brilliant	 Blue	 G-250,	phosphoric	 acid	 and	methanol)	 was	 added	 in	 each	 sample	 and	 the	measurement	 of	 the	absorbance	was	performed	at	595	nm	using	a	spectrophotometer.			A	 standard	 curve,	 prepared	with	 bovine	 serum	albumin	 (BAS),	was	 used	 to	 quantify	 the	unknown	protein	content	of	the	nuclear	extracts.				
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3.9.3 ELISA assay 
 Nuclear	 extracts	 were	 used	 to	 evaluate	 the	 translocation	 of	 NF-kB	 (p65)	 and	 Nrf2	transcription	 factors	by	 a	ELISA	kit	 commercially	 available	 (Cayman	Chemical,	Michigan,	USA).	The	96-well	plate	used	for	this	assay	contained,	on	the	bottom	of	each	immobilized	well,	 double-strand	 DNA	 sequences	 characterized	 by	 the	 presence	 of	 NF-kB	 or	 Nrf2	responsive	elements,	respectively.	The	transcription	factor	(NF-kB	or	Nrf2),	contained	in	the	sample,	binds	specifically	these	sequences	and,	in	this	way,	it	can	be	detected	by	the	addition	of	 a	 specific	 primary	 antibody.	 The	 addition	 of	 a	 secondary	 antibody	 conjugated	 with	horseradish	 peroxidase	 (HRP),	 allows	 the	 development	 of	 a	 measurable	 colorimetric	reaction.	After	stopping	the	reaction	with	sulfuric	acid,	 the	absorbance	was	read	through	spectrophotometer	at	450	nm,	0.1s	(VictorTM	X3,	Perkin	Elmer,	Walthman	MA,	USA).		
3.10 IN VITRO GASTRIC DIGESTION OF FRAGARIA X ANANASSA 
EXTRACT 
 Gastric	 digestion	 was	 simulated	 using	 an	 in	 vitro	 approach	 (Oomen	 A.G.	 et	 al.	 2003;	Versantvoort	C.H.	et	al.,	2005).	Strawberry	extract	(200	mg)	was	mixed	with	2	mL	of	saliva	juice	solution	(pH	6.5	±	0.1;	12	mM	KCl,	2	mM	KSCN,	7.4	mM	NaH2PO4,	4	mM	Na2SO4,	5	mM	NaCl,	1.8	mM	NaOH,	3.3	mM	urea,	89	μM	uric	acid,	145	mg	L-1	amylase	and	50	mg	L-1	mucin)	and	incubated	for	5	min	under	constant	shaking	at	37°C.	After	this	first	step,	4	mL	of	gastric	juice	(pH	1.1	±	0.1;	47	mM	NaCl,	2.2	mM	NaH2PO4,	11	mM	KCl,	2.7	mM	CaCl2,	5.7	mM	NH4Cl,	8.3	mL	L-1	HCl,	3.6	mM	glucose,	0.1	mM	glucuronic	acid,	1.4	mM	urea,	1.5	mM	glucosamine	hydrochloride,	1	g	L-1	BSA,	1	g	L-1	pepsin	and	3	g	L-1	mucin)	were	added	and	incubated	for	2	h	at	37°C	in	constant	agitation.	Simulated	gastric	digested	extract	was	frozen,	lyophilized	and	store	at	-20°C	until	use.	The	digested	extract	was	tested	on	different	biological	activities	comparing	the	effect	to	non-treated	control	adjusted	with	a	mixture	of	saliva	and	gastric	juice.			
3.11 MEASUREMENT OF THE RELEASE OF PRO-INFLAMMATORY 
MEDIATORS  
 
3.11.1 IL-8 release 
	For	measurement	of	IL-8	secretion,	AGS	and	GES-1	cells	were	grown	in	24-well	plates	(DB	FalconTM)	 (30000	 cells/well)	 for	 48	 hours;	 then,	 cells	 were	 treated	 with	 the	 pro-
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inflammatory	stimulus	(TNFa	at	10	ng/ml)	and	the	extracts	or	single	compounds.	After	6	h	treatment,	the	medium	was	removed	and	stored	at	−20	C	until	the	assay.		IL-8	 was	 quantified	 by	 an	 enzyme-linked	 immunosorbent	 assay	 (ELISA)	 Kit	 (Peprotech,	London,	UK).	Corning	96-well	EIA/RIA	plates	(Sigma	Aldrich,	Milan,	Italy)	were	coated	with	the	antibody	provided	 in	 the	ELISA	Kit	 and	 incubated	overnight	 at	 room	 temperature	 to	allow	the	binding	between	the	antibody	and	the	bottom	of	the	wells.	After	blocking	phase,	the	samples	were	transferred	into	wells	at	room	temperature	for	2	hours.	The	IL-8	in	the	samples	was	detected	by	the	use	of	a	biotinylated	antibody	and	of	HRP-conjugated	avidin	(horseradish	 peroxidase).	 The	 colorimetric	 reaction	 between	 HRP	 enzyme	 and	 3,3′,5,5′-Tetramethylbenzidine	 (TMB)	 (Sigma	 Aldrich,	 Milan,	 Italy)	 was	 read	 using	 a	spectrophotometer	at	450	nm,	0.1s	(VictorTM	X3,	Perkin	Elmer,	Walthman	MA,	USA).	The	quantification	of	IL-8	was	performed	through	a	standard	curve	supplied	with	the	ELISA	Kit	(0	–	1000	pg/mL).	Data	were	expressed	considering	100%	the	absorbance	related	to	the	TNFa-induced	IL-8	release.		
3.11.2 IL-6 release 
	For	measurement	of	IL-6	secretion,	AGS	and	GES-1	cells	were	grown	in	24-well	plates	(DB	FalconTM)	 (30000	 cells/well)	 for	 48	 hours;	 then,	 cells	 were	 treated	 with	 the	 pro-inflammatory	stimulus	 (TNFa	 at	10	ng/ml)	and	 the	extract	or	single	compounds.	After	6	hours	treatment,	the	medium	was	removed	and	stored	at	−20	C	until	the	assay.		IL-6	 was	 quantified	 by	 an	 enzyme-linked	 immunosorbent	 assay	 (ELISA)	 Kit	 (Peprotech,	London,	UK).	Corning	96-well	EIA/RIA	plates	(Sigma	Aldrich,	Milan,	Italy)	were	coated	with	the	antibody	provided	 in	 the	ELISA	Kit	 and	 incubated	overnight	 at	 room	 temperature	 to	allow	the	binding	between	the	antibody	and	the	bottom	of	the	wells.	After	blocking	phase,	the	samples	were	transferred	into	wells	at	room	temperature	for	2	hours.	The	IL-6	in	the	samples	was	detected	by	the	use	of	a	biotinylated	antibody	and	of	HRP-conjugated	avidin	(horseradish	 peroxidase).	 The	 colorimetric	 reaction	 between	 HRP	 enzyme	 and	 3,3′,5,5′-Tetramethylbenzidine	 (TMB)	 (Sigma	 Aldrich,	 Milan,	 Italy)	 was	 read	 using	 a	spectrophotometer	at	450	nm	0.1s	 (VictorTM	X3,	Perkin	Elmer,	Walthman	MA,	USA).	The	quantification	of	IL-6	was	performed	through	a	standard	curve	supplied	with	the	ELISA	Kit	(0	–	1500	pg/mL).	Data	were	expressed	considering	100%	the	absorbance	related	to	the	TNFa-induced	IL-6	release.						
Materials and Methods 
 53 
3.11.3 MMP-9 release 
 For	measurement	of	MMP9	secretion,	AGS	and	GES-1	cells	were	grown	in	24-well	plates	(DB	FalconTM)	 (30000	 cells/well)	 for	 48	 hours;	 then,	 cells	 were	 treated	 with	 the	 pro-inflammatory	stimulus	(TNFa	at	10	ng/ml)	and	the	extract	or	single	compounds.	After	24	hours	treatment,	the	medium	was	removed	and	stored	at	−20	C	until	the	assay.	MMP-9	was	quantified	 by	 an	 enzyme-linked	 immunosorbent	 assay	 (ELISA)	 Kit	 (Raybiotech,	 Georgia,	USA).	The	samples	were	transferred	 in	the	96-well	plate	supplied	 in	the	Kit,	containing	a	specific	antibody	for	MMP-9,	and	incubated	for	2.5	hours	at	room	temperature	under	slight	stirring.	Following,	the	wells	were	washed,	and	a	biotinylated	antibody	was	added	for	1	hour	(at	 room	 temperature	 under	 slight	 stirring);	 after	 washing	 unbound	 antibody,	 HRP-conjugated	streptavidin	was	added	in	the	wells	for	45	minutes	(at	room	temperature	under	slight	stirring).	The	color	developed	through	the	reaction	with	TMB	substrate	was	read	using	a	spectrophotometer	at	450	nm	0.1s	(VictorTM	X3,	Perkin	Elmer,	Walthman	MA,	USA).	The	quantification	of	MMP-9	was	performed	through	a	standard	curve	supplied	with	the	ELISA	Kit	(0	–	6000	pg/mL).	Data	were	expressed	considering	100%	the	absorbance	related	to	the	TNFa-induced	MMP-9	release.		
3.12 ORAC ASSAY (OXYGEN RADICAL ABSORBANCE CAPACITY) 
 ORAC	assay	is	a	well-known	method	used	in	order	to	evaluate	the	antioxidant	capacity	of	extracts	and	molecules	derived	from	natural	products	(Ou	B.	et	al.,	2001;	Dávalos	A.	et	al.,	2004).	 The	 ORAC	 assay	 measures	 the	 ability	 of	 extracts/compounds	 under	 study	 to	counteract,	 in	the	time,	oxidation	of	a	 fluorescent	probe	(loss	of	 fluorescence)	by	peroxyl	radicals.	 In	 this	 context,	 fluorescein	 is	 used	 as	 fluorescence	 probe,	 while	 AAPH	 (2,2'-Azobis(2-amidinopropane)	 dihydrochloride)	 is	 commonly	used	 as	 free	 radical	 generator.	The	Fragaria	X	ananassa	extract	and	the	single	ellagitannins	were	mixed	with	fluorescein	and	 AAPH	 in	 96-well	 plate,	 the	 fluorescence	 (excitation	 wavelength:	 485	 nm;	 emission	wavelength:	535	nm)	was	read	for	60	minutes	with	an	interval	of	2	minutes	maintaining	the	plate	reader	to	37°C.	The	antioxidant	capacity	of	the	samples	correlates	to	the	fluorescence	decay	 curve,	 which	 is	 usually	 represented	 as	 the	 area	 under	 the	 curve	 (AUC).	 The	 AUC	derived	 from	each	 sample	was	used	 in	 order	 to	 calculate	 the	 antioxidant	 capacity	 of	 the	extract	or	single	compounds,	using	the	equation	obtained	from	the	standard	curve	of	 the	Trolox	 (Sigma	Aldrich,	Milan,	 Italy),	which	was	 considered	 as	 reference	 compound.	Data	were	expressed	as	µM	Trolox	equivalents.		
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3.13 GENE EXPRESSION 
 
3.13.1 RNA extraction 
 AGS	and	GES-1	cells	were	grown	in	24-well	plates	(DB	FalconTM)	(30000	cells/well)	for	48	hours;	then,	the	cells	were	treated	with	the	pro-inflammatory	stimulus	(TNFa	at	10	ng/ml)	and	the	pure	compounds	(agrimoniin	and	casuarictin).	After	6	hours	treatment,	the	medium	was	removed.	The	cells	were	lysed	through	the	addition	of	the	Qiazol	lysis	buffer	(QIAGEN	GmbH,	Germany)	according	 to	 the	 indications	provided	by	 the	manufacturer,	 in	order	 to	obtain	cell	lysis	and	inactivation	of	the	endogenous	RNases.	The	lysates	were	frozen	at	-80°C	until	the	following	RNA	purification	steps.	Total	RNA	was	isolated	from	the	cell	lysates	using	the	miRNeasy®	Mini	Kit	(QIAGEN	GmbH,	Germany),	according	 to	 the	manufacturer's	protocol.	A	set	of	RNase-free	DNase	(QIAGEN	GmbH,	Germany)	was	used	to	ensure	the	complete	elimination	of	genomic	DNA.	Total	RNA	was	eluted	in	35	μL	of	nuclease-free	water	and	stored	at	-80°C.	The	concentration	of	the	isolated	RNA	was	evaluated	by	spectrophotometry	(NanoDrop	ND-1000,	ThermoFisher	Scientific).	The	purity	of	the	samples	was	estimated	by	measuring	the	ratio	between	the	optical	densities	of	the	samples	at	260	nm	and	280	or	230:	
v Ratio	A260/A280	®	protein	contamination,	expected	value	1.8-2	
v Ratio	A260/A230	®	solvent	contamination,	expected	value	2-2.2		
3.13.2 cDNA synthesis 
 cDNA	was	synthetized,	after	elimination	of	any	residual	genomic	DNA,	using	the	RT2	First	Strand	kit	(QIAGEN,	GmbH,	Germany),	according	to	the	manufacturer's	indications.	400	ng	of	total	RNA,	of	each	sample,	were	used	to	produce	cDNA.			
3.13.3 qPCR 
	Quantitative	analysis	of	gene	expression	was	performed	using	a	384-well	PCR	array,	related	to	human	genes	involved	in	the	inflammatory	process	and	coding	for	chemokines,	cytokines,	receptors,	 TNFa	 family	members	 and	 other	 pro-inflammatory	mediators	 (RT2	 ProfilerTM	PCR	array:	PAHS-011ZE	Human	Inflammatory	Cytokines	and	Receptors,	QIAGEN	Sciences,	USA).		In	this	array,	each	well	contained	the	primers	for	a	specific	target	gene	(in	total	84	different	 target	 genes),	 or	 housekeeping	 gene	 for	 data	 normalization	 (5	 different	housekeeping	genes).	Moreover,	the	array	included	some	controls:	one	control	for	genomic	DNA	contamination,	three	controls	for	the	repeatability	of	the	reverse	transcription	reaction	and	three	controls	for	the	repeatability	of	the	PCR	reaction.	
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A	diluted	aliquot	of	cDNA,	equivalent	to	400	ng	total	RNA,	was	mixed	with	the	SYBR®	Green	Master	 Mix	 RT2	 reagent	 (QIAGEN	 Sciences,	 USA)	 according	 to	 the	 manufacturer's	instructions	and	loaded	into	the	384-well	array.	The	real-time	PCR	was	performed	using	the	CFX384TM	Real-Time	PCR	Detection	System	(coupled	to	C1000TM	Thermal	Cycler)	(Bio-Rad	Laboratories	Srl,	Segrate,	Italy),	heating	the	plate	at	95°C	for	10	min.,	followed	by	40	cycles	of	15	s	at	95°C	and	1	min.	at	60°C.	The	threshold	cycle	value	for	each	gene	(Ct)	was	automatically	provided	by	the	management	software	CFX	ManagerTM	(Bio-Rad),	depending	on	the	amplification	curves.	The	baseline	and	the	threshold	values	were	set	manually	as	recommended	by	the	PCR	array	manual.	The	analysis	of	the	data	was	performed	using	the	ΔΔCt	method	(Livak	&	Schmittgen,	2001),	through	 the	 web	 portal	 SABiosciences	 company	 (QIAGEN	 Sciences,	 USA)	(www.SABiosciences/pcrarraydataanalysis.php).	The	Ct	cut-off	was	set	to	35.	Data	 were	 normalized	 on	 the	 basis	 of	 housekeeping	 genes:	 hypoxanthine-guanine	phosphoribosyl	 transferase	 1	 (HPRT1),	 beta-2-microglobulin	 (B2M),	 ribosomal	 protein	lateral	 stalk	 subunit	 P0	 (RPLP0),	 beta-actin	 (ACTB)	 and	 glyceraldehyde-3-phosphate	dehydrogenase	 (GAPDH).	 In	 each	 experiment,	 the	 housekeeping	 genes	with	 a	 variability	higher	than	±1	threshold	cycle	among	the	different	experimental	conditions,	were	excluded	to	the	analysis.		
3.14 STATISTICAL ANALYSIS 
	All	 data	 were	 expressed	 as	 mean	 ±	 s.d.	 of	 at	 least	 four	 experiments.	 The	 number	 of	experiments	for	each	assay	is	specified	in	the	figure	legends;	data	were	analyzed	by	unpaired	one-way	analysis	of	variance	(ANOVA)	followed	by	Bonferroni	as	post-hoc	test.	Statistical	analyses	were	done	using	GraphPad	Prism	6.0	software	(GraphPad	Software	Inc.,	San	Diego,	CA,	 USA).	 p	 <	 0.05	 was	 considered	 statistically	 significant.	 IC50s	 were	 calculated	 using	GraphPad	Prism	6.00	software.		
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4.1 INHIBITORY ACTIVITY OF FRAGARIA EXTRACTS ON IL-8 
RELEASE AND NF-kB SIGNALING IN TNFa-TREATED AGS CELLS  
 IL-8	is	released	in	high	amount	by	gastric	epithelial	cells	during	H.	pylori	infection	and	NF-
kB	is	a	transcription	factor	involved	in	the	expression	of	several	pro-inflammatory	genes,	including	IL-8.	For	these	reasons,	the	first	part	of	the	work	was	aimed	to	study	the	effects	of	tannin-enriched	extracts	from	Fragaria	X	ananassa	and	Fragaria	vesca	on	IL-8	and	NF-kB	signaling.	 The	 activity	 of	Fragaria	X	ananassa	extract	was	 also	 assessed	 after	 an	 in	 vitro	gastric	digestion,	in	order	to	simulate	the	digestive	processes	occurring	in	humans.			
4.1.1 Inhibitory effect of Fragaria X ananassa extract on IL-8 and NF-kB 
pathway in TNFa-treated AGS cells  
 In	order	to	evaluate	the	effect	of	Fragaria	X	ananassa	extract	on	IL-8	secretion,	IL-8	promoter	activity,	NF-kB	driven	 transcription	 and	nuclear	 translocation,	AGS	 cells	were	 co-treated	with	 the	 stimulus	 TNFa	 (10	 ng/mL)	 and	 the	 extract	 at	 different	 concentrations	 (0.1	 –	 5	μg/mL).					
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
Figure	15	shows	that	tannin-enriched	extract	from	Fragaria	X	ananassa	is	able	to	inhibit	all	the	parameters	evaluated	in	a	concentration	dependent	manner,	with	IC50s	below	1	µg/mL.	
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Figure	15.	Effect	of	Fragaria	X	ananassa	extract	on	IL-8	release	(A),	IL-8	promoter	activity	(B),	NF-kB	nuclear	translocation	(C)	and	NF-kB	driven	transcription	(D)	in	TNFa-treated	AGS	cells.	Data	 are	 expressed	 in	 percentage,	 relative	 to	 the	 stimulated	 control,	 which	 is	 arbitrarily	assigned	to	the	value	of	100%.	**p	<	0.01,	***p	<	0.0001	versus	TNFa. 
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In	 detail,	 the	 IC50s	 on	 IL-8	 release	 and	 expression	 are	 0.25	 µg/mL	 and	 0.17	 µg/mL	respectively,	 while	 the	 IC50s	 on	 NF-kB	 nuclear	 translocation	 and	 transcription	 are	 0.30	
µg/mL	and	0.23	µg/mL	respectively.	To	evaluate	the	real	involvement	of	NF-kB	in	the	IL-8	expression,	an	IL-8	promoter	carrying	a	 mutation	 at	 the	 NF-kB	 binding	 site	 was	 used.	 It	 loses	 responsiveness	 to	 TNFa	 and,	consequently,	 to	 strawberry	 extract	 suggesting	 that	 inhibition	 of	 IL-8	 promoter	 activity	operates	through	impairment	of	NF-kB	signaling.		The	treatment	with	the	reference	compound	(20	μM	EGCG)	yielded	the	expected	inhibition	of	 the	 tested	 parameters:	 >70%	 inhibition	 of	 IL-8	 secretion,	 >80%	 inhibition	 of	 IL-8	promoter	activity,	>85%	inhibition	of	NF-kB	driven	 transcription	and	>90%	inhibition	of	p65	translocation.			
4.1.2 Inhibitory effect of Fragaria vesca extract on IL-8 and NF-kB pathway 
in TNFa-treated AGS cells  
 Tannin-enriched	 extract	 from	 Fragaria	 vesca	 species	 was	 tested	 on	 IL-8	 expression	 and	release	 and	 NF-kB	 signaling	 pathway	 (NF-kB	 driven	 transcription	 and	 nuclear	translocation).	AGS	cells	were	co-treated	with	the	stimulus	TNFa	(10	ng/mL)	and	the	extract	at	increasing	concentrations	(0.1	–	2.5	μg/mL).	 		
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Figure	16.	Effect	of	the	Fragaria	vesca	extract	on	IL-8	release	(A),	IL-8	promoter	activity	(B),	NF-kB	nuclear	translocation	(C)	and	NF-kB	driven	transcription	(D)	in	TNFa-treated	AGS	cells.		Data	 are	 expressed	 in	 percentage,	 relative	 to	 the	 stimulated	 control,	 which	 is	 arbitrarily	assigned	to	the	value	of	100%.	*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	TNFa. 
0
20
40
60
80
100
120
TNFα - + +++
F. vesca
(µg/mL)
- - 0.25 0.5 1 2.5
+ +
0.1
***
*** *** *** *** ***IL-8	pr
omoter
	activity
	
(%	vs.	
TNFα)
0
20
40
60
80
100
120
TNFα
***
**
*********
-
- -
+ ++ + ++
10.50.250.1 2.5F. vesca
(µg/mL)
IL-8	se
cretion
	
(%	vs.	
TNFα)
0
20
40
60
80
100
120
TNFα
******
*
-
- -
+ ++ +
1 2.50.5F. vesca
(µg/mL)
NF-κB	n
uclear	t
ransloca
tion	
(%	vs.	T
NFα)
0
20
40
60
80
100
120
140
TNFα
***
*** ***
-
-
+ ++ +++
- 10.1 0.50.25 2.5F. vesca
(µg/mL)
***NF-κB	d
riven	tr
anscrip
tion
(%	vs.	T
NFα)
Results 
 59 
The	graphs	in	Figure	16	demonstrate	that	Fragaria	vesca	extract	inhibits	all	the	parameters	tested	in	a	concentration	dependent	way.	The	wild	strawberry	extract	shows	the	following	IC50s:	0.29	µg/mL	on	IL-8	release,	0.27	µg/mL	on	IL-8	promoter	activity,	0.42	µg/mL	on	NF-
kB	driven	transcription	and	0.79	µg/mL	on	NF-kB	nuclear	translocation.	Although	 below	 1µg/mL,	 these	 IC50s	 are	 slightly	 higher	 compared	 to	 those	 obtained	 by	testing	Fragaria	X	ananassa	extract,	suggesting	that	the	extract	from	Fragaria	vesca	is	less	active	in	comparison	to	that	from	Fragaria	X	ananassa.	As	 mentioned	 above,	 EGCG	 was	 used	 as	 reference	 compound	 exerting	 the	 expected	inhibitory	activity	on	each	parameter.			
4.1.3 Inhibitory effect of Fragaria X ananassa extract, after in vitro gastric 
digestion, on IL-8 and NF-kB pathway in TNFa-treated AGS cells  
	To	 test	 the	 chemical	 stability	 and	 biological	 activity	 of	 strawberry	 tannins	 in	 the	 harsh	environment	of	the	human	stomach,	Fragaria	X	ananassa	extract	was	subjected	to	an	in	vitro	gastric	digestion,	as	described	in	the	Material	and	Method	section.	Then,	the	digested	extract	was	assessed	on	the	same	parameters	analyzed	with	undigested	extract.		AGS	cells	were	co-treated	with	the	stimulus	TNFa	(10	ng/mL)	and	the	extract	at	different	concentrations	(0.25	–	5	µg/mL).			
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Figure	17.	Effect	of	the	Fragaria	X	ananassa	extract,	after	in	vitro	gastric	digestion,	on	IL-8	release	 (A),	 IL-8	promoter	activity	 (B),	NF-kB	nuclear	 translocation	 (C)	 and	NF-kB	driven	transcription	(D)	in	TNFa-treated	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.		*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	TNFa. 
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The	activity	of	strawberry	extract,	subjected	to	simulated	gastric	digestion,	on	IL-8	release	is	unchanged,	the	IC50s	of	digested	and	undigested	extracts	are	similar,	0.25	and	0.31	µg/mL	respectively.	While	considering	 the	other	parameters,	a	 slight	 loss	of	activity	 is	observed	with	the	digested	extract.	The	IC50s	of	the	digested	extract	on	the	NF-kB	driven	transcription	and	 nuclear	 translocation	 are	 around	 5	 or	 6-fold	 higher	 than	 those	 calculated	 with	undigested	 extract.	 Moreover,	 the	 complete	 inhibition	 of	 TNFa-induced	 IL-8	 promoter	activity,	 NF-kB	 driven	 transcription	 and	 nuclear	 translocation	 is	 reached	 at	 higher	concentrations	with	respect	to	the	native	extract.		EGCG	was	used	as	 reference	compound	exerting	 the	expected	 inhibitory	activity	on	each	parameter.																									
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4.2 CHEMICAL COMPOSITION OF TANNIN-ENRICHED EXTRACTS 
FROM STRAWBERRIES 
	Chemical	characterization	of	strawberry	extracts	was	performed	in	collaboration	with	the	research	group	of	Dr.	Fulvio	Mattivi	(Department	of	Food	Quality	and	Nutrition,	Research	and	Innovation	Centre,	Fondazione	Edmund	Mach,	San	Michele	all’Adige,	Italy).	
	
	
	
	In	Table	1	the	chemical	characterization	of	the	tannin-enriched	strawberry	extracts	before	and	after	in	vitro	digestion	is	reported.	A	total	of	41	different	polyphenols	were	detected	in	both	undigested	extracts.	Agrimoniin	and	casuarictin	are	the	main	ellagitannins	occurring	in	strawberry	extracts,	while	the	second	most	abundant	class	of	polyphenols	is	procyanidins	(procyanidin	B1-B4).	About	40-50%	of	strawberry	extracts	are	composed	by	oligomeric	and	polymeric	proanthocyanidins.	Other	classes	of	polyphenols,	such	as	flavonones,	flavanones,	flavonols,	dihydrochalcones	are	present	 in	 lower	amounts.	Anthocyanins,	 instead,	are	not	present	 most	 likely	 because	 due	 to	 lower	 molecular	 weight	 they	 were	 removed	 during	chromatography	Sephadex	LH-20,	which	allows	to	obtain	extracts	enriched	in	tannins.	
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Table  1
Chemical composition of tannin-enriched extracts from strawberries.
Compound Tannins enriched extract in vitro digested extract
strawberry wild strawberry strawberry
!g/g !g/g !g/g
methyl gallate 0.5 0.1 2.0
fraxin 0.1 0.2 0.0
chlorogenic acid 1.6 2.2 2.7
trans-coutaric acid 0.2 0.1 0.4
trans-piceide 6.0 4.8 11.2
cis-piceide 28.6 1.0 15.1
phloretin 0.7 0.2 20.1
phlorizin 366.2 31.8 281.5
trilobatin 39.4 2.5 29.9
luteolin 64.8 118.4 45.3
luteolin-7-O-glucoside 8.8 1.3 5.8
naringenin 1.0 1.9 6.8
catechin 19223.4 17242.4 21486.1
epicatechin 346.0 653.0 317.1
procyanidin B1 15630.6 15553.1 21082.8
procyanidin B2 + B4 (as eq. Procyanidin B2) 1660.8 2510.5 667.4
procyanidin B3 (as eq. Procyanidin B1) 27270.7 18310.6 17710.4
kaempferol 112.7 12.5 77.1
quercetin 24.2 6.8 35.2
taxifolin 7.3 10673.2 5.1
kaempferol-3-glucoside 1164.9 494.6 1023.9
kaempferol-3-rutinoside 99.1 2.4 84.4
dihydrokaempferol 78.8 49.9 70.2
quercetin-3-glucuronide 1815.4 175.0 1824.9
kaempferol-3-glucuronide 1197.8 19.9 935.3
4-hydroxybenzoic acid 229.1 156.1 248.0
p-coumaric acid 11.1 0.2 14.3
gallic acid 2.1 6.8 28.0
caffeic acid 2.4 0.1 0.8
trans-ferulic acid 1.1 0.0 2.5
urolithin A 0.4 1.2 8.3
ellagic acid 1675.9 2378.5 1845.6
pyrocatechol 116.6 106.9 97.6
quercetin-3-glucoside + quercetin-3-galactoside (as eq. quercetin-3-glucoside) 148.7 798.3 116.9
isorhamnetin-3-glucoside 15.4 317.8 10.3
methyl ellagic acid rhamnoside 19.9 7697.2 13.5
agrimoniin 42903.8 52297.8 31563.8
casuarictin 46471.3 23169.2 42866.3
sanguiin H6 2241.0 2069.6 3078.3
Total polyphenols (MS/MS analysis) 162988.4 154868.1 145635.2
proanthocyanidins 485576.0 360983.2 349877.7
Total polyphenols (MS/MS analysis and proanthocyanidins) 648564.4 515851.3 495513.0
Fig. 1. Tannin-enriched extracts from strawberries and wild strawberries inhibit NF-"B signaling in TNF#-treated AGS cells.
Table	1.	Chemical	composition	of	tannin-enriched	extracts	from	strawberries. 
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Only	Fragaria	X	ananassa	 extract	was	subjected	 to	an	 in	vitro	 gastric	digestion	since	 this	species	is	more	active	than	Fragaria	vesca,	moreover	its	consumption	is	much	more	diffused	among	the	population.	The	 chemical	 analysis	 of	 the	material	 subject	 to	 simulated	 gastric	 digestion	 reveals	 that	among	ellagitannins,	agrimoniin	is	the	most	affected	(26%	loss	with	respect	to	8%	loss	of	casuarictin).	 Even	 the	 procyanidin	 fraction	 undergoes	 chemical	 modification,	 in	 fact	 the	content	of	procyanidin	B1	increases	by	26%	while	that	of	procyanidin	B3	decreases	by	35%.	This	 increase	 in	procyanidins	B1	 is	 probably	due	 to	 the	degradation	of	 other	 condensed	tannins.	Almost	negligible	degradation	of	ellagitannins	to	urolithins	is	observed	since	only	minor	 amounts	 of	 urolithin	 A	 (7.9	 µg/g)	 are	 formed,	 starting	 from	 about	 90	 mg/g	 of	agrimoniin	and	casuarictin.		The	 relative	 stability	 of	 casuarictin,	 agrimoniin	 and	 sanguiin	 H-6	 to	 hydrolysis	 can	 be	inferred	 also	 from	 the	 modest	 release	 of	 gallic	 acid	 and	 ellagic	 acid	 following	 in	 vitro	digestion	(25.9	µg/g	and	169.7	µg/g,	respectively).			
4.3 INHIBITORY ACTIVITY OF PURE TANNINS AND ELLAGIC ACID 
ON IL-8 RELEASE AND NF-kB SIGNALING IN TNFa-TREATED AGS 
CELLS 	Agrimoniin	and	casuarictin,	belonging	to	the	class	of	ellagitannins,	are	the	most	abundant	compounds	 occurring	 in	 both	 Fragaria	 extracts	 (as	 reported	 in	 Table	 1)	 and	 they	 are	present	at	comparable	concentrations.	Moreover,	they	are	chemically	stable	after	simulated	gastric	 digestion.	 On	 the	 basis	 of	 these	 findings,	 I	 examined	 the	 effects	 of	 these	 pure	compounds	on	the	NF-kB	signaling	and	IL-8	expression	and	release.	The	experiments	were	aimed	to	investigate	the	contribution	of	these	compounds	to	the	activity	observed	with	the	extracts	and	to	identify	the	underlying	molecular	mechanisms.		The	 strawberry	 extracts	 contain	 also	 significant	 amount	 of	 condensed	 tannins,	 such	 as	procyanidin	B1	and	B3.	Therefore,	the	biological	activity	of	procyanidin	B1	was	evaluated,	in	AGS	cells	stimulated	with	TNFa,	on	the	same	pro-inflammatory	parameters	previously	indicated.	This	compound	was	chosen	as	a	representative	member	of	condensed	tannins,	procyanidin	B3	was	not	tested	since	it	is	not	commercially	available.	In	the	extracts,	free	ellagic	acid	is	present	at	biologically	significant	concentrations,	1.7	and	2.4	mg/g	 of	 strawberry	 and	wild	 strawberry	 extract,	 respectively.	 Hence,	 I	 inferred	 that	ellagic	 acid	might	 contribute	 to	 the	 biological	 activities	 exhibited	 by	 the	 tannin-enriched	
Results 
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extracts	 shown	above.	Moreover,	 from	 the	 structure-activity	point	of	 view,	 the	moiety	of	ellagic	 acid	 is	 a	 common	 feature	 of	many	 ellagitannins	 found	 in	 strawberries	 and	 other	natural	sources.	For	these	reasons	I	decided	to	investigate	the	biological	activities	of	ellagic	acid	in	TNFa-treated	AGS	cells.			
4.3.1 Inhibitory effect of agrimoniin on IL-8 and NF-kB pathway in TNFa- 
treated AGS cells  
 Agrimonin	was	evaluated	on	IL-8	release,	IL-8	promoter	activity,	NF-kB	driven	transcription	and	nuclear	translocation	in	AGS	cells.	The	cells	were	co-treated	with	the	stimulus	TNFa	(10	ng/mL)	and	the	pure	molecule	at	different	concentrations	(0.1	–	2.5	μM).	 		
	
 
 	
	
		
 									The	pure	compound	was	able	to	inhibit	all	the	parameters	in	concentration	dependent	way	(Figure	18).	Inhibition	of	TNFa-induced	IL-8	secretion	by	agrimoniin	occurs	with	an	IC50	(0.09	µM)	much	lower	than	those	observed	in	the	analysis	of	the	other	parameters	(0.42	µM	on	IL-8	promoter	activity,	0.50	µM	on	NF-kB	driven	transcription	and	0.81	µM	on	NF-kB	nuclear	translocation).	These	results	suggested	that	agrimoniin	inhibits	IL-8	release	acting	on	NF-kB	pathway,	 as	 demonstrated	by	 the	 inhibitory	 effects	 observed	 on	NF-kB	driven	transcription	and	p65	translocation,	but	also	on	other	biological	targets.	EGCG	was	used	as	reference	compound	exerting	the	expected	inhibitory	activity	on	each	parameter.	 
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Figure	18.	Effect	of	agrimoniin	on	IL-8	release	(A),	IL-8	promoter	activity	(B),	NF-kB	nuclear	translocation	 (C)	 and	NF-kB	driven	 transcription	 (D)	 in	TNFa-treated	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.		**p	<	0.01,	***p	<	0.0001	versus	TNFa.	
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4.3.2 Inhibitory effect of casuarictin on IL-8 and NF-kB pathway in TNFa- 
treated AGS cells  
 Casuarictin	was	evaluated	on	IL-8	release,	promoter	activity,	NF-kB	driven	transcription	and	nuclear	 translocation	 in	AGS	cells.	The	cells	were	co-treated	with	 the	stimulus	TNFa	 (10	ng/mL)	and	the	pure	molecule	at	different	concentrations	(0.05	–	5	μM).	 				
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	Casuarictin	 is	 able	 to	 inhibit	 all	 the	 parameters	 in	 a	 concentration	 dependent	 manner	(Figure	 19).	 This	 pure	 ellagitannin	 reduces	 IL-8	 secretion	 (IC50:	 0.29	 µM)	 at	 the	 same	concentrations	 required	 to	 dampen	 p65	 translocation	 (IC50:	 0.33	 µM),	 NF-kB	 driven	transcription	 (IC50:	 0.29	 µM)	 and	 IL-8	 promoter	 activity	 (IC50:	 0.19	 µM).	 These	 results	indicate	that	casuarictin	affect	IL-8	release	acting	solely	as	a	pure	NF-kB	inhibitor.	EGCG	was	used	as	 reference	compound	exerting	 the	expected	 inhibitory	activity	on	each	parameter.	 			
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Figure	19.	Effect	of	casuarictin	on	IL-8	release	(A),	 IL-8	promoter	activity	(B),	NF-kB	nuclear	translocation	 (C)	 and	 NF-kB	 driven	 transcription	 (D)	 in	 TNFa-treated	 AGS	 cells.	 Data	 are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.		*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	TNFa.	
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4.3.3 Inhibitory effect of procyanidins B1 on IL-8 and NF-kB pathway in 
TNFa-treated AGS cells  
 Procyanidin	B1	was	 tested	on	 IL-8	release,	promoter	activity,	NF-kB	driven	transcription	and	nuclear	translocation	in	AGS	cells.	The	cells	were	co-treated	with	the	stimulus	TNFa	(10	ng/mL)	and	the	pure	molecule	at	different	concentrations	(0.1	–	50	μM).	 				
																As	 shown	 in	 Figure	 20,	 procyanidin	 B1	 reduces	 TNFa-induced	 IL-8	 secretion	 in	 non-concentration	dependent	manner,	exerting	a	statistically	significant	inhibition	around	44%	at	 the	 concentration	 of	 1	 µM,	 while	 no	 effect	 on	 p65	 translocation	 and	 NF-kB-driven	transcription	is	observed	at	concentration	as	high	as	50	µM.	These	effects	suggest	the	ability	of	this	representative	condensed	tannin	to	counteract	TNFa-induced	IL-8	release	without	interfering	with	the	NF-kB	pathway.	EGCG	was	used	as	 reference	compound	exerting	 the	expected	 inhibitory	activity	on	each	parameter.	 				
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Figure	20.	Effect	of	procyanidin	B1	on	 IL-8	 release	(A),	 IL-8	promoter	activity	 (B),	NF-kB	nuclear	translocation	(C)	and	NF-kB	driven	transcription	(D)	in	TNFa-treated	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.		**p	<	0.01,	***p	<	0.0001	versus	TNFa.	 
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4.3.4 Inhibitory effect of ellagic acid on IL-8 and NF-kB pathway in TNFa- 
treated AGS cells  
 Ellagic	acid	was	tested	on	IL-8	release,	promoter	activity,	NF-kB	driven	transcription	and	nuclear	 translocation	 in	AGS	cells.	The	cells	were	co-treated	with	 the	stimulus	TNFa	 (10	ng/mL)	and	the	pure	molecule	at	different	concentrations	(0.05	–	10	μM).	 										
	
						
	
		In	 Figure	 21	 it	 is	 shown	 that	 ellagic	 acid	 inhibits	 all	 the	 parameters	 in	 a	 concentration	dependent	manner,	the	IC50s	calculated	are:	IL-8	release	=	2.56	µM	IL8	promoter	activity	=	0.62	µM	NF-kB	nuclear	translocation	=	1.68	µM	NF-kB	driven	transcription	=	0.44	µM	These	 IC50	 values	 suggest	 that	 ellagic	 acid	 moiety	 contributed,	 at	 least	 in	 part,	 to	 the	biological	activity	of	ellagitannins	and	similarly	to	agrimoniin	and	casuarictin,	ellagic	acid	counteract	the	activation	of	IL-8	secretion	elicited	by	TNFa	in	an	NF-kB-dependent	manner.	
0
20
40
60
80
100
120
TNFα -
- -
+ ++ +
10.5 2.5Ellagic acid
(µM)
*** ***
++ ++
0.050.1 5 10
*****
IL-8	se
cretion (%	vs.	
TNFα)
0
20
40
60
80
100
120
TNFα
*********
***
***
- +
-
+ + + + +
Ellagic acid
(µM)
- 0.25 1 52.50.5
IL-8	pr
omoter
	activity
(%	vs.	
TNFα)
0
20
40
60
80
100
120
TNFα -
- -
+ ++ +
10.5 2.5Ellagic acid
(µM)
***
***
NF-κB	n
uclear	
translo
cation
(%	vs.	
TNFα) *
0
20
40
60
80
100
120
TNFα
*********
***
***
- +
-
+ + + + +
Ellagic acid
(µM)
- 0.1 0.5 2.510.25
+
5
***
NF-κB	
driven	
transcr
iption
(%	vs.	
TNFα)
A B 
C D 
Figure	21.	Effect	of	ellagic	acid	on	IL-8	release	(A),	IL-8	promoter	activity	(B),	NF-kB	nuclear	translocation	(C)	and	NF-kB	driven	transcription	(D)	in	TNFa-treated	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.		*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	TNFa. 
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However,	other	chemical	and	stereochemical	features	seem	to	impact	its	ability	to	interact	with	biological	targets.		EGCG	was	used	as	 reference	compound	exerting	 the	expected	 inhibitory	activity	on	each	parameter.			
4.4 SUMMARY OF IC50 VALUES 	
Biological	process	 NF-kB	signaling	pathway	 IL-8	expression	and	secretion	
Biological	assay	 p65	translocation	
NF-kB	driven	
transcription	
IL-8	promoter	
activity	
IL-8	secretion	
strawberry	 0.30	µg/ml	 0.23	µg/ml	 0.17	µg/ml	 0.25	µg/ml	wild	strawberry	 0.79	µg/ml	 0.42	µg/ml	 0.27	µg/ml	 0.29	µg/ml	strawberry	(digested)	 1.71	µg/ml	 1.07	µg/ml	 0.48	µg/ml	 0.31	µg/ml	Agrimoniin	 0.81	µM	 0.50	µM	 0.42	µM	 0.09	µM	Casuarictin	 0.33	µM	 0.29	µM	 0.19	µM	 0.29	µM	Ellagic	acid	 1.68	µM	 0.44	µM	 0.62	µM	 2.56	µM	Procyanidins	B1	 inactive	 inactive	 inactive	 44%	inhibition	at		1	µM	
Table	2.	IC50	of	tannin-enriched	extracts	and	strawberry	tannins	for	the	tested	biological	activities.	Results	are	the	mean	of	at	least	three	experiments	performed	in	triplicate.																			
Results 
 68 
4.5 CHARACTERIZATION OF GES-1 CELL LINE 
	Despite	AGS,	a	tumour	gastric	epithelial	cell	line,	is	a	well-established	in	vitro	model	and	one	of	 the	 mostly	 reported	 in	 literature	 to	 study	 the	 effects	 of	 natural	 products	 on	 gastric	inflammation,	 it	 appears	appropriate	 to	 investigate	 the	biological	 activities	of	 extracts	or	pure	 compounds	 derived	 from	plants,	 using	 an	 in	 vitro	model	 closer	 to	 a	 normal	 gastric	epithelium.		Indeed,	 GES-1	 cell	 line	 represents	 a	model	 of	 normal	 gastric	 epithelial	 cells	 (Ke	 Y.	 et	 al.,	1994).	It	has	been	used	in	less	works,	compared	to	AGS	cells,	reported	in	literature;	however,	this	cell	line	is	less	characterized	and	only	fragmented	information	about	the	release	of	pro-inflammatory	mediators	and	the	activation	of	transcription	factors	involved	in	the	gastric	inflammation	are	available.		For	these	reasons,	before	testing	the	Fragaria	extracts,	I	decided	to	investigate	the	ability	of	this	 cell	 line	 to	 respond	 to	 TNFa,	 evaluating:	 the	 release	 of	 several	 pro-inflammatory	mediators	(IL-8,	IL-6	and	MMP-9),	the	mRNA	levels	of	several	pro-inflammatory	genes	and	the	activation	of	NF-kB	pathway.	
	
4.5.1 TNFa-induced IL-8, IL-6 and MMP-9 release and NF-kB driven 
transcription in GES-1 and AGS cells 
 GES-1	and	AGS	cells	were	stimulated	with	TNFa	(10	ng/mL)	at	different	times,	in	order	to	evaluate	the	release	of	some	NF-kB-dependent	pro-inflammatory	mediators	(IL-8,	IL-6	and	MMP-9)	 exerting	 a	 key	 role	 in	 the	 gastric	 inflammation,	 and	 the	 activation	 of	 the	NF-kB	transcription	factor.		
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AGS GES-1 
Figure	22.	Effect	of	TNFα	on	the	release	of	IL-8	(green	bars),	IL-6	(red	bars)	and	MMP-9	(blue	bars)	and	on	the	activation	of	NF-κB	transcription	factor	(orange	bars)	in	GES-1	and	AGS	cells.	Data	are	expressed	in	pg/mL.	*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	TNFa. 
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As	shown	in	Figure	22,	NF-kB	driven	transcription	and	IL-8	release	are	induced	by	TNFa	in	both	cell	models.	Differences	are	observed	in	IL-6	and	MMP-9	release;	in	fact,	the	secretion	of	these	two	pro-inflammatory	mediators	is	increased	(in	time-dependent	manner),	by	the	stimulus	 TNFa,	 in	 GES-1	 cells	 only.	 Despite	NF-kB	 factor	 is	 involved	 in	 IL-6	 and	MMP-9	expression	and	it	is	activated,	by	TNFa,	in	our	cell	models,	this	pro-inflammatory	stimulus	is	not	able	to	induce	the	release	of	IL-6	and	MMP-9	in	AGS	cells.																														
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4.5.2 TNFa-induced pro-inflammatory genes in GES-1 and AGS cells 
 In	order	to	better	characterize	GES-1	cell	model,	the	expression	of	84	key	genes	mediating	the	inflammatory	response	was	evaluated	using	an	array	(Human	Inflammatory	Cytokines	and	Receptors	RT2	Profiler	PCR	Array)	commercially	available.		
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Figure	23.	Heat	map.	Effect	of	TNFa	on	the	expression	of	84	pro-inflammatory	genes	in	GES-1	and	AGS	cells.	The	cells	were	treated	with	TNFa	(10	ng/mL)	for	6	h.	Data	are	expressed	as	log2	(Fold	Change). 
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GES-1	and	AGS	cells	were	treated	with	TNFa	(10	ng/mL)	for	6	hours	in	order	to	evaluate	the	expression	 of	 84	 pro-inflammatory	 genes,	 coding	 mostly	 for	 chemokines,	 cytokines,	receptors	and	TNF	superfamily	members,	 in	 the	 two	cell	models.	The	results	 reported	 in	
Figure	23	show	that	TNFa	up-regulates	several	chemokines	in	both	GES-1	and	AGS	cells,	for	example	IL-8	(CXCL8)	and	CCL20	are	up-regulated	in	both	cell	lines	while	CCL2	only	in	GES-1	cells.	Among	TNF	superfamily	members,	TNF	(TNFa)	and	LTB	(TNFC)	are	highly	expressed	in	both	cell	models.	IL-6	and	MMP-9	expression	 is	 induced,	by	TNFa,	 in	GES-1	cells	but	not	 in	AGS	cells:	 IL-6	expression	is	unchanged	compared	to	the	basal	level,	while	MMP-9	is	not	expressed	in	this	cell	model,	 reflecting	what	previously	observed	on	the	release	of	 these	pro-inflammatory	mediators.	These	data	show	that	the	ability	of	GES-1	and	AGS	cells	to	respond	to	TNFa	 is	characterized	by	differences	in	the	expression	of	some	pro-inflammatory	genes,	some	genes	are	upregulated	in	both	cell	models,	while	others	in	GES-1	or	AGS	cells;	GES-1	cells	could	be	an	interesting	model	to	study	the	activity	of	natural	extracts	on	the	major	mediators	involved	in	the	gastric	inflammation.	The	heat	map	shows	the	mean	of	three	experiment,	data	are	expressed	as	log2	(Fold	Change).	Fold	Change	are	calculated	as	TNFa	vs.	CTRL.	The	Ct	cut-off	is	set	to	35.																		
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4.6 INHIBITORY ACTIVITY OF STRAWBERRY TANNINS ON NF-kB 
PATHWAY AND THE RELEASE OF PRO-INFLAMMATORY 
MEDIATORS IN GES-1 CELLS 
	
Fragaria	 X	 ananassa	 extract	 and	 pure	 ellagitannins	 were	 tested	 on	 NF-kB	 driven	transcription	and	on	the	release	of	some	NF-kB-dependent	pro-inflammatory	mediators	(IL-8,	IL-6	and	MMP-9)	in	GES-1	cells.	Since	NF-kB	driven	transcription	and	IL-8	release	were	induced,	 by	 TNFa,	 in	 both	 GES-1	 and	 AGS	 cells,	 the	 activity	 of	 the	 extract	 and	 single	compounds,	on	these	parameters,	was	compared	in	the	two	cell	models	in	order	to	verify	if	the	effect	observed	in	tumor	gastric	epithelial	cells	was	maintained	also	in	normal	gastric	epithelial	cells.		
4.6.1 Fragaria X ananassa extract inhibit NF-kB driven transcription and 
the release of IL-8, IL-6 and MMP-9 in GES-1 cells 
 
 
 
 
 				 						In	 order	 to	 investigate	 the	 effects	 of	 tannin-enriched	 extract	 from	 Fragaria	 X	 ananassa	species,	on	 the	parameters	previously	 indicated,	 tumor	and	normal	gastric	cells	were	co-treated	with	the	stimulus	TNFa	(10	ng/mL)	and	the	extract	at	different	concentrations	(0.1	–	10	µg/mL).	As	 demonstrated	 in	 Figure	 24,	 strawberry	 extract	 is	 able	 to	 inhibit	 NF-kB	 driven	transcription	(IC50:	2.15	µg/mL),	IL-8	release	(IC50:	2.23	µg/mL)	and	IL-6	release	(IC50:	0.92	
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Figure	24.	Effect	of	Fragaria	X	ananassa	extract	on	NF-kB	driven	transcription	(A),	IL-8	release	(B),	IL-6	release	(C)	and	MMP-9	release	(D)	in	TNFa-treated	GES-1	and	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.	*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	TNFa. 
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µg/mL)	in	concentration	dependent	manner	in	GES-1	cells,	while	a	mild	activity	is	observed	on	MMP-9	release	(IC50	>	5	µg/mL).	The	extract	appears	more	active	in	AGS	cells,	in	fact	the	IC50s	obtained	in	AGS	cells	on	NF-kB	driven	transcription	and	IL-8	release	(0.93	µg/mL	and	1.15	µg/mL,	respectively)	are	lower	than	those	calculated,	on	the	same	parameters,	in	GES-1	cells	(2.15	µg/mL	and	2.23	µg/mL,	respectively).	EGCG	20	µM	was	used	as	 reference	 compound:	>70%	 inhibition	of	 IL-8	 secretion,	 >50%	inhibition	of	IL-6	release,	>80%	inhibition	of	MMP-9	release	and	>50%	inhibition	of	NF-kB	driven	transcription.			
4.6.2 Pure ellagitannins inhibit NF-kB driven transcription and the release 
of IL-8, IL-6 and MMP-9 in GES-1 cells 
 In	order	to	investigate	the	effects	of	agrimoniin	and	casuarictin,	the	cells	were	co-treated	with	the	stimulus	TNFa	(10	ng/mL)	and	the	extract	at	different	concentrations	(0.1	–	5	µM).	
 
 														The	 two	 compounds	 are	 able	 to	 reduce,	 in	 GES-1	 cells,	 each	 parameter	 in	 concentration	dependent	manner,	showing	the	following	IC50s:	NF-kB	driven	transcription	®	0.39	µM	(agrimoniin),	0.49	µM	(casuarictin)	IL-8	release	®	0.50	µM	(agrimoniin),	0.51	µM	(casuarictin)	IL-6	release	®	0.28	µM	(agrimoniin),	0.28	µM	(casuarictin)	 	MMP-9	release	®	0.60	µM	(agrimoniin),	0.41	µM	(casuarictin)	
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Figure	25.	Effect	of	agrimoniin	 (blue	bars)	and	 casuarictin	(green	bars)	on	NF-kB	driven	 transcription	(A),	 IL-8	release	(B),	 IL-6	release	(C)	and	MMP-9	release	(D)	 in	TNFa-treated	GES-1	and	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.	*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	TNFa. 
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These	values	suggest	that	the	two	ellagitannins,	in	GES-1	cells,	affect	each	pro-inflammatory	parameter	 with	 very	 similar	 IC50s.	 Similarly	 to	 strawberry	 extract,	 as	 described	 in	 the	previous	paragraph,	the	two	ellagitannins	appear	more	active	in	AGS	cells	compared	to	GES-1	cells;	this	is	confirmed	comparing	the	IC50	values:		
 GES-1 cells AGS cells 
NF-kB driven transcription 0.39	µM	(agrimoniin)		0.49	µM	(casuarictin)	 0.33	µM	(agrimoniin)		0.16	µM	(casuarictin)	
IL-8 release 0.50	µM	(agrimoniin)		0.51	µM	(agrimoniin)	 0.21	µM	(agrimoniin)		0.21	µM	(casuarictin)			EGCG	20	µM	was	used	as	 reference	 compound:	>70%	 inhibition	of	 IL-8	 secretion,	 >50%	inhibition	of	IL-6	release,	>80%	inhibition	of	MMP-9	release	and	>50%	inhibition	of	NF-kB	driven	transcription.																							
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4.7 AGRIMONIIN AND CASUARICTIN INHIBIT THE EXPRESSION OF 
SOME PRO-INFLAMMATORY GENES IN GES-1 AND AGS CELLS 
 
          			
	GES-1	and	AGS	cells	were	treated	with	TNFa	(10	ng/mL)	and	agrimoniin	or	casuarictin	(1	
µM)	for	6	hours.	The	effect	of	these	compounds	on	the	expression	of	84	pro-inflammatory	genes	was	evaluated	using	a	real-time	PCR,	as	reported	in	Materials	and	Methods	section.	In	both	cell	lines,	agrimoniin	and	casuarictin	are	able	to	decrease	the	mRNA	levels	of	most	up-
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Figure	26.	Heat	map.	Effect	of	agrimoniin	and	casuarictin	on	TNFa-induced	gene	expression	of	84	pro-inflammatory	genes	in	GES-1	and	AGS	cells.	The	cells	were	treated	with	TNFa	(10	ng/mL)	and	agrimoniin	and	casuarictin	for	6	h.	Data	are	expressed	as	log2	(Fold	Change). 
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regulated	genes.	The	two	molecules	appear	more	active	in	AGS	cells	compared	to	GES-1	cells;	for	example,	on	IL-8,	TNF	and	LTB	genes,	agrimoniin	and	casuarictin	clearly	show	a	higher	ability	to	reduce	the	mRNA	levels	of	these	genes	in	AGS	cells	than	in	GES-1	cells.			The	heat	map	shows	the	mean	of	three	experiment,	data	are	expressed	as	log2	(Fold	Change).	Fold	Change	are	calculated	as	MOLECULE	vs.	TNFa.	The	Ct	cut-off	is	set	to	35.		
4.8 INHIBITORY ACTIVITY OF FRAGARIA X ANANASSA EXTRACT 
ON H. PYLORI-INDUCED IL-8 RELEASE  	GES-1	and	AGS	cells	were	treated	with	H.	pylori	(ratio	H.	pylori:cells	50:1)	and	Fragaria	X	
ananassa	extract	at	increasing	concentrations	(10	–	100	µg/mL).	After	6	hours	treatment	the	culture	medium	was	collected	in	order	to	measure	the	amount	of	IL-8.	H.	pylori	was	used	to	reproduce	an	experimental	setting	closer	to	the	pathological	condition.													As	shown	in	Figure	27,	Fragaria	X	ananassa	extract	is	able	to	reduce	IL-8	release	in	both	cell	lines.	The	IC50	of	the	extract	in	AGS	cells	is	lower	than	in	GES-1	cells	(30.8	and	40.0	µg/mL,	respectively),	thus	confirming,	as	observed	in	the	previous	results,	that	the	extract	is	more	active	 in	AGS	model.	At	 the	highest	 concentration	 tested	 (100	µg/mL)	 the	 release	of	 the	chemokine	is	reported	at	the	basal	level.	This	is	a	preliminary	data,	it	needs	to	be	confirmed	with	other	experiments.	EGCG	50	µM	was	used	as	 reference	 compound,	 showing	around	50%	of	inhibition.				
Figure	27.	Effect	of	Fragaria	X	ananassa	extract	on	H.	pylori-induced	IL-8	release	in	GES-1	and	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	stimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.	 
GES-1 AGS 
0
20
40
60
80
100
120
140
IL-8	rel
ease
(%	vs.	H
.	p
ylo
ri)	
H. pylori
F. ananassa
extract
(µg/mL)
- + + + + +
- - 10 25 50 100
***
***
0
20
40
60
80
100
120
IL-8	rel
ease
(%	vs.	H
.	p
ylo
ri)	
H. pylori
F. ananassa
extract
(µg/mL)
- + + + + +
- - 10 25 50 100
***
***
***
***
Results 
 77 
4.9 ANTIOXIDANT ACTIVITIES OF STRAWBERRY TANNINS 	Oxidative	 stress	 is	 increased	 in	 the	gastric	mucosa	 infected	with	 the	bacterium	H.	pylori,	enhancing	the	risk	of	damage	to	the	gastric	mucosa.	Since	gastric	epithelial	cells	contribute	to	ROS	production,	the	antioxidant	capacity	of	the	strawberry	extract	and	pure	ellagitannins	was	 assessed.	 Moreover,	 I	 tested	 the	 effect	 of	 the	 single	 ellagitannins	 on	 Nrf2	 nuclear	translocation,	this	transcription	factor	is	activated	in	presence	of	stress	oxidative	conditions,	regulating	the	expression	of	cytoprotective	genes	(including	NQO1	and	GSTs).	
 
4.9.1 Antioxidant capacity of the strawberry extract and pure ellagitannins 
 The	 antioxidant	 capacity	 of	 the	 extract	 and	 pure	 ellagitannins	 was	 measured	 by	 ORAC	method,	 as	 described	 in	 Materials	 and	 Methods.	 This	 method	 measures	 the	 oxidative	degradation	of	fluorescein,	after	the	addition	of	the	free	radical	generator	AAPH	in	a	cell-free	system,	 leading	 to	 a	 decrease	 in	 fluorescence,	 prevented	 by	 the	 presence	 of	 antioxidant	compounds.	 This	 method	 allows	 to	 evaluate	 the	 scaveging	 activity	 of	 extracts	 and	 pure	compounds	against	peroxyl	radicals	in	a	cell-free	system.												
Fragaria	X	ananassa	extract	was	tested	in	the	concentration	range	0.25	-	1	µg/mL,	while	the	two	ellagitannins	 in	the	concentration	range	0.05	–	1	µM.	Figure	28	shows	that	Fragaria	extract	 (A)	 and	 single	 compounds	 (B)	 are	 able	 to	 counteract	 peroxyl	 radicals	 (acting	 as	scavengers)	in	a	concentration	dependent	manner.		
4.9.2 Agrimoniin and Casuarictin inhibit Nrf2 nuclear translocation in GES-
1 and AGS cells 
 Nrf2	is	a	transcription	factor	able	to	respond	to	oxidative	stress,	regulating	the	expression	of	cytoprotective	genes,	including	antioxidant	endogenous	enzymes.	Since	oxidative	stress	is	increased	during	H.	pylori	infection,	agrimoniin	and	casuarictin	were	evaluated	for	their	
Figure	28.	Antioxidant	capacity	of	the	strawberry	extract	(A)	and	pure	ellagitannins	(B)	measure	by	ORAC	method.	Data	are	expressed	as	μM	Trolox	equivalents. 
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contribution	 to	promote	Nrf2	nuclear	 translocation	and,	 consequently,	 its	 transcriptional	activity.	
																			Since	it	has	been	observed	that	TNFa	is	not	able	to	induce	Nrf2	nuclear	translocation	in	GES-1	and	AGS	cells,	I	tested	the	activity	of	agrimoniin	and	casuarictin,	on	this	parameter,	in	basal	conditions.	The	two	ellagitannin	(5	µM)	were	tested	at	different	times	(1,	2,	3	and	6	hours)	in	GES-1	and	AGS	 cells.	 These	molecules	 reduce	 the	 basal	 levels	 of	 Nrf2	 nuclear	 translocation	 in	 time	dependent	manner,	both	in	GES-1	and	AGS	cells.	In	GES-1,	agrimoniin	exerts	a	statistically	significant	inhibition	after	1-hour	treatment,	while	casuarictin	after	3	hours	treatment.	In	AGS	cells,	agrimoniin	exerts	a	statistically	significant	inhibition	after	1-hour	treatment,	while	casuarictin	after	2	hours	treatment.	These	results	suggest	that	the	two	ellagitannins	are	not	able	to	induce	the	expression	of	the	genes	regulated	by	Nrf2.			
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Figure	29.	Effect	of	agrimoniin	(A,	C)	and	casuarictin	(B,	D)	on	Nrf2	nuclear	translocation	in	GES-1	and	AGS	cells.	Data	are	expressed	in	percentage,	relative	to	the	unstimulated	control,	which	is	arbitrarily	assigned	to	the	value	of	100%.	*p	<	0.05,	**p	<	0.01,	***p	<	0.0001	versus	CTRL. 
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Gastritis	is	an	inflammatory-based	disease	involving	millions	of	people	in	the	world,	acute	gastritis	 is	 caused	 by	 several	 risk	 factors,	 such	 as	 stress,	 use	 of	 anti-inflammatory	 drugs	(NSAIDs),	alcohol	abuse	and	bile	reflux,	while	the	chronic	form	is	mostly	due	to	Helicobacter	
pylori	 infection.	 H.	 pylori	 is	 a	 non-invasive	 pathogenic	 bacterium	 able	 to	 induce	 an	inflammatory	 response	 through	 the	 contact	 with	 the	 surface	 of	 gastric	 epithelial	 cells	(Harada	A.	et	al.,	1996);	it	is	one	of	the	most	successful	human	bacterial	parasites	which	can	persist	lifelong	if	not	treated	efficiently	(Graham	D.Y.	et	al.,	2010).	It	colonizes	more	than	half	of	 the	 human	 population	 (Parsonnet	 J.,	 1995).	 Despite	 some	 infected	 people	 are	asymptomatic,	with	moderate	 inflammation	detectable	 only	 by	 biopsy	 and	histology,	 the	most	common	consequence	of	H.	pylori	infection	is	chronic	gastritis;	chronic	infection	may	lead	to	the	development	of	severe	gastric	pathologies,	including	gastric	ulcers	(10-15%	of	cases),	gastric	adenocarcinoma	and	gastric	lymphoma	(1-2%	of	cases)	(Parsonnet	J.	et	al.,	1991;	Moss	S.	et	al.,	1992), This	bacterium	has	been	classified	as	a	Type	1	carcinogen	by	World	Health	Organization.	During	H.	pylori	infection,	gastric	epithelial	cells	release	several	pro-inflammatory	cytokines,	which	play	a	key	role	in	development	of	gastric	diseases.		This	 response	 is	highly	dependent	on	 the	activation	of	NF-κB	 in	gastric	epithelial	 cells,	 a	transcription	 factor	 involved	 in	 gastric	 inflammatory	 processes.	 Several	 studies	demonstrated	 that	H.	 pylori	 infection	 induces	macrophages	 to	 release	 pro-inflammatory	cytokines,	such	as	TNFα,	which	in	turn	bring	the	activation	of	NF-κB	in	gastric	epithelial	cells.		Once	activated	by	pro-inflammatory	stimuli,	 including	TNFα,	NF-κB	translocates	from	the	cytoplasm	into	the	nucleus	where	it	promotes	the	expression	of	numerous	genes	involved	in	inflammation,	including	IL-8	(Yasumoto	K.	et	al.,	1992;	Keates	S.,	1997).		Currently,	there	are	different	therapeutic	approaches	for	H.	pylori	eradication	based	on	the	administration	 of	 proton	 pump	 inhibitors	 in	 association	 with	 antibiotics;	 although	antimicrobial	 therapy	 appears	 the	 best	 way	 to	 eliminate	 the	 bacterium	 and	 related	inflammation,	 it	 is	 characterized	 by	 some	 factors	 leading	 to	 therapy	 failure,	 including	bacterial	and	host-related	factors,	resistance	to	the	antibiotics	and	side	effects	(Graham	D.Y.	et	al.,	2010).	The	 search	 for	 new	 strategies	 able	 to	 interfere	 with	 these	mechanisms	 by	 preventing	 a	prolonged	inflammation	could	bring	benefit	to	a	large	number	of	subjects.	In	this	respect,	botanicals	are	widely	consumed	all	over	the	world	for	health	purposes,	as	different	types	of	products,	including	herbal	products.	An	emerging	research	provides	substantial	evidence	to	classify	 strawberries	 as	 a	 functional	 food	with	 several	preventive	 and	 therapeutic	health	benefits	(Basu	A.	et	al.,	2014;	Afrin	S.	et	al.,	2016).			
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Strawberry	is	one	of	the	most	commonly	consumed	fruits	in	the	world	and	it	is	an	important	source	 of	 sugars,	 vitamins,	 fibers,	 micronutrients	 and	 polyphenols,	 including	anthocyanosides	 (pelargonidin	 and	 cyanidin	 glycosides)	 and	 tannins,	 in	 particular	condensed	tannins	(procyanidins)	and	hydrolysable	tannins	(especially	ellagitannins,	such	as	 agrimoniin)	 (Buendia	 B.	 et	 al.,	 2010;	 Gasperotti	 M.	 et	 al.,	 2013).	 Recently,	 our	 group	demonstrated	that	ellagitannin-enriched	extracts	 from	fruits	of	raspberry	and	blackberry	inhibit	ethanol-induced	gastritis	in	rats	acting	on	the	NF-kB	pathway;	the	anti-inflammatory	effect	was	ascribed,	at	 least	 in	part,	 to	the	presence	of	 the	ellagitannins	sanguiin	H-6	and	lambertianin	C.	(Sangiovanni	E.	et	al.,	2013).	Regarding	strawberry,	it	has	been	shown	the	ability	 of	 the	 extract	 to	 inhibit	 ethanol-induced	 gastritis	 in	 rats	 and	 this	was	 ascribed	 to	anthocyanosides	 (Alvarez-Suarez	 J.M.	 et	 al.,	 2011).	 Although	 tannins	 are	 important	components	 of	 strawberries,	 until	 now	 the	 activity	 of	 these	 strawberry	 compounds,	 on	gastric	inflammation,	is	unknown.	An	interesting	point	is	that	these	compounds	are	not	absorbed	and	metabolized	in	the	acid	environment	of	 the	stomach,	suggesting	that	their	activity	 is	exerted	 in	situ	 (Bioavaibility	and	metabolism	of	ellagic	acid	and	ellagitannins,	in	Chemestry	and	Biology	of	Ellagitannins,	Quideau	Editor,	2009;	Rios	L.Y.	et	al.,	2002).		The	results	obtained	in	this	study,	in	AGS	cell	model	of	gastric	inflammation,	clearly	show	that	tannins	from	Fragaria	X	ananassa	and	Fragaria	vesca	significantly	attenuate	the	release	of	IL-8,	a	key	mediator	in	gastric	diseases,	at	concentrations	lower	than	1	µg/ml.	Considering	the	 average	 volume	 of	 gastric	 content	 in	 adult	 individuals	 during	 a	 meal	 (0.6	 L),	 this	concentration	 can	 be	 easily	 achieved	 upon	 consumption	 of	 a	 regular	 serving	 of	 fresh	strawberries	(100	g).	Coherently	with	their	chemical	composition,	tannin-enriched	extracts	from	both	Fragaria	species	inhibit	IL-8	secretion	by	TNFa-treated	cells	in	a	similar	fashion.	Moreover,	 the	 biological	 activities	 of	 strawberry	 tannins	 are	maintained	 upon	 simulated	digestion,	consistently	with	the	slight	changes	in	the	chemical	profile.		This	 study	 demonstrates	 that	 the	 anti-inflammatory	 activity	 of	 strawberry	 tannins	 is	strongly,	 although	 not	 exclusively,	 related	 to	 inhibition	 of	 the	 NF-κB	 pathway,	 a	 central	player	 in	 inflammatory	diseases,	 including	gastritis.	AP-1	 complex	was	unaffected	by	 the	inflammatory	 stimulus	 TNFa	 and	 by	 strawberry	 tannins	 in	 AGS	 cells,	 however,	 the	involvement	and	modulation	of	other	pathways	cannot	be	excluded.	On	 the	 basis	 of	 the	 characterization	 of	 the	 extracts,	 I	 selected	 the	major	 components	 of	strawberry	tannins	to	dissect	their	contribution	to	the	anti-inflammatory	activities	observed	with	 the	 extracts.	 Investigation	was	 focused	 on	 agrimoniin	 and	 casuarictin,	 as	 the	main	
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ellagitannins	 found	 in	 these	 berries,	 ellagic	 acid,	 as	 a	 common	 chemical	 determinant	 of	ellagitannins,	and	procyanidin	B1,	as	representative	of	condensed	tannins.		The	results	indicate	that	agrimoniin	dampen	IL-8	secretion	by	inhibiting	the	NF-κB	pathway	and	by	acting	on	other	targets,	except	AP-1.	Findings	are	consistent	with	previous	reports	on	the	anti-inflammatory	and	immunomodulatory	use	of	plants	containing	agrimoniin,	such	as	Potentilla	 spp.	 (Bazylko	A.	 et	 al.,	 2013),	 and	Agrimonia	 spp.	 (Miyamoto	K.	 et	 al.,	 1988;	Murayama	 T.	 et	 al.,	 1992),	 and	 the	 ability	 of	 pure	 agrimoniin	 to	 prevent	 LPS-induced	secretion	of	IL-8	by	human	neutrophils	(Granica	S.	et	al.,	2015).	Casuarictin	exhibits	anti-inflammatory	 properties	 with	 high	 selectivity	 for	 the	 NF-κB	 pathway,	 at	 least	 in	 TNFa-treated	AGS	cells.	This	observation	was	not	previously	reported	in	the	literature.		Ellagic	 acid	 inhibits	 the	 NF-κB	 pathway	 and	 IL-	 8	 secretion	 in	 epithelial	 gastric	 cells	 at	concentrations	as	low	as	1–2	µM	that	could	be	easily	reached	upon	moderate	consumption	of	strawberries.	Being	the	ellagic	acid	moiety	present	in	all	ellagitannins,	it	 is	conceivable	that	 it	 may	 contribute	 to	 the	 biological	 activities	 of	 these	 compounds.	 Since	 condensed	tannins	are	abundant	in	the	extract,	they	could	contribute	to	the	anti-inflammatory	activity.	Procyanidin	 B1	was	 selected	 as	 representative	 condensed	 tannin	 and	 evaluated	 on	 IL-8	release	and	NF-κB	pathway.	This	molecule	is	active	only	on	IL-8	secretion	and	inactive	on	the	other	parameters	tested,	suggesting	that	this	condensed	tannin	attenuated	IL-8	secretion	without	affecting	the	NF-κB	pathway	in	AGS	cells	subject	to	TNFa	treatment.		This	first	part	of	the	project	demonstrates	that	strawberry	tannins,	either	as	enriched	extract	or	as	pure	compounds,	are	quite	stable	after	simulated	gastric	digestion	and	they	were	able	to	exert	anti-inflammatory	effects	on	gastric	epithelial	cells	by	inhibiting	the	inflammatory	response	to	TNFa	through	NF-κB-dependent	and	independent	mechanisms.		AGS	cell	line,	a	tumour	gastric	epithelial	cells,	is	a	well-established	in	vitro	model	and	one	of	the	mostly	 used	 in	 literature	 in	 order	 to	 study	 the	 effects	 of	 natural	 products	 on	 gastric	inflammation;	thus,	it	appears	interesting	to	investigate	the	biological	activities	of	extracts	or	pure	compounds	derived	from	plants,	using	an	in	vitro	model	closer	to	a	normal	gastric	epithelium.	GES-1	cell	line	represents	a	model	of	normal	gastric	epithelial	cells.	It	is	used	in	some	works	reported	in	literature,	however	this	cell	line	is	not	well-characterized	and	only	few	 information,	 about	 the	 release	 of	 pro-inflammatory	mediators	 and	 the	 activation	 of	transcription	factors	involved	in	the	gastric	inflammation,	are	available.	Before	testing	the	strawberry	extract	and	pure	tannins,	I	deeply	investigated	and	compared	the	 ability	 of	 GES-1	 and	AGS	 cells	 to	 respond	 to	 TNFa	 stimulus,	 in	 terms	 of	 release	 and	expression	of	some	pro-inflammatory	mediators.	Differences	were	observed	between	the	
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two	cell	lines,	for	example	IL-6	and	MMP-9	expression	and	release	were	induced,	by	TNFa,	in	GES-1	cells	but	not	in	AGS	cells.	However,	NF-kB	activity	was	induced	in	both	cell	lines,	suggesting	that	TNFa	is	not	able	to	activate,	in	AGS	cells,	other	transcription	factors	involved	in	the	expression	of	these	two	pro-inflammatory	mediators.	According	to	what	reported	in	literature,	pro-inflammatory	mediators	like	IL-8,	IL-6,	MMP-9,	TNFa,	IL-1b,	CSF-2,	CCL2,	CCL20	and	LTb,	produced	by	gastric	epithelium,	possess	a	key	role	in	gastric	inflammation	(Tanahashi	T.	et	al.,	2000;	Jung	H.C.	et	al.,	1997;	Shimada	T.	et	al.,	 1998;	 Caruso	 R.	 et	 al.,	 2007;	 Yoshida	 A.	 et	 al.,	 2009;	 Mejías-Luque	 R.	 et	 al.,	 2016);	moreover,	 their	 expression	 is	 NF-κB-dependent	 (Hiscott	 J.	 et	 al.,	 1993;	 Shimizu	H.	 et	 al.,	1990;	Matsusaka	T.	et	al.,	1993;	Mori	N.	et	al.,	2003;	Shakhov	A.N.	et	al.,	1990;	Ueda	A.	et	al.,	1994;	Kuprash	D.V.	et	al.,	1996;	Schreck	R.	et	al.,	1990;	Zhao	L.	et	al.,	2014).	These	mediators	are	 involved	 in	 different	 processes,	 like	 recruitment	 of	 immune	 cells,	 degradation	 of	extracellular	matrix	components	and	activation	of	different	pathways	(including	canonical	and	 non-canonical	 NF-κB	 pathway).	 Fragaria	 X	 ananassa	 extract	 and	 pure	 ellagitannins	exert	anti-inflammatory	activities	 in	normal	gastric	epithelial	cells	 (GES-1),	 inhibiting	 the	release	of	IL-8,	IL-6	and	MMP-9,	the	expression	of	the	genes	previously	mentioned	and	NF-κB	 activity.	 Although	 around	 1-2	 µg/ml	 for	 Fragaria	 extract	 and	 below	 1	 µM	 for	 pure	ellagitannins,	 the	 IC50s	 obtained	 in	 GES-1	 cells	 were	 slightly	 higher	 compared	 to	 those	calculated	in	AGS	cells.		The	 activity	 of	 strawberry	 tannins	 was	 also	 maintained	 in	 normal	 and	 tumor	 gastric	epithelial	cells	after	infection	with	the	bacterium	H.	pylori,	however	the	IC50s	were	higher	compared	to	those	obtained	using	TNFa	as	stimulus	(30.8	µg/mL	in	AGS	and	40.0	µg/mL	in	GES-1)	but	again	reachable	after	consumption	of	strawberry.	The	presence	of	H.	pylori	results	also	in	reactive	oxygen	species	(ROS)	and	reactive	nitrogen	species	 (RNS)	 production	 by	 the	 gastric	 mucosa,	 there	 are	 many	 cell	 types	 that	 can	contribute	to	the	production	of	ROS/RNS,	including	the	epithelial	cells	(Naito	Y.	et	al.,	2002).		ROS	has	a	role	in	the	activation	of	NF-κB	pathway	and	if	produced	in	excess	they	can	damage	gastric	mucosal	cells	and	cause	the	peroxidation	of	membrane	lipids,	thereby	increasing	the	level	of	lipid	peroxide	(LPO)	in	damaged	tissues	(Suzuki	M.	et	al.,	1994).	Nuclear	factor-E2-related	factor	2	(Nrf2)	is	a	transcription	factor	which	control	cellular	redox	homeostasis	and	protect	cells	from	oxidative	stress	(Itoh	K.	et	al.,	1997;	Kensler	T.W.	et	al.,	2007).	In	response	to	oxidant	stimuli,	Nrf2	proteasomal	degradation	 induced	by	Keap1	 is	suppressed,	which	results	firstly	in	an	increased	nuclear	accumulation	of	Nrf2	and	secondly	in	a	transcriptional	induction	of	cytoprotective	genes	(Kobayashi	A.	et	al.,	2006).	
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Agrimoniin	 and	 casuarictin,	 unexpectedly,	 reduce	 the	 basal	 levels	 of	 Nrf2	 nuclear	translocation	 in	 GES-1	 and	 AGS	 cells,	 suggesting	 a	 reduced	 production	 of	 antioxidant	enzymes.	This	effect	could	be	explained	with	the	ability	of	these	compounds	to	counteract	the	basal	reactive	oxygen	species	of	the	cells	acting	as	radical	scavengers,	in	this	way	the	cell	can	decrease	its	basal	antioxidant	defenses.	However,	our	interpretation	of	these	results	is	just	speculative	and	needs	further	investigations.	Moreover,	Nrf2	inhibition	in	tumor	gastric	epithelial	 cells	 could	 increase	 the	 effects	 of	 anticancer	 drugs;	 in	 fact,	 it	 has	 been	demonstrated	in	literature	that	Nrf2	is	stably	overexpressed	in	cancer	cells	where	enhances	cell	 proliferation	 (Singh	 A.	 et	 al.,	 2008;	 Chian	 S.	 et	 al.,	 2014).	 Overexpression	 of	 Nrf2-regulated	detoxifying	enzymes	contributes	to	advantages	on	cancer	cells	for	resistance	to	cytotoxicity	of	anticancer	drugs	(Ohnuma	T.	et	al.,	2011;	Singh	A.	et	al.,	2008).	In	conclusion,	this	study	demonstrates	that	strawberry	tannins,	either	as	enriched	extract	or	as	pure	compounds,	act	on	gastric	epithelial	cells	by	inhibiting	the	inflammatory	response	to	TNFa,	 with	 concentrations	 easily	 reachable	 in	 vivo.	 They	 were	 quite	 stable	 in	 the	 acid	environment,	 suggesting	 that	 their	 activity	 could	 be	 maintained	 also	 in	 vivo.	 While	procyanidins	are	widely	present	in	natural	sources	and	their	biological	activities	have	been	well	documented,	ellagitannins	can	be	found	in	some	foods	only	and	represent	an	emerging	class	of	phytochemicals.	Agrimoniin	and	casuarictin,	at	the	moment,	are	not	commercially	available.	According	to	available	data,	agrimoniin	and	casuarictin	could	be	considered	the	most	consumed	ellagitannins	in	the	world	because	of	the	large	presence	of	strawberries	in	the	 human	 diet	 (Vrhovsek	 U.	 et	 al.,	 2012).	 The	 anti-inflammatory	 action	 of	 strawberry	tannins	at	the	stomach	level,	if	supported	to	further	investigation	in	a	co-culture	epithelial	gastric	 cells/bacterium,	 coupled	 with	 the	 previously	 reported	 anti-H.	 pylori	 activity	(Funatogawa	 K	 et	 al.,	 2004),	 makes	 these	 compounds	 exploitable	 as	 preventive	 or	 co-adjuvant	agents	in	gastric	diseases.	This	work	 shows	 the	anti-inflammatory	activity	of	 strawberry	 tannins	and	 their	 stability	during	simulated	gastric	digestion;	however,	the	experimental	setting,	characterized	by	the	use	of	two	gastric	epithelial	cell	models,	is	not	able	to	reproduce	all	the	processes	that	take	place	 during	 gastric	 digestion	 in	 humans.	 For	 example,	 the	mucus	 layer	 produced	 in	 the	stomach	 by	 specific	 cells	 could	 be	 a	 factor	 affecting	 the	 activity	 of	 the	molecules	 under	investigation	in	this	study.	For	these	reason,	clinical	studies	are	needed	in	order	to	confirm	the	 activity	 of	 these	 compounds.	 Despite	 the	 bacterium	H.	 pylori	 is	 able	 to	 colonize	 the	stomach	of	humans,	 inducing	a	strong	inflammation,	 there	are	evidences	 in	the	 literature	
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reporting	 lower	 virulence	 in	 rodents	 than	 in	 humans,	 thus	 limiting	 the	 usage	 of	 animal	models	to	study	the	effect	of	these	extracts/compounds.	
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